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Abstract
As society is aging, the frequency of age-related diseases is increasing. An area of age-related
diseases that requires special attention is that of ocular diseases as they eventually cause blind-
ness and therefore have a huge impact on the quality of life of the patient. Understanding the
underlying cause of the disease and being able to treat it effectively is thus becoming increasingly
important. To evaluate the effectiveness of a treatment, the behaviour of the medication in the
body needs to be known or estimated. Monitoring the diffusion of medication is commonly re-
ferred to as pharmacokinetics, and the pharmacokinetics of ophthalmic medication are currently
assessed by sacrificing animal eyes at given points in time after the application of the drug. This
procedure does not allow for a high enough temporal resolution and incorporates a number of
disadvantages such as the fact that the eyes are non-human and that the behaviour of the drug has
to be extrapolated from the data obtained from different eyes. An instrument that can measure the
pharmacokinetics of ophthalmic medication in a non-invasive manner will therefore increase the
knowledge about the behaviour of the compound of interest considerably.
This thesis presents a novel ocular fluorophotometer which can measure the diffusion of inherently
ophthalmic drugs with high temporal and axial resolution (0.6 s and 124µm, respectively) and a
sensitivity of 2 nM in terms of Fluorescein concentration. The design process of the instrument and
its performance in terms of resolution and noise are discussed. Thorough consideration of the eye
safety of the instrument is presented. The instrument is calibrated for both a fluorescence standard
(Fluorescein sodium salt) and an ophthalmic drug for treating open angle glaucoma (Brimonidine)
and it is shown that the concentration of a sample with high signal to noise ratio can be accurately
recovered with an error below 20%. It is however found that for samples with less good signal
to noise ratios the accuracy decreases significantly. The repeatability of the measurements is also
assessed and found to be slightly worse than the accuracy with an error of below 23% within
one week. The calibration in in vitro porcine eyes is also discussed and suggestions made for its
improvement. Further measurements of diffusing fluorescent compounds are then presented and
discussed. It is found that the diffusion can be monitored with high temporal resolution and that
the concentration after complete diffusion is measured correctly. Finally, measurements of in vivo
eyes of human volunteers are presented and discussed. The instrument is shown to be of a similar
standard to a commercially available instrument, and it is believed that the instrument presented
here has the potential to become the new gold standard ocular fluorophotometer.
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Chapter 1
Introduction
"Oculus animi index", the eyes are a mirror of the soul, an old Latin proverb says. What is meant
is that the eyes and face reflect our inner thoughts, but this proverb can also be translated into
a modern medical context. Our eyes are refined optical instruments which we use to assess our
surroundings and find our way in the world. They can, however, also be used by researchers and
ophthalmologists to observe and quantify processes that are going on in our bodies. The aqueous
humour, which fills the anterior chamber of the eye and is thus the first compound that is observed
when looking into the eye, is derived from the body’s blood supply and thus frequently contains
metabolites and medication also found elsewhere in the body. Therefore, the eye can be a window
to the compounds present both in the eye and in the bloodstream - a window to the well-being of
the body.
The society we live in today is without a doubt an aging one, leading to an increase in frequency of
age-related diseases. One of the areas that requires special attention is that of ocular diseases, since
ocular diseases such as glaucoma and age-related macular degeneration have a huge impact on
the quality of life. They eventually cause blindness, thus restricting the freedom and independent
living capabilities of the patient. Therefore, understanding the causes of these diseases and having
2
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the ability to treat them effectively is becoming increasingly important.
To be able to evaluate the effectiveness and efficiency of a drug and design an appropriate treat-
ment for a patient, the behaviour of the medication in the body needs to be known or at least esti-
mated. The temporal distribution of the concentration of the drug throughout the body thus has
to be evaluated and understood before treatment. The monitoring of the processes a medication
undergoes in a body is classified as pharmacokinetics, or in other words as "what the body does
to the drug" [1]. Pharmacokinetics is the mathematical basis for assessing the processes that the
drug undergoes after administration and the time course over which these processes take place.
The processes a drug undergoes in the body are absorption, distribution, metabolism and excre-
tion, generally shortened as ADME, and knowledge of these processes and the rates at which they
occur can be used to define the drug concentration within the region of interest.
Currently, pharmacokinetic modelling is used to define the processes of ADME and thus estimate
the concentration at the region of interest. The behaviour of the drug in the body is however de-
pendent on many factors such as the general health of the patient and the combination with other
medical compounds present in the blood, so that the estimation of the actual pharmacokinetics in
a patient relies on drug and metabolite concentrations measured in plasma, blood or urine sam-
ples at specific time points after administration [2][3]. For ocular pharmacokinetics, the relevant
tissues cannot be sampled in humans and the evaluation of opthalmic drugs before they are re-
leased onto the market therefore has to be performed using animal models [4]. The radioactively
labelled compound is administered and the animals are sacrificed and dissected at different time
points throughout the trial to measure the concentration of the drug at the point of interest.
Although the drug diffusion through cornea, sclera and other tissues in the eye has been thor-
oughly studied [5][6], not much is known about the diffusion and distribution of ophthalmic drugs
in the aqueous humour which makes topical treatment at the point of interest very difficult. As
described above, the pharmacokinetics of opthalmic drugs are currently evaluated using test ani-
mals, but this, apart from being a complicated surgical procedure, is a high cost and material factor
since many eyes have to be sacrificed to get a better understanding of the temporal diffusion be-
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haviour of the drug. Furthermore, the eyes that these tests are performed on are generally healthy
and also not human which makes it hard to predict the behaviour of the drug in the real world
application. Most importantly though, this does not enable the researcher to get a clear picture of
the actual diffusion properties of the drug or its behaviour in different eyes since there are com-
paratively big time gaps between the sacrifice of eyes and the number of eyes that can be used is
limited.
Therefore, a system that can monitor the diffusion of ophthalmic medication non-invasively over
long periods of time in near real time will increase the knowledge about the specific behaviour
of the compound of interest considerably and thus enable researchers to design medications for a
more effective and efficient treatment.
This dissertation presents an instrument which aims to solve this problem. The instrument, here-
after also referred to as the F410, is capable of monitoring the diffusion of inherently fluorescent
ophthalmic drugs with a quantum yield as low as 0.43%1 continuously over any given time span
with a temporal resolution of 0.6s and an axial resolution of 124µm. A data point is recorded every
20µm throughout the depth of the anterior chamber to the back of the lens. Since this particular
prototype was designed to be able to measure the pharmacokinetics of Alphagan-P (Brimonidine),
an α2 adrenergic agonist used for treating open-angle glaucoma produced by Allergan Inc. which
has an absorption maximum in the UV wavelength region, the wavelength used for exciting the
fluorescence in the anterior chamber of the eye is 402 nm. The excitation source can however easily
be changed to adapt the instrument for other applications.
The instrument operates in a physically non-invasive manner since the medication is purely mea-
sured using light and thus reduces the number of animal eyes that have to be sacrificed to zero.
It furthermore enables the researcher to monitor the diffusion of the medication in several eyes at
once. Several other instruments have been developed which would be suitable for tracking flu-
orescent drugs in the anterior chamber of the eye, the accepted gold standard instrument being
the Fluorotron MasterTM (Coherent Radiation Inc., California, USA), but although they have been
1As measured following the guide published by Jovin-Horiba [7]
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used to measure auto-fluorescence and fluorescent dyes in the anterior chamber of the eye, as far
as the author is aware none of them have been used to actively track the position and concentra-
tion of fluorescing ophthalmic medication over a given length of time. They furthermore take a
comparatively long time to acquire a set of data (approximately 20 s for a single anterior cham-
ber scan with the Fluorotron MasterTM), and they do not have the necessary resolution and depth
discrimination to monitor the diffusion properties of the drug accurately enough to gain any new
understanding.
The F410, on the other hand, has the advantage that no sectioned or three-dimensional images
are being acquired, but a one-dimensional depth scan through the anterior chamber of the eye is
obtained. This not only makes the scanning process much faster but also reduces the disk space
needed to save the data. It furthermore allows for on-the-fly data analysis after each scan, assur-
ing that a specified number of well aligned scans is taken and that no data that is too noisy or
otherwise unusable is saved to disk. This helps with the usability of the system since the operator
does not have to go through the scans and use personal judgment to find the ones that meet all
the criteria of a well aligned scan. It also makes sure that the correct, statistically significant num-
ber of scans is being taken at the first instance, so no re-measurement of patients needs to occur.
Since the F410 consists of the combination of a confocal reflection microscope and a confocal fluo-
rescence microscope, both resolution and depth discrimination are improved compared to similar
instruments.
In addition to these advantages the instrument is fairly small, transportable and can be mounted
on an ophthalmic stage for ease of measurement and patient comfort. The F410 is cost-effective
and thus affordable even for small institutions.
Since the instrument measures the ocular dimensions in addition to the fluorescence from within
the eye, it can also be used to simultaneously monitor corneal and tear film thicknesses with a
small change of pinhole size for better axial resolution. This will help to create better understand-
ing of the effects of dry eye syndrome and its treatments on the tear film and cornea, again en-
abling a more tailored approach to individual treatment. With a few modifications the instrument
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can also be used to monitor the diffusion of medication in the posterior chamber of the eye, thus
creating access to better understanding diseases that affect the retina such as age-related macular
degeneration, which is currently the second largest cause of blindness in the developed world [8].
However, the applications the F410 is suitable for are not limited to the eye but can for example be
extended to measuring the diffusion properties of skin.
The author therefore believes that this novel, non-invasive instrument will play a leading role in
better understanding the diffusion properties of inherently fluorescent ophthalmic medication and
reducing the number of animal sacrifices necessary for this area of research.
1.1 Synopsis
This dissertation deals with the measurement of the diffusion of inherently fluorescent medication
in the anterior chamber of the eye. In the second chapter, a short summary of the human eye
and its function is given, alongside with a discussion of common diseases that affect the anterior
section of the eye. A literature review on existing instruments for measuring fluorescence in the
eye is presented and the limitations of the available instruments discussed.
In chapter three, the basic theory behind confocal microscopy and the principle of fluorescence is
summarised. The concept of the point-spread function and axial resolution is introduced both for
conventional reflection systems and fluorescent systems, which is important in the evaluation of
an instrument’s performance. The Beer-Lambert law of absorption is introduced which influences
the intensity of the measured fluorescence and thus plays an important role for the instrument
presented in this thesis. In the last section of this chapter fluorescence decay curves are modelled
for Fluorescein to show how the intensity is dependent on the measurement depth.
Chapter four describes the fluorescence properties of the drug to be measured, Brimonidine. The
design of the instrument for measuring fluorescence in the anterior chamber of the eye is presented
and its performance in terms of axial resolution and measurement noise discussed in depth. The
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safety of the instrument for extended viewing by human eyes is evaluated thoroughly.
Chapter five deals with the calibration of the instrument. The calibration routine is first explained
using a model and then shown to work in cuvettes. Both Fluorescein and Brimonidine calibrations
are presented at laser powers that are beyond the eye safe limit and within the exposure limit safe
for the eye with the current configuration of the instrument. It is shown that the instrument can
recover the concentration from the measured fluorescence intensity and both the accuracy and the
repeatability of the obtained measurement is assessed. The calibration of the instrument for in
vitro porcine eyes is also presented and evaluated in this chapter.
Further experiments are presented in chapter six. The central corneal thickness and tear film thick-
ness was measured after the application of eye drops for treating dry eye syndrome, and it was
found that the thickness increased temporarily after the application of the eye drops. The mea-
surements were taken with a commercially available instrument and a prototype of the instru-
ment presented in this thesis. Measurements of drops of Fluorescein and Brimonidine diffusing
in cuvettes are presented and it is shown that the diffusion can be monitored in near real time.
The concentrations can be recovered from the measurements accurately for Fluorescein but the
results show that the fluorescence properties of Brimonidine need further investigation before the
concentration can be recovered from the measurement. Measurements of the diffusion of both
Brimonidine and Fluorescein in in vitro porcine eyes are also presented and discussed. It is shown
that a better way of calibrating the instrument to in vitro eyes has to be found. Lastly, this chapter
presents a study of the autofluorescence of the human cornea and lens measured both over one
day and one week in healthy volunteers. It is found that the corneal autofluorescence seems to
decrease over the course of a day which contradicts findings made in the literature.
Chapter seven concludes with a summary of the findings presented in this thesis, and chapter eight
gives suggestions for improvements and future work. These include basic measures to improve
the signal to noise ratio and to increase the eye safe laser power to achieve better sensitivity of the
instrument.
Chapter 2
Background
2.1 Structure and diseases of the human eye
2.1.1 The Eye - A Brief Summary
The human eye is a very complex and not yet fully understood system which consists of several
components (fig. 2.1). The main components that will be shortly introduced in this section are the
tear film, the cornea, the aqueous humour, the iris, the lens, the vitreous humour and the retina.
The tear film is the outermost component of the eye and crucial for nourishing and lubricating the
cornea as well as maintaining the general health of the eye surface and preventing infections. It is
made up of three layers, the mucous, the aqueous and the lipid layer. The mucous layer produced
in the conjunctival goblet cells located above the tarsal portion is a hydrophilic layer coating the
cornea, allowing for an even distribution of the tear film. The second layer is mostly made up
out of water (hence the name aqueous layer) and is produced in the lacrimal glands. It moistures
and provides the cornea with oxygen and nutrients such as salt, electrolytes and vitamins. The
outermost lipid layer is produced by the meibomian (tarsal) glands and provides a hydrophobic
8
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Figure 2.1: Schematic diagram of a horizontal section through a right eye [9].
barrier that prevents tears from spilling onto the cheek and also retards evaporation. A schematic
diagram of the lacrimal apparatus is shown in figure 2.2.
Figure 2.2: A schematic digram of the human lacrimal apparatus showing
the production and drainage components with a) lacrimal gland, b) supe-
rior lacrimal punctum, c) superior lacrimal canal, d) lacrimal sac, e) inferior
lacrimal punctum, f) inferior lacrimal canal, g) nasolacrimal canal and h)
tarsal portion [10].
The cornea is the clear outer component of the eye in front of the iris and the lens which accounts
for the major part of the eye’s optical power (about two thirds [11]). It merges into the sclera, the
white outer coat of the eye. Both tissues are mainly made out of collagen fibres with a homoge-
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neous structure, protecting the inner parts of the eye. The collagen fibres in the cornea, however,
are much more organised than the ones in the sclera, giving the main reason why the cornea in
contrast to the sclera is transparent [12]. The limbus (not shown in the diagram) is the merg-
ing point of cornea and sclera; special structures for draining aqueous humour from the anterior
chamber of the eye are located here.
The aqueous humour is produced by the ciliary processes located in the ciliary body behind the
iris, and flows into the posterior chamber of the eye between the iris and the lens. It then passes
through the pupil into the anterior chamber, where it is drained through the trabecular meshwork
located in the limbus into Schlemm’s canal and thus out of the eye into the bloodstream (fig. 2.3).
The mechanisms of aqueous humour formation are not yet completely understood, but it has
been shown that part of it is produced by filtration of blood plasma [13]. The role of the aqueous
humour is to supply nutrients to the intraocular components such as the cornea and lens and to
transport waste material away. It also creates an intra-ocular pressure to mechanically support the
anterior structures of the eye and ensure normal optical function.
The main blood supply of the eye is located in the uveal tract which consists of the iris, the ciliary
body and the choroid. The iris is the aperture stop for the optical system eye, being opaque due to
deposition of melanin pigment and blood vessels. Muscles in the iris control the size of the pupil.
The ciliary body is not only responsible for producing aqueous humour but also controls lens
accommodation via the ciliary muscles. The choroid layer covers the complete posterior segment,
supplying the retinal photoreceptors with blood.
Behind the iris lies the lens, which together with the iris forms the separation between the anterior
and the posterior chamber of the eye. The crystalline lens is the second refractive component in
the eye in addition to the cornea, accounting for roughly one third of the eye’s optical power. Its
focal length is variable (in contrast to the fixed focus of the cornea) and is controlled by the ciliary
muscles. By changing the shape of the lens, the eye can view objects over a large range of focal
distances. The crystalline lens sits within a lens capsule which forms its outermost layer [15].
The lens itself can then be divided into two regions, the nucleus and the cortex [16]. It consists
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Figure 2.3: Diagram showing the flow of the aqueous humour. The aqueous
is produced by the ciliary processes in the ciliary body and released into the
posterior chamber. It then flows through the pupil into the anterior chamber
where it is drained through the trabecular mashwork and Schlemm’s canal
into the bloodstream. Courtesy: National Eye Institute, National Institutes
of Health (NEI/NIH) [14].
of concentric layers of protein filled fibre cells which stretch from the anterior epithelium to the
posterior surface of the lens [12][15].
The vitreous humour, which fills the posterior chamber of the eye, accounts for about 80% of
the interior volume of the eye [11]. It consists of water, hyaluronic acid and collagen fibres [17].
Due to the collagen fibres in relation with the hyaluronic acid, the vitreous has a gel-like structure
which mechanically supports surrounding structures such as the retina. In contrast to the aqueous
humour, the vitreous humour is not replenished. The physiological function of the vitreous is
unclear, but there is evidence that it regulates the growth and shape of the eye during development
[18]. It might also serve as a shock absorber for the retina.
The retina, finally, is the innermost layer of the eye. It is constructed out of different types of cells
of which the most important ones are the ganglion cells, which are the nerve cells that transport
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Figure 2.4: A schematic cross section of the human retina [19]. The yellow
arrow indicates the direction of the incoming light. 1: Ganglion cells, 2:
Interneurons, 3: Photoreceptors.
the visual signal to the brain, and the photoreceptors. The ganglion cells and photoreceptors
are connected by a network of interneurons that transform the chemical change induced by the
photoreceptors into a neuronal signal. Counterintuitively, the ganglion cells lie closest to the lens
of the eye with the interneurons behind them. The light therefore has to pass through the layers of
nerve cells before it reaches the retina. The blood supply of the retina is provided by the choroid
which lies below the photoreceptors and is not transparent. The photoreceptors can be divided
into two groups, the rod cells and the cone cells, where the rod cells are responsible for low-light
black and white vision and are most dense in the peripheral area of the cornea whereas the cone
cells are responsible for daylight colour vision. They are most dense in the fovea, the spot of
the retina with the highest photoreceptor density that controls sharp central vision. A schematic
section through the retina is shown in figure 2.4.
The average dimension of the anterior-posterior axis is 24.2 mm [20], but this number varies from
person to person and more so in diseased eyes. The thickness of the tear film is approximately 3µm
[21][22]. Other sources state the tear film to be approximately 10µm [23]. The mean thickness of
the cornea is 0.52 mm [24], the depth of the anterior chamber is about 3.5 mm in an adult eye [11].
The lens has a thickness of approximately 4 mm and the depth of the vitreous chamber is about
16.6 mm (both measured in Prof. Girkin’s eye).
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2.1.2 Dry Eye Syndrome
Keratoconjunctivitis sicca (KCS), also called ‘dry eye syndrome’ (DES) is a condition caused by the
eye not producing enough tears or the tears evaporating too quickly. If the tear film is changed
in any way such as the lacrimal glands not producing enough of the aqueous substance (aqueous
tear-deficient dry eye) or the meibomian glands being infected and thus not able to produce the
lipid layer which slows evaporation (evaporative dry eye), the cornea cannot be nourished by only
the tear film any longer. To compensate for this deficiency, the cornea is nourished via the blood
vessels in the conjunctiva and in the eye lids, leading to swollen lids and red eyes. In addition to
the eyes becoming dry and tired, this malfunction of the tear film can also lead to inflammation of
the cornea which can result in ulcers or scars on the cornea and some loss of vision.
The condition can be caused by a general fault in the tear producing apparatus, but it is also ad-
vanced by the intake of drugs which alter the composition of the tear film over a longer period
of time such as antihistamines, β-blockers, neuroleptics, oestrogen, reserpine, antidepressants and
others [25][26], but other sources claim that some of these medications do not have any influence
on KCS [27]. Other contributing circumstances include age as the most common cause, skin dis-
ease around the region of the eye, infrequent blinking when working at the computer, long-term
contact lens wear, immune system disorders, hot, dry or windy climate, air-conditioning and pas-
sive as well as active smoking. Women are roughly 1.5 times more likely to suffer from KCS than
men [27], and the prevalence of the disease seems to be higher in Asian populations [28].
Dry eye syndrome rarely leads to total loss of vision, but it has a huge impact on the quality of
life of the patient. It makes it more difficult to perform daily tasks such as reading, driving or
using a computer. Symptoms include a stinging, burning, sandy feeling in the eye, a feeling that
the pressure in the eye is elevated, pain and redness of the eye, heavy eyelids, episodes of blurred
vision, extensive tear flow, a stringy discharge from the eye and eye fatigue [25][26].
There are various approaches to treating KCS depending on the cause of the illness. Normally, the
condition is caused by external factors such as an underlying disease, taking medication, wearing
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contact lenses or working in a dry environment or in front of a computer. In most of these cases
KCS can be cured by removing the causing factor. Unfortunately, this is not always possible.
Several other options exist for these more severe conditions, including giving of ‘artificial tears’ to
moisten the eye when the condition is mild. In more severe cases, lubricating ointments to be used
at night are given, or punctal plugs are inserted into the punctus of the eye to block tear drainage.
If these plugs are effective, the punctus can be cauterised. If the cornea is inflamed, cyclosporine
is the only drug available [25] to treat the symptoms. It increases tear production and reduces
corneal damage.
2.1.3 Glaucoma
‘Glaucoma’ denominates a group of diseases which can damage the optic nerve at the point where
it leaves the eye, including atrophy of the optic nerve, loss of retinal ganglion cells and cupping
of the nerve head [29]. It is the largest cause of blindness in the developed world [8]. Figure 2.5
shows how this disease affects the vision in comparison to the vision of a healthy person.
(a) Normal vision (b) Vision with glaucoma
Figure 2.5: Demonstration on how the vision of a glaucoma patient deteri-
orates. a) Two playing children seen as by a normal person. b) The same
picture seen as by a person suffering from glaucoma. Courtesy: National
Eye Institute, National Institutes of Health (NEI/NIH) [14].
Elevated intra-ocular pressure (IOP) is one of the main risk factors for developing glaucoma, but
it is no longer considered to be the only trigger. Glaucoma may also be caused by a mixture of
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several factors such as high IOP1 and weakness of the optic nerve, or even when no elevated IOP
is present. Advanced age, ethnic origin, genetic predisposition, severe myopia and thinness of the
cornea are now also known to be risk factors [29][14][30].
The pressure in the eye is controlled by the production and drainage of aqueous humour. Normally,
there is an equilibrium between the production and drainage of aqueous humour, but when the
aqueous cannot leave the eye due to blockage or if too much fluid is produced, the pressure rises,
leading to a high risk of developing glaucoma.
Glaucoma is divided into four main groups, with open-angle (chronic) glaucoma being the most
common form. In chronic glaucoma, the aqueous humour reaches the drainage channels (thus the
name open-angle: The angle in which iris and limbus meet is accessible) but is not transported out
of the eye due to the slow blockage of the channels over many years. This leads to a slow buildup
of the intra-ocular pressure leading to impaired vision due to damage of the optic nerves. Acute
(closed-angle) glaucoma, in contrast, develops when there is a sudden and complete blocking of
the aqueous flow in the eye. This is caused by the iris pushing forward against the trabecular
meshwork, hindering the aqueous humour from exiting the eye. This form of glaucoma may go
along with the development of severe pain and causes permanent damage to the optical nerves
if not immediately treated, but it is also much less common in western countries. The two other
forms of glaucoma are seldom: Secondary glaucoma develops when the IOP rises due to another
eye condition, and congenital glaucoma is a rare but serious form of glaucoma in babies caused
by malformations in the eye [14][30].
Although elevated intra-ocular pressure is only one of the major risk factors of glaucoma, the
treatment currently available still only concentrates on lowering the IOP by using various phar-
maceuticals, laser trabeculoplasty and trabeculectomy. The two latter options are not desirable
because of the disturbance they cause to the system eye, trabeculectomy even more so since it in-
volves creating a new hole for the fluid to exit the eye. Both methods work well on some patients,
1Normal intra-ocular pressure is defined to be in the range of 8 to 21 mm Hg. A pressure that is higher than 21 mm Hg
is classified as being ocular hypertensive [11].
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but not all, and the effects may wear off over time, creating the need for further treatment.
Depending on the severity of the rise in IOP the treatment is usually started using eye drops which
lower the IOP by reducing the production of aqueous humour or opening up the drainage chan-
nels. A wide range of pharmaceuticals is available, many of them containing β-blockers which
are normally used to treat patients with heart problems. They lower pulse frequency and blood
pressure and can have other side effects which are highly undesirable. A second problem consists
in that only about 5% of the eyedrops stay in the eye [31]. The rest are washed out or even worse
enter the bloodstream which can lead to side-effects.
Due to these problems, researchers are currently working on developing an implant to replace the
eye drops, releasing medication over a longer period of time directly into the vitreous chamber of
the eye. This will increase the efficiency of the drug and also reduce the side effects because the
medication dosage can be decreased. Unfortunately, not much is known about drug movement in
the eye. The overall aim of this PhD therefore is to measure drug movements and concentrations
in the anterior chamber of the eye.
2.2 Current techniques for measuring the diffusion of medica-
tion or fluorescent compounds in the anterior chamber
There are, of course, available techniques for measuring the pharmacokinetic properties of non-
fluorescent and fluorescent medication in the anterior chamber of the eye. The most common
technique for evaluating the pharmacokinetics of any ocular drug is to administer the drug to
test animals and sacrifice their eyes at specific points in time after the administration of the drug
to measure the concentration in the relevant ocular tissues [4]. As already mentioned in the in-
troduction to this dissertation, this process does not provide high enough temporal resolution to
evaluate the complete behaviour of the respective medication. Furthermore, many eyes have to
be sacrificed to obtain one measurement curve, which makes the whole procedure extraordinarily
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complicated and expensive, apart from the fact that many animals have to die for the sake of re-
search. Another complication is that different reactions to the drug between animals can neither be
excluded nor quantified so that it is not possible to evaluate their influence on the measurement.
A similar, if less destructive, method is applied to quantify the behaviour of the drug in vivo in a
single individual. After the drug has been administered, one or more relevant levels are measured
at specific time points by extracting concentrations from for example blood, urine or plasma [2][3].
From these concentrations, an estimate of the concentration at the site of interest can be made
using mathematic modelling [3]. However, as with the animal experiments, these measurements
do not provide good enough temporal resolution for the complete understanding of the behaviour
of the medication. Furthermore this method creates the added disadvantage that the concentra-
tion of interest cannot be measured at the actual relevant position but has to be estimated from
concentrations measured elsewhere.
A non-invasive method that can accurately measure the concentration within the eye with high
temporal and spatial resolution is therefore needed to address these issues. This will enable a much
better understanding of the temporal behaviour of the drug as well as reducing the cost of the
drug-trials since less or no animals have to be sacrificed to evaluate the ocular pharmacokinetics
of the respective medication.
However, an ophthalmic compound can only be detected non-invasively if it has some unique
optical property such as e.g. fluorescence, polarisation or coherence of scattered or reflected light
that varies with concentration, or if it can be measured indirectly through measuring the opti-
cal properties of another compound. An example of the latter would be to measure fluorescein
concentrations and clearance times to determine the influence of a specific opthalmic drug on the
aqueous humour flow or the behaviour of the tear film [32][33]. It would however be most desir-
able to measure the concentration of the medication itself rather than just being able to quantify
its influence on other parameters.
Since the task of this dissertation was to build an instrument that can measure the ophthalmic drug
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known as Brimonidine, which is a very weakly inherently fluorescent compound, non-invasively,
this review of currently available measurement methods will concentrate on the detection of fluo-
rescence from within the anterior chamber of the eye.
Instruments that measure the fluorescence from any part within the eye are generally referred to
as ocular fluorophotometers. Of these, quite a few different models are available which will be
discussed in this section.
Although the idea of quantitatively measuring the concentration of Fluorescein in the anterior
chamber of the eye has been around since the late 19th century [34], and some instruments were
built in the first half of the 20th century that were able to subjectively quantify the concentration
of Fluorescein in the eye [35][36], the first objective ocular fluorophotometer was not built until
1954 when Langham and Wybar modified a slit lamp to research the origin and the circulation
of the aqueous humour [37]. Their fluorophotometer was able to measure relative changes in
concentration which were related to an absolute value that was obtained from the aqueous hu-
mour which was extracted immediately after the last measurement with the fluorophotometer.
Maurice improved Langham’s instrument by addressing issues such as uncertainty of the target
area (eye-instrument alignment), internal scattering that was reaching the photodetector and poor
sensitivity due to the light source which did not have high enough intensity in the blue wave-
lengths [38]. Maurice’s instrument was then further improved by Waltmann and Kaufman in 1970
[39] who used fibre optics to stabilise the target area and modified the optical set up such that
only an adapter was needed to turn a commercially available slit-lamp into a fluorophotometer.
Aoshima et al. shortly afterwards demonstrated a fluorophotometer that had a much higher sen-
sitivity than aforementioned devices due to the use of a single photon counter as the detector [40].
This fluorophotometer was not used for ocular measurements, but the improvements made could
be implemented into any existing ocular fluorophotometer just as easily. In 1977, Smith et al. [41]
made another improvement by replacing the mercury arc lamps used in the fluorophotometers
before for a tungsten-halogen lamp which is a much more stable light source. They furthermore
improved the signal to noise ratio by using an optical chopper and lock-in amplifier to reject any
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signal that came not from the sample, such as dark noise from the photo-multiplier.
Minor improvements were made by Jones et al. in both 1979 and 1982 [42][43], but no further
break-through was achieved until 1985 when McLaren and Brubaker were the first to apply scan-
ning of the beam along the optical axis in the anterior chamber to take measurements in rapid
succession [44]. This technique had been used for vitreous fluorophotometry [45], but had not
been applied to the anterior chamber beforehand. Very shortly afterwards, Coherent Radiation
Inc. invented the Fluorotron MasterTM which addressed many of the issues of other fluoropho-
tometers by providing optimised aptertures, filters, light sources etc [46][47]. Since this instru-
ment was mainly developed for vitreous fluorophotometry, the main improvement was that by
using a novel optical design no contact lens was needed to measure the fluorescence in the pos-
terior chamber of the eye, which all previous vitreous fluorophotometers did not achieve. Since
this instrument also provided improved axial resolution and was reviewed to be superior to other
commercially available instruments [48], it became the standard fluorophotometer used in ocular
research and has been used widely since then (e.g. [49][50][51][52][53]). It has been accepted as
the "gold standard" ever since [54].
The instruments discussed above have been used to measure either the auto-fluorescence of the
cornea and lens, or to measure certain properties of the cornea, aqueous humour and blood-ocular
barriers and the influence of medication on them. They have, however, very rarely been applied
to measure the actual medication itself. In fact, the author of this thesis could not find any proof in
the literature that compounds other than highly fluorescent dyes and markers have been used to
assess the pharmacokinetics of specific drugs. This means that either an indirect method is used
or the molecular structure of the drug has to be altered, leading to unpredictable errors in the
measurement.
In addition, even though the Fluorotron MasterTM has been accepted as the gold standard fluo-
rophotometer, its axial resolution is not sufficient to resolve individual layers such as the tear film
from the cornea. The axial resolution in a confocal microscope is normally measured by scanning
a highly reflective surface such as a mirror through the focus of the beam and measuring the full
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width at half maximum of the returned point spread function as described in chapter 3. The res-
olution in a fluorophotometer, however, is measured in a slightly different way due to historical
reasons. The website of the Fluorotron MasterTM [55] states the axial resolution ("Depth of res-
olution") as 2 mm at 3% peak signal. According to Zeimer [45] and Munnerlyn [46], this value
relates to the half width at the point of the point-spread function where the signal has fallen to
3% of the peak signal. This slightly unusual definition of the axial resolution has been derived
on the grounds that in fluorophotometry signals strongly varying in fluorescence are encountered
very close to each other, for example the fluorescence from the retina or the crystalline lens (very
high signal) in comparison to the fluorescence from the vitreous humour (very low signal). It is
therefore most important to know how much of the high signal is "tailing" into the low signal
next to it and at what distance the low signal can be read accurately without falsification by the
neighbouring peak.
Due to the optical design of the Fluorotron MasterTM, where the measurement volume and thus
the axial resolution is defined by the steepness of the angle with which the excitation and the
emission beam intercept and the width of the excitation and detection slits, it is not likely that a
better axial resolution can be achieved while keeping a high sensitivity. The anterior chamber can
only be measured with an axial resolution (as defined above, not the full width at half maximum!)
of 0.2 mm when using a special adapter for the instrument since the Fluorotron was originally
designed to measure the fluorescence in the posterior chamber of the eye, which is still one of its
main applications. A higher axial resolution is however needed to obtain more precise profiles of
fluorescence distribution within the anterior chamber and to be able to resolve e.g. the tear film
from the cornea [52][56][32][57].
The scientific community will therefore benefit greatly from an instrument that has high axial
resolution so that individual layers of components can be resolved. It would also be of use if the
compound of interest can be measured directly rather then via indirect methods, although using
fluorescence as the quantity of detection this obviously will only work with inherently fluorescent
medication or drugs that have been tagged with a fluorescent compound.
Chapter 3
Theory
The measurement principle of the instrument presented in this thesis is based on confocal mi-
croscopy in combination with fluorescence detection. This chapter therefore introduces the basic
theory behind the confocal principle as well as the definition of axial and lateral resolution of an
instrument. The theory of fluorescence is also discussed and the additional theory of the combina-
tion of fluorescence with a confocal imaging principle is presented. Furthermore the Beer-Lambert
law of absorption is introduced. Since the instrument will first be tested on homogeneous so-
lutions of Fluorescein a simulation of the intensity decay of several modelled concentrations of
Fluorescein was additionally carried out to predict the behaviour of the measurement data.
3.1 Confocal fluorescence microscopy
3.1.1 The confocal principle
The use of a confocal imaging system to improve image resolution and contrast and to enable
optical sectioning and thus the collection of three-dimensional images was first thought of and
21
CHAPTER 3. THEORY 22
(a) (b)
Figure 3.1: Schematic drawings of Minsky’s confocal microscope in a) trans-
mitted and b) reflected light mode [58].
patented by Marvin Minsky in 1957 [58], who is a cognitive scientist in the field of artificial in-
telligence and wanted to obtain three-dimensional, real-time images of neural networks in brain
tissue for his research [59]. Unfortunately, his invention met with little interest. This was probably
because the computers that re-constructed the measured intensities from each point into a three-
dimensional image were very slow, leading to disproportionately long image acquisition times.
Furthermore no high-quality images could be obtained using the method suggested by Minsky
since the image was build on a cathode ray tube, leading to poor image quality, and the available
light sources were not intense enough to allow for good enough signal to noise ratios.
Minsky’s invention was forgotten until 1971, when Davidovits and Egger implemented a laser
as light source, thus drastically improving the signal strength [60]. They also added a computer-
controlled scanning mechanism to scan the sample through the focus, making image acquisition
a lot easier. The confocal microscope was then subject to only minor improvements until White
and Amos created the first laser scanned user friendly system in 1985 [61], which increased the
image acquisition speed drastically compared to the optically superior sample scanning method
used before [62]. After this new addition, the requests to fund the purchase of this equipment in-
creased monumentally [63]. After further development the confocal microscope was finally com-
mercialised in the late 1980s [64]. During the 90s, improvement in optics and electronics as well as
computing power lead to a sheer explosion in the number of applications for which confocal laser
scanning microscopy was and still is the perfect choice.
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Figure 3.2: Schematic diagram of a wide-field microscope.
Conventional microscopes generally use a technique called wide-field illumination to illuminate
the specimen. In this technique, a wide cone of light is focused into the sample, covering a large
volume (figure 3.2). Conventional microscopes are generally either configured in transmission or
in reflection mode. In transmission mode, the illumination light is transmitted through the sample
towards the objective lens, whereas in reflection mode the illumination light is focused into the
sample through the objective lens. Most of the light transmitted or reflected by the sample is
then collected by the objective lens and can be viewed either directly through an eyepiece or can
be projected onto a camera. The collected signal will be a convolution of signals from all layers
within the sample that transmit or reflect enough light to be picked up by the detector, significantly
reducing contrast and resolution of the acquired image, especially when imaging through thick
specimens. This leads to the three-dimensional interpretation of the data becoming very complex
since this technique does not offer good enough axial resolution to distinguish between the focal
plane and the layers that lie above and below it.
This problem can be circumvented by cutting the sample into thin slices which do not generate
much background signal, but this is not always feasible and even less often desired. Researchers
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Figure 3.3: Schematic diagram of a typical confocal microscope.
nowadays mainly want to understand the function and behaviour of the specimen they are inves-
tigating in relation to its natural surroundings and if possible while being alive. Cutting the speci-
men into thin slices is - for obvious reasons - quite detrimental to that. A number of algorithms has
been developed to aid with the interpretation of three-dimensional images from thicker samples,
but they are only a cure for the symptom and not for the problem and require comparatively long
calculation times.
In a confocal microscope, on the other hand, a different imaging technique is used that almost
eliminates the problem of the image being blurred by signal from layers that are not in focus. This
is achieved by using pinholes in optical conjugate planes in front of the illumination light source
and the detector. The pinhole in front of the light source creates a diffraction limited point source
that is re-imaged into the sample. The collected transmitted or reflected light only travels through
the conjugate pinhole in front of the detector if it is coming from the focal plane; unwanted signal
from out-of-focus planes is rejected at the pinhole, leading to a much higher signal to noise ratio.
The general principle of a confocal microscope, configured in reflection mode, is shown in figure
3.3. Light from an illumination source, depicted in bright blue in the diagram, is focussed through
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a pinhole before passing through a beam splitter onto the back aperture of the objective lens. It is
then focussed into the sample by the objective lens, being reflected by features in the sample, sim-
ilar to a conventional microscope. The reflected light from the focal plane within the sample, also
shown in bright blue, is collected by the objective lens and diverted by the beam splitter before
being focussed through the detector pinhole onto the detector. Light reflected from out of focus
regions, however, is not focussed at the pinhole as shown by the dotted dark blue line. It cre-
ates a comparatively large spot at the pinhole plane of which only a small fraction passes through
the pinhole and is thus collected by the detector, contributing to the resulting image. Using this
principle of optically conjugate pinholes to illuminate the sample and collect the reflected signal
results in a much better signal to noise ratio and drastically improves the axial resolution of the
system. Two-dimensional images can easily be obtained by scanning the focal spot of the illumi-
nation beam across the sample, and three-dimensional image stacks can be computed by altering
the position of the objective lens along the optical axis after each two-dimensional scan.
Axial and lateral resolution of a confocal system
The resolution that can be achieved with a confocal microscope is limited by several factors. Even
in a perfect imaging system that does not have any optical aberrations, the objective lens will not
re-image the (infinitely small) point source as a point into the sample. Diffraction of the light at the
boundaries of the lens will spread out the image of the excitation point so that the light is focussed
to an intensity distribution within the specimen rather than an infinitely small point. Thus, the
imaging properties of a system are characterised by the spread of the image of a point source when
focussed by the objective lens. This intensity distribution is called point-spread function (PSF) and
takes the form of an Airy diffraction pattern [65]. An example of resolved and unresolved Airy
patterns is given in figure 3.4.
Resolution is defined as the distance between two features that are just distinguishable. For an
ideal, aberration-free objective lens, both the lateral and the axial resolution are only limited by
the wavelength of the illumination light, the numerical aperture (NA) of the lens and diffraction.
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(a) (b) (c)
Figure 3.4: The theoretical axial point-spread function of the F410. (a)
Intensity distribution of a single point. (b) Two resolved points showing
the Rayleigh criterion. (c) Two unresolved points.
The imaging is said to be diffraction-limited in this scenario. The NA is related to the semi-aperture
of the lens α and the refractive index n of the sample the beam is focused through by
NA = n · sinα. (3.1)
The Airy diffraction pattern formed by the objective lens can be calculated from diffraction theory
using a number of approximations. For a system with cylindrical symmetry it is conventional and
convenient to use the dimensionless optical coordinates ν and u instead of real space units [66][67]
for the calculation. The lateral coordinate ν is defined by
ν = r · 2pi
λm
sinα = r · 2pi
λ
NA, (3.2)
with r being the radial coordinate relative to the optical axis and λm = λ/n being the wavelength
of the light in the medium with refractive index n. Similarly, the axial coordinate is defined by
u = z · 2pin
nλm
sin2α = z · 2pi
nλ
NA2, (3.3)
with z being defined relative to the focal point. The image intensity of a point imaged by a lens
can be written as [67]
I = |h|2 , (3.4)
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where h is the amplitude PSF of the lens given by
h(u, ν) =
∫ 1
0
P (ρ) e
1
2 juρ
2
J0(νρ)ρdρ. (3.5)
This is the Fourier transform of the circular aperture of the objective lens.
Since the parameter u represents the defocus of the lens, it can be set to u = 0 when the assumption
is made that the lens focusses on the object plane. Following Born and Wolf this yields [66]
I(0, ν) ∝
∣∣∣∣2J1(ν)ν
∣∣∣∣2 (3.6)
for the intensity of the point across the focal plane, where J1(ν) is the first-order Bessel function
of the first kind. The intensity distribution along the optical axis can similarly be found by setting
ν = 0 [66]:
I(u, 0) ∝
(
sinu4
u
4
)2
. (3.7)
As mentioned above, the lateral and axial distribution of the intensity follows from diffraction at
the circular aperture of the objective lens and forms an Airy pattern. Figure 3.4(a) shows that the
intensity distribution has several side lobes surrounding the main peak intensity. Two features of
equal intensity within the sample are said to be resolved if the maximum of the Airy pattern of
the first feature falls into the first minimum of the Airy pattern of the other feature. This definition
of resolution was first derived by Lord Rayleigh [68]. If this definition is followed, the lateral
resolution is defined as the radius of the Airy disc which stretches laterally from the centre of the
maximum of order zero to the centre of the first minimum. The centre of the first minimum is
found at ν0 = 1.22pi, which when inserted into equation (3.2) leads to
r0 =
0.61λ
NA
. (3.8)
Equally, the first minimum of the axial PSF can be found at u0 = 4pi, and if substituted into equa-
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tion (3.3) yields
z0 =
2nλ
NA2
. (3.9)
Figure 3.4(b) demonstrates that two points are resolved if their separation is equal or greater than
r0, leading to a drop in intensity of approximately 20% between the two points [66]. This radius of
the Airy disc is normally used to define resolution in wide-field microscopy.
In a confocal micrsocope, however, the image results from the illumination of the sample from
a point source and the detection of the transmitted or more commonly reflected light through a
conjugate point, the detection pinhole. Both the intensity distribution of the illumination point and
of the detection point are described by the PSF of the system. The resolution is then determined
by the product of the illumination and the detection PSF[66][65]:
PSFconf = PSFill · PSFdet, (3.10)
or, in terms of intensity distribution,
Iconf ∝
∣∣∣∣2J1(ν)ν
∣∣∣∣4 , (3.11)
leading to a "sharpening" of the central Airy disc. The Rayleigh criterion for resolution can under
these circumstances not be used to define the resolution of the system. The Rayleigh criterion is
related to the position of the first minimum of the intensity distribution, and this position does
not change when the distribution is squared. Using the Rayleigh criterion would thus lead to an
underestimation of the resolution of the system, since resolution is not only a function of the sepa-
ration of two individual points but also of the contrast between those two points. As stated above,
using the Rayleigh criterion of resolution in a conventional microscope leads to an intensity "dip"
of approximately 20% between the two maxima. Through the sharpening of the PSF in confocal
microscopy, this dip would increase significantly if the Rayleigh criterion was used to determine
the resolution, thus leading to a theoretical resolution much bigger than actually available. This
problem can be circumvented, and several different approaches to this problem exist.
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The first approach as suggested by Webb [65] is to use the dip in intensity between two points in a
conventional microscope, i.e. 20%, to find the axial and lateral distance from the centre of the Airy
disc at which the two points can be resolved in a confocal microscope. The separations between
the maximum intensities of those two points are then
r0 =
0.44λ
NA
(3.12)
for the lateral resolution and
z0 =
1.5nλ
NA2
(3.13)
for the axial resolution respectively.
An alternative approach suggested by Müller [66] is to use the full-width half-maximum (FWHM),
the spread of the intensity distribution at half the maximum intensity, instead of the radius of the
Airy disc as used in conventional microscopy to determine the resolution of a confocal microscope,
since contrary to the radius of the Airy disc, the FWHM in a confocal microscope differs from that
in a conventional microscope. For the conventional case, it is a reasonable approximation to say
that the FWHM equals the radius of the Airy disc, i.e. the distance to the first minimum:
FWHM ≈ r0. (3.14)
The FWHM of the confocal PSF is then determined by the square of the illumination PSF and thus
FWHMconf =
FWHMill√
2
. (3.15)
The factor of 1√
2
describes the decrease of the width of the FWHM with squaring of the PSF.
Both the lateral and the axial resolution are therefore increased by a factor of
√
2 in comparison to
conventional microscopy and yield
r0 =
0.61λ√
2NA
=
0.43λ
NA
(3.16)
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and
z0 =
2nλ√
2NA2
=
1.41nλ
NA2
(3.17)
for the lateral and the axial resolution respectively. These values are very similar to those derived
by Webb.
The FWHM of the axial PSF is a value that is easy to measure by scanning the focus of the objective
lens through a highly reflective sample such as a mirror. It is therefore commonly used to describe
the axial resolution of a system. However, it should be noted that the FWHM of the axial PSF
does not actually correspond to the axial resolution as defined in equations (3.9) and (3.17) since it
does by definition not use the distance to the first minimum as the criterion. To find the distance
from the centre of the Airy disc to the position of the lateral half maximum intensity value, ν
from equation (3.2) has to be set to ν = 1.02pi, and to find the axial distance for the point of half
maximum intensity, z = 3.52pi. This leads to a relation between the FWHM and the lateral and
axial resolution of [65][66]
FWHMlat = 0.84 · r0 (3.18)
and
FWHMax = 0.88 · z0. (3.19)
From the derivation of the resolution of a confocal microscope it follows that both the lateral and
axial resolution decrease with pinhole size. Increasing the size of the detector pinhole thus in-
creases the volume that is sampled from the specimen, and therefore the overall intensity on the
detector and the signal to noise ratio. This is an important trade-off that has to be kept in mind
when designing a confocal instrument. It is no use having an instrument that is able to distinguish
between features that are say 1 µm apart, if this means that virtually no signal reaches the detector
and the signal to noise ratio is poor. On the other hand, the pinhole should not be made too big
since if it is above a certain size a confocal microscope will have no better axial resolution than a
conventional microscope or might even perform worse [67].
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Figure 3.5: A Jablonski diagram, the schematic representation for the process
of fluorescence.
3.1.2 Fluorescence microscopy
Theory of fluorescence
The confocal principle described in section 3.1.1 works both in the described normal illumination
mode and in fluorescence mode. Fluorescent imaging is however the more widely used method
by life scientists since it allows for better distinction of specific features.
The process of fluorescence is best explained using a Jablonski diagram (figure 3.5). When light
of the correct wavelength is incident on a fluorescent compound, an electron within one of the
molecules of the fluorophore will absorb a photon with a certain probability. The absorption of the
photon’s energy excites the electron from a low energy ground state (S0) into a high energy excited
state (S1), which is associated with a change in the molecular orbital of the electron. Within each
state, there are several vibrational and rotational energy levels which the electron can be excited to,
but they are unstable and after a very short transient time (sub-picoseconds [69]) the electron falls
back into the lowest energy level within the excited state. The energy released during this process
is absorbed as heat by the surrounding molecules. From the lowest energy level of S1 the electron
falls back into the low-energy ground state S0, releasing the remaining held energy in form of a
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photon of a longer wavelength. The time that passes until all the energy has been released as a
longer wavelength photon is called the fluorescence life-time, τ , and is normally in the range of
nanoseconds.
The light emitted by the fluorophore is always of lower energy and thus longer wavelength than
the excitation light. This is due to the electron losing energy as heat when falling from a higher
vibrational level in S1 back into the lowest energy level of S1 in the transient process described
above. Furthermore, the electron does not always fall back to the lowest energy level in S0 but
might fall into a vibrational energy level. The energy and thus wavelength of the emitted photon
depends on which level the electron falls back to. After the electron has re-entered the unexcited
ground state, it can go through the process of absorbing and emitting light almost indefinitely
until either the intensity of the excitation light has become too weak for the electrons to absorb
photons by moving the focus or the fluorescent molecule has photobleached, which is a process
that is not yet fully understood and leads to the modification of the fluorophore so that it no longer
fluoresces.
It is important to note that light absorption and emission only occurs at specific wavelengths de-
pendent on the fluorophore used. This is due to the fact that the absorption and emission bands are
defined by the energy gaps between the different states the electron can exist in, which is highly
dependent on the specific molecule used. Furthermore, the fact that the fluorescence occurs at
longer wavelengths allows for the detection of fluorescent signals that are weak in comparison
to the excitation intensity, especially if an emission filter is used to single out the emission wave-
length from the excitation wavelength. An example of the absorption and emission spectrum of
the standard fluorophore Fluorescein in an aqueous solution is given in figure 3.6.
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Figure 3.6: Absorption and fluorescence spectrum of Fluorescein.
Quantum yield and fluorescence quenching
The efficiency with which fluorescence is emitted depends on the molecular structure of the fluo-
rophore. This efficiency is known as the quantum yield Q [69] and is expressed by the equation
Q =
Number of photons emitted
Number of photons absorbed
(3.20)
and has a value from 0 to 1. There are however a number of mechanisms that can lead to non-
radiative energy transfer so that the absorbed energy is not emitted as a photon of longer wave-
length. An example of this is energy transfer through collision with other molecules, which re-
duces the number of electrons in the excited state without generating fluorescence. If there is a
so called acceptor molecule present that matches the energy bands of the fluorophore, the stored
energy can also be transferred to this acceptor molecule by long-range interaction, again without
any release of radiation. Furthermore, there is a small possibility that the electron will not be ex-
cited into a singlet state but into a so called triplet state T1, a process called inter-system crossing.
Normally, electrons are paired, meaning that they have a spin opposite to each other and a total
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spin of zero. There is a quantum mechanical probability though that the electron that gets excited
has the same spin as the electron left behind, in which case the total spin equals one. There are
three spin combinations that electrons can take to create a total spin of one, and the excited state
they are in is thus called a triplet state, in contrast to the singlet state where only one combination
of spins is possible to yield a total spin of zero.
For the energy to be released from the triplet to the ground state T1 → S0, a so called "forbidden"
transition needs to take place where the electron has to flip its spin. The probability of this to
happen is very low, making the decay rate of this energy transition slow. It can take up to several
seconds to complete. This process is therefore denoted phosphorescence rather than fluorescence.
From this triplet state, the molecule cannot only return to the ground state S0 but also bleach in a
photochemical reaction. As a last example of processes that can lead to non-radiative energy trans-
fer, re-absorption of the fluorescent light has to be mentioned. This can occur if the emission and
absorption spectra of the fluorophore overlap, again reducing the number of emitted photons. All
these mechanisms that lead to a reduction in the number of photons emitted by the fluorophore
are denoted as quenching [70][71] and can, if they occur, reduce the quantum yield of a system
quite significantly [71]. An example of fluorescence quenching in an aqueous Fluorescein solution
is shown in figure 3.7. It is clearly visible that above a certain concentration the relationship be-
tween the fluorescence intensity and the concentration starts to become non-linear. It is possible to
predict the amount of quenching present in a system if several factors are known, however since
every compound has specific characteristics finding a model for the quenching of one compound
does not automatically lead to a general prediction for other compounds. It would therefore be be-
yond the scope of this thesis to predict the behaviour of the quenched fluorescence intensity with
concentration of Fluorescein. Instead, it is taken care to only use the linear part of the intensity
versus concentration curve for calibration as is common practice when using fluorophores that are
prone to quenching.
Fluorescence only occurs where enough photons of the correct excitation wavelength are present
to excite the molecules into a higher energy state as described above. Since a focal spot is scanned
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]
Figure 3.7: Fluorescence intensity of Fluorescein versus concentration. The
relationship between intensity and concentrations starts to become non-
linear at high concentrations due to self-quenching mechanisms.
across the specimen to create a two-dimensional image, the intensity of the laser is usually chosen
such that fluorescence is mainly excited within the focal volume, providing some initial axial sec-
tioning capability. The intensity of the excitation light is usually significantly lower in out of focus
planes so that fewer photons are absorbed and less fluorescence occurs. One could therefore argue
that imaging in fluorescent mode using a laser excitation source rather than in transmission or
reflection mode using wide-field illumination leads to a certain intrinsic confocality of the system.
However, the out of focus planes still generate enough fluorescence to be measured by the detec-
tor and thus disturb the resulting image significantly, if less so than in a conventional microscope.
Therefore the combination of the confocal principle with fluorescent imaging results in the perfect
tool for the life scientist that not only provides three-dimensional imaging capability at excellent
lateral and axial resolution but also the possibility to distinguish different processes and parts of
interest within the specimen with high contrast by using selective fluorophores.
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3.1.3 Resolution of a confocal fluorescence system
As in a reflection or transmission confocal microscope, the resolution in a system that images
fluorescence rather than reflected or transmitted light is determined by a multiplication of the
PSF of the focus in the sample and the PSF created by the pinhole. However, contrary to a non-
fluorescent system, these PSFs cannot be considered to be exactly the same due to the shift in
wavelength between the excitation and the emission light. It therefore follows that
PSFconf = PSFex · PSFem, (3.21)
where the subscripts ex and em denominate the excitation and emission (or detection) PSF, respec-
tively. To correct for this shift in wavelength, the ratio of the excitation and emission wavelength
β has to be added to the equation. It can then be shown [66] that the FWHM of the lateral PSF is
approximated by
FWHMrconf ≈
FWHMrex√
1 + β2
≈ 1√
1 + β2
· 0.61λex
NA
. (3.22)
Similarly, the influence of the shift in wavelength on the axial resolution results in
FWHMzconf ≈
1√
1 + β2
· 2nλex
NA2
. (3.23)
Therefore, both the axial and the lateral resolution in a fluorescence confocal microscope is lower
than in a reflection confocal microscope.
3.2 Depth-dependent fluorescence intensity decay through ab-
sorption
The intensity of the fluorescence excited in a homogenous solution of a fluorophore will change
depending on where in the solution the focus of the excitation beam is. This is due to the fact that
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Figure 3.8: A schematic diagram demonstrating the Beer-Lambert law.
the deeper the focus is, the more photons will have been absorbed and scattered in the volume
of solution the beam has already passed through, thus leaving less photons available to excite
molecules of the fluorophore deeper within the solution. This leads to a decrease of the fluorescent
signal which is dependent on the depth of the focus, the concentration of absorbing particles and
their absorption properties.
This phenomenon is usually described in terms of either absorbance or transmittance of light
through a thickness of solution rather than in terms of loss of fluorescent signal with depth, but
the principle behind both are the same:
A solution of thickness l is divided into infinitesimal thin slices perpendicular to an axis z that is
parallel to the direction the photons travel in. These slices have an area A and thickness dz along
the z-axis. Each of these slices contains a number density of absorbing particles, N , which may
be described as having an area of absorption, the absorption cross section σ, so that when hit by
a photon within this area the probability of absorption is 1. Otherwise the photon is transmitted
through the slice (figure 3.8). It therefore follows that the fraction of photons that are absorbed in
this slice is equal to the fraction of the absorption area of the particles in respect to the whole area
of the slice, σNdz.
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If the intensity of the light incident on the slice of solution described above is expressed as Iz , the
decrease in intensity as the light passes through the slice can be written as −dIz and is given by
dIz = −σNIzdz,
where dz denotes the change in thickness of the slice. Note that the change in intensity always
has to be negative since fewer photons pass through the slice than are incident on it. The solution
of this first order differential equation after separation of variables gives the available intensity at
position z:
ln(Iz) = −σNz + C.
For a real slice of thickness l, the intensity is I0 at z = 0 and Il at z = l. The difference in intensity
measured when entering (z = 0) and leaving (z = l) the solution can then be written as:
ln(Il)− ln(I0) = (−σNl + C)− (−σN0 + C) = −σNl,
which leads to the equation that describes the fraction of light that is being transmitted by the
solution:
T =
Il
I0
= e−σNl. (3.24)
Therefore, the intensity Il that is left of an initial intensity I0 after the beam has passed through a
solution with depth l, concentration N and absorption cross section σ is defined by
Il = I0e
−σNl. (3.25)
It is, however, generally considered to be easier to use the base 10 logarithm rather than the natural
logarithm. The general convention is thus to write equation (3.25) as
Il = I010
−cl, (3.26)
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where c is the concentration in moles per litre and  is the material- and wavelength-specific ex-
tinction coefficient. Note here that c 6= σN , but the base 10 logarithm can easily be converted to
the natural logarithm by multiplying ln(10) so that σN = ln(10)c. Using the base 10 logarithm
holds other advantages as well since the molar concentration is more often used than the number
density of absorbing particles per unit volume to describe the concentration of a solution, and the
extinction coefficient of a specific material is found more often in the literature than its absorption
cross section.
The principle of light absorption as a function of the thickness of a slice of material was first
described by Bouguer and Lambert. Beer later added that the absorption is also dependent on
the concentration of absorbing particles within the thickness of this slice [72], and together these
two principles form the Beer-Lambert law which describes that the the absorption of light in per-
cent, A, when travelling through a material of thickness l in cm, is dependent on a material-
and wavelength-specific constant, σ in cm2, and the concentration of absorbing particles, N in
molecules per cm3 [69]:
A = ln(
Il
I0
) = σNl. (3.27)
Or, alternatively as derived above,
A = log(
Il
I0
) = cl, (3.28)
so that when the absorbance, the path length and the concentration of the sample are known the
absorption cross section and/or the extinction coefficient can be calculated.
3.3 Modelling fluorescence decay curves
The Beer-Lambert law predicts the intensity of the light transmitted through a sample from the
incident intensity and material specific coefficients. The F410, however, measures the returned
fluorescent light from the sample and not the transmitted light, nor is the actual incident intensity
measured. Therefore the law is used in a slightly different context where I0 is the initial intensity
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of the fluorescent light at position 0 (no attenuation of the excitation beam), and Il is consequently
the predicted fluorescence intensity at position l in the sample. The law can be modified this way
since the intensity of the fluorescent light is linearly dependent on the intensity of the excitation
light so that when the excitation light attenuates according to Beer’s law, the excited fluorescence
will attenuate with the same factor.
The initial fluorescence intensity I0 is however not only dependent on the intensity of the exci-
tation light but also on the concentration of the fluorophore in the sample. Therefore, the model
of attenuation has to be changed slightly to accommodate for the change in initial intensity with
concentration c:
Il = I0(c) · e−ln(10)·cl (3.29)
Thus, to model the decay of the fluorescence from a fluorophore of known concentration c or N
with depth of focus within the solution, both I0(c) or I(N)and  or σ have to be found.
To create a valid model of the behaviour of the fluorescence intensity with fluorophore concen-
tration and depth of excitation beam the properties of Fluorescein Sodium salt (F6377, Sigma-
Aldrich), a fluorescent standard very commonly used in ophthalmic research [73], were used.
Fluorescein has an absorption maximum at 493.5 nm and an emission maximum at 515 nm, both
slightly depending on the buffer solution. However, Fluorescein’s quantum yield -and thus its
extinction coefficient- is strongly pH dependent with a buffer solution of pH 9.5 giving the high-
est quantum yield of 0.95 [74][75]. Purified water, on contrary, has a pH of 7.0 and thus reduces
the quantum yield significantly to about 0.76 [76], although values as high as 0.92 have also been
reported [74]. Furthermore, the literature concentrates on the extinction coefficient and absorption
cross section measured at the most used excitation wavelength, 488 nm[70][75][77]. Since both
values are wavelength- and pH-dependent, this creates a problem when not working at the usual
excitation wavelength or the generally used pH level since very little information can be found in
the literature about other wavelengths and pH levels. Therefore the extinction coefficient had to
be calculated from the absorbance using the Beer-Lambert law (equation (3.28)).
CHAPTER 3. THEORY 41
Figure 3.9: Fit to the initial fluorescence intensities at position zero. R2 =
0.9925
To get a good estimate of the extinction coefficient  the absorbances of Fluorescein solutions at
different molar concentrations were measured with a professional spectrophotometer (Shimadzu
UV-3600) as described in section 4.1. Since the path length of the cuvette is known, the extinction
coefficient for each wavelength contributing to the loss of signal can be calculated. Equation (3.28)
was chosen over equation (3.27) since the concentration of the sample solutions was calculated
in moles per litre rather than in the number density of absorbing particles per unit volume. The
extinction coefficients were calculated both for the excitation wavelength of 402 nm to account for
the absorption of the excitation light, and for the maximum emission wavelength as measured by a
professional spectrometer (Jobin Yvon Horiba FluoroMax 3) of 510 nm to account for re-absorption
of fluorescent light within the solution. The calculated extinction coefficients 402 and 510 were
then combined to form the complete attenuation coefficient, . The best estimate of the combined
extinction coefficient was found by taking the mean of the values for the individual combined
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Figure 3.10: Theroretical intensity decay with depth of focus for different
Fluorescein concentrations ranging from 10 to 100µM.
extinction coefficients calculated from the different concentrations:
 = (0.77± 0.04)M−1µm−1,
valid only if the concentration is given in moles per litre and the depth in micrometres, otherwise
the coefficient has to be accommodated for changes in magnitude. These magnitudes for concen-
tration and depth were chosen since the concentrations measured by the F410 span a range from
low nanomoles to high micromoles per litre and thus will be easiest to read in scientific notation,
and the position of the scanning stage that holds the final lens and thus gives the position of the
focus within the sample is recorded in micrometres by the instrument.
I0(c) can also easily be modeled using the maximum fluorescence intensities measured for differ-
ent Fluorescein concentrations by a commercial spectrometer; however to make the model closer
to the actual measurements taken by the instrument described in this thesis, the fluorescence inten-
sities at position zero of the scanning lens (i.e. no attenuation of the excitation beam) for different
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Fluorescein concentrations as measured with the F410 were used. The initial intensities and the
linear fit are shown in figure 3.9. For this model the whole data set was used to find the gradient
of the fit. This is however only valid when modelling and it has to be kept in mind that for the
correct calibration of the instrument the quenched concentrations need to be omitted as explained
above. I0(c) can therefore be determined and was found to be
I0(c) = 4.47 · 106 VM · c,
again only valid if the concentration is given in moles per litre. Thus, the intensity of the fluores-
cence Il coming from any depth l within a solution can be modelled for any chosen concentration
c by inserting the determined constants into equation (3.29).
An example of modelled curves ranging from 10 to 100µM in 10µM steps is shown in figure 3.10.
As expected, it is clearly visible that the decay rate slows down with lower concentrations. Since
the decay rate changes linearly with concentration it can be used to calculate the concentration
from a given intensity as described in chapter 5.
Chapter 4
Instrumentation
To be able to build an instrument that is capable of measuring the compound of interest, in this
case the glaucoma medication Brimonidine, the fluorescence properties of that compound need to
be known. Measurements to determine the quantum yield of Brimonidine were therefore carried
out. Since it was found that Brimonidine does not have a very high quantum yield it became clear
that the instrument would have to be extremely sensitive to be able to measure the concentrations
of interest to Allergan Inc. An instrument with a confocal set-up was therefore chosen to ensure
high sensitivity and a good axial sectioning capability. The instrument presented in this chapter is
based on a prototype optical glucose meter supplied by Lein AD which was redesigned and then
consequently built by the author of this thesis to be able to simultaneously measure reflection and
fluorescence and incorporate the minimal number of lenses to reduce the background fluorescence
in the system. The performance of this novel instrument in terms of axial resolution and signal to
noise ratio are discussed in this chapter. Since the instrument is to be used on human volunteers,
special attention is given to the consideration of the laser safety of the instrument for intentional
viewing.
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4.1 Measurement of the quantum yield of Brimonidine
For the construction of the instrument it was of importance to know how sensitive it had to
be to be able to measure the pharmaceutical compound of interest, in this case the glaucoma-
medication Brimonidine. Initial tests performed by the manufacturer showed that Brimonidine is
an intrinsic fluorophore. However its fluorescence is very weak and additionally quenched by the
Bromine present in the compound. Therefore it was considered useful to quantify the strength of
Brimonidine’s fluorescence to determine what specifications the instrument had to be built to. The
quantification of the fluorescence of a specific compound is generally achieved by measuring the
quantum yield, i.e. the efficiency by which absorbed photons are transformed into fluorescence.
The quantum yield of any fluorescent compound can be measured using different concentrations
of two reference standard fluorophores as well as the compound of interest and a calibrated spec-
trometer as described in the "Guide to Recording Fluorescence Quantum Yields" published by
Jobin Yvon Horiba [7].
4.1.1 Methodology
To find the quantum yield of any fluorescent compound, five concentrations of two reference stan-
dard fluorophores and of the sample need to be measured. The concentrations of the solutions
are chosen such that the absorbances are identical for each compound, and dependent on the path
length of the measurement cuvette. For a path length of 10 mm, no solutions with absorbances
greater than 0.1 at any wavelength in the absorption spectrum should be used since non-linearity
effects through self-quenching can occur at high concentrations as described in chapter 3. If a
longer path length cuvette is to be used for the measurement, the maximum absorbance has to be
adjusted accordingly to keep the absorbance at the same value, e.g. 0.2 for a path length of 20 mm.
Since a path length of 10 mm was chosen for this experiment, solutions with absorbances as close
as possible to 0.02, 0.04, 0.06, 0.08 and 0.10 are then to be created for each of the three compounds.
Once the solutions have been made, the absorption spectrum has to be measured to confirm the
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value of absorption for each compound and concentration; then, the fluorescence spectrum at a
chosen excitation wavelength is recorded. The integrated intensity of each fluorescence measure-
ment is plotted against the absorbance for that sample for each of the compounds. The resulting
graph will show a linear relationship between the intensity and the absorbance with an intercept
at zero if the measurement has been taken correctly. If this linear relationship is not visible, the
measurement has to be repeated. The gradients determined from the linear regression are directly
related to the quantum yields of the compounds through equation (4.1) [7]:
ΦX = ΦST
(
MX
MST
)(
n2X
n2ST
)
, (4.1)
where the subscripts X and ST denominate the unknown sample and the reference standard re-
spectively, Φ is the quantum yield, M the gradient determined from the graph of integrated fluo-
rescence intensity against absorbance and n the refractive index of the solvent.
As a first step, the two reference standards are cross-calibrated using equation (4.1) by calculating
the quantum yield of each sample relative to the other, i.e. using one fluorophore as the test
sample (X) and the other as the standard sample (ST). The calculated quantum yield should match
the values found in the literature. Since the measurement process to obtain the quantum yield is
susceptible to error due to incorrect dilutions of concentrations, the value is generally considered
to be a good match if the integrated intensity values have good linearity with an intercept at zero
and when the calculated quantum yield is within 10% of the literature value. If the calculated
values deviate too much from the actual value, the measurements have to be repeated. Once
this process is completed and satisfactory values have been obtained for the reference samples,
the quantum yield for the test sample can be determined using the same method. However, for
the test sample two values of the quantum yield are calculated, one using the first fluorophore
as reference standard and one using the other fluorophore as reference standard. The average of
these two values then represents the quantum yield of the test sample. This process is necessary
to further reduce the error in the measurement.
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Figure 4.1: Fluorescence spectra of Fluorescein (red, 3µM), Rhodamine B
(green, 7µM) and Brimonidine (black, 26 mM). Excitation wavelength was
402 nm.
4.1.2 Measurement results
For the purpose of measuring the quantum yield of Brimonidine, Fluorescein and Rhodamine B
were chosen as reference fluorophores, firstly because they are well accepted reference standards
for such measurements [77][78] and secondly because they were readily available within the re-
search group. In a first attempt to measure the quantum yield, the protocol mentioned above
was followed strictly. An example of the fluorescence spectra obtained is shown in figure 4.1 for
the lowest concentrations of Fluorescein (3µM) and Rhodamine B (7µM) as well as the highest
concentration of Brimonidine (26 mM). This graph shows that Brimonidine fluoresces very little
even at very high concentrations, in fact so little that the signal to noise ratio of the measurements
was very poor. This was due to the fact that the integration time on the spectrometer was set
to only one second for the reference standard measurements and had to be kept constant for all
measurements to obtain comparable results.
The area of the fluorescence spectrum for each concentration and compound was then calculated
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Figure 4.2: Fluorescence intensity shown versus absorbance for the three
measured compounds. The intensity of Rhodamine is non-linear with the
absorbance due to fluorescence quenching.
using Origin 7. The results of the measurements are shown in figure 4.2. The value of the quantum
yield of Brimonidine can be calculated using the gradients displayed on the graph for the respec-
tive compound and the known values of the quantum yield for Fluorescein (about 0.76 in pure
water [76]) and Rhodamine B (approximately 0.68 in 94% ethanol [79]).
However, the graph shows some problems with this measurement. Firstly, the values of Brimonidine,
although being linear with absorbance, do not intercept the y-axis at zero. This does obviously not
alter the gradient of the linear fit, but it shows that this measurement was not very accurate and
therefore has to be repeated until a satisfactory relationship is measured that does have an inter-
cept at zero, probably using a longer integration time on the spectrometer to reduce the noise.
Secondly, the values obtained for Rhodamine seem to be subject to self-quenching processes. This
might be explained by the fact that the absorbances of the chosen concentrations did exceed the
maximum value of 0.1 at wavelengths that are longer than the measurement wavelength. The val-
ues follow a linear trend for the first three measurement points as shown by the linear regression
but then start to become non-linear with absorbance. This measurement therefore also has to be
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Figure 4.3: Correct measurement of fluorescence intensity with absorbance.
No quenching is present.
repeated using lower concentrations of Rhodamine.
To increase the signal to noise ratio, the measurements were subsequently repeated using a longer
integration time of 2 s and a physical width of 2 mm on both the excitation and the emission slit,
increasing the spectral bandwidth and the intensity of the fluorescent signal recorded by the spec-
trophotometer. The concentrations used did not follow the protocol presented above but were
mixed for convenience rather than identical absorbances across the different compounds. This
was assumed a valid approach since this will not change the gradient of the integrated intensity
versus absorbance plot. The offset of the Brimonidine data set could not be removed from the
measurement. The integrated fluorescence intensity versus absorption curves obtained for the
three different compounds used in the measurement are shown in figure 4.3. The offset in the
Brimonidine curve is most likely due to the absorption spectrometer being less sensitive than the
fluorescence spectrometer (two different machines were used to measure the respective values)
and thus not detecting the correct absorbances for the low concentrations of Brimonidine whereas
the fluorescence was still detected. Another possible explanation is that scattering from the water
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or the Brimonidine molecules themselves hides the absorbance which is very low for those con-
centrations (in the range of 0.001 - 0.004). It is also possible that fluorescence quenching occurs in
all measured concentrations of Brimonidine and the correct intercept is thus not found. To account
for this offset, two fits to the curve of Brimonidine were used to calculate its quantum yield: A first
fit that was forced through the zero intercept on the y-axis and a second fit that was allowed to
intercept the y-axis at the most appropriate point.
The literature value of the quantum yield of Rhodamine B in ethanol varies widely from 0.49 [80]
to 0.97 [81], depending on the type of ethanol. Since optics grade ethanol was used for this mea-
surement, the values for 94% ethanol (between 0.68 [79] and 0.97) were assumed to be closest to
the true value. The measurement shows that Rhodamine in the ethanol used for this measurement
has a slightly higher quantum yield than Fluorescein since the gradient of the integrated intensity
versus absorbance curve is steeper (9.6×109 in comparison to 8.4×109 for Fluorescein). Therefore
the mean of the two known values was taken and thus a quantum yield of 0.825 was assumed for
Rhodamine B for the calculations. The same problem applies to Fluorescein where values ranging
from 0.65 [81] to 0.92 [74] can be found in the literature. The value of 0.92 seems however a bit
high considering that the pH of water (pH = 7.0) is below the pH that yields the highest quantum
yield (pH > 9.0). This value was therefore disregarded and the mean of 0.65 and 0.76 was taken
and the quantum yield of Fluorescein in water thus considered to be 0.705.
The quantum yields calculated for Fluorescein and Rhodamine B from the measurement curves
were 0.68 and 0.85 respectively, which is within the 10% error band as specified in the measure-
ment protocol and actually very close to the assumed value. This shows that the measurement
parameters were valid. Brimonidine’s quantum yield was then calculated using the values ex-
tracted from the literature and was found to be 0.0035 for the fit with the non-zero intercept and
0.0047 for the forced zero intercept fit. The average of these two measurements is 0.0041. It was
therefore assumed that Brimonidine has a quantum yield of approximately 0.41%.
In comparison, the quantum yield of Fluorescein in water is approximately 0.7 as calculated above.
This shows that Brimonidine fluoresces approximately 171 times less than Fluorescein, meaning
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that the instrument has to be built to be very sensitive to be able to measure concentrations smaller
than 1µM of Brimonidine which is the goal of this project. In animal eyes, concentrations of
Brimonidine as small as 80 nM have been measured using radioactive labelling [82]. It would
therefore be excellent if the F410 could achieve the same sensitivity, and in fact in discussions
with Allergan the desired lowest measurable value was set to be 10 ng ml−1 which is equal to
33 nM. However, if a concentration of smaller than 500 nM can be measured that would be a great
achievement.
The calculation of the quantum yield of Brimonidine is not only useful to help determine the
physical sensitivity the instrument needs to have (i.e. to help decide which set up and which
photo-detectors need to be used to achieve the goal set above), but also to be able to relate the
measurements taken with Brimonidine to a reference standard which was chosen to be Fluorescein
dissolved in purified water. This is particularly important for other researchers who might be
interested in using the instrument built during this project for other compounds since they will be
able to relate the measurements presented in this thesis to their own compound using the relation
between Brimonidine’s and Fluorescein’s quantum yield, as long as the quantum yield of the
compound they want to investigate is known or can be measured. This means that if they know
that a 100 nM solution of a compound with a quantum yield of 0.0041 can be measured using this
instrument, they will be able to calculate what concentration of their compound will be measurable
using the same set-up.
4.2 The F410
4.2.1 Specifications
The research project discussed in this thesis is a collaboration between Durham University and
two industrial partners, Allergan Inc. and Lein AD Ltd. The instrument built during the course
of this PhD or an improved version thereof is to be used in real life applications either on animal
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models or in clinical trials to measure the diffusion of Brimonidine, a drug for treating open angle
glaucoma, in the anterior chamber of the eye. Specifications to which the instrument has to ad-
here to thus had to be agreed upon. These specifications define the parameters and performance
aim of the instrument such as laser and electrical safety and accuracy and resolution of the mea-
surement. The final set of specifications was drafted after the best design of the instrument was
determined and can be seen in appendix A. The performance of the instrument in relation to these
specifications will be discussed both in the next section, in chapter 5 and in chapter 6.
4.2.2 Experimental set-up
Figure 4.4: Schematic diagram of the F410. After the beam leaves the laser
part of it is transmitted through a beam splitter onto a laser power monitor.
The other part is reflected by the beam splitter and reflected by a dichroic
mirror before being collimated by a lens. It is then focused by a scanning
lens, which scans the focus of the beam along the optical axis of the instru-
ment through the sample. The returned fluorescent light is transmitted by
the dichroic mirror onto the fluorescence detector while any reflected light is
reflected off the dichroic mirror onto the reflection detector.
The F410 is a combination of a confocal reflection microscope and a confocal fluorescence micro-
scope. It does however not create a magnified fluorescence or reflection image of the sample.
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Instead, it generates a depth profile of the signal strength along the optical axis of the eye. Unlike
a microscope, where either only the fluorescence or only the reflection from the sample can be
recorded, the F410 measures both signals simultaneously, thus adding spatial information to the
fluorescence signal. This enables the researcher to not only know how much fluorescence is emit-
ted, and consequently determine the concentration in the sample, but also where in the sample the
fluorescence occurred. This provides crucial information when monitoring the diffusion proper-
ties of the compound of interest.
The major part of the instrument was built using the Thorlabs 32 mm cage-mount system to make
the set-up small and more rigid than a conventional bench-top set-up. This decreases the chance
of accidental misalignment of optics with respect to each other since they are interconnected and
forced into alignment by the cage structure.
A schematic diagram of the F410 is shown in figure 4.4, and a correct optical representation in fig-
ure 4.5. A photograph of the optical set up is shown in figure 4.6.The pigtail laser diode (Thorlabs,
λ = 402 nm, 10 mW) is coupled into the instrument using a cage mount adapter. Part of the beam
then passes through a 8:92 (reflection:transmission) cube mounted pellicle membrane beam split-
ter (Thorlabs) and is focused by a plano-convex lens (f = 50 mm, Thorlabs) onto a photo detector
(Thorlabs, 350-1100 nm, λmax = 970 nm) for the purpose of external monitoring of the laser inten-
sity. The other part of the beam is reflected off the beam splitter onto a dichroic mirror (Thorlabs,
50% transmission/reflection at 425 nm, reflection band 380-410 nm, transmission band 440-700 nm)
which reflects the blue light towards a collimating lens (achromatic doublet, Thorlabs, f = 200 mm).
The collimated beam is focussed by a doublet meniscus lens combination (CVI Melles Griot, f
= 47.11 mm) that is mounted on a motorised stage (SMAC Europe Ltd.) which scans the focus
along the optical axis of the instrument through the sample. Light that is reflected off the sample
passes back through the scanning lens, is diverted by the dichroic mirror towards the first beam
splitter and is subsequently focused through a pinhole (= 100µm) mounted in an xyz transla-
tion stage onto the reflection detector (Thorlabs, 350-1100 nm, λmax = 970 nm). Any fluorescent
light emitted from the sample has a longer wavelength and passes through the dichroic mirror.
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Figure 4.5: A schematic diagram of the instrument as simulated in Zemax.
It is then focussed through an additional longpass emission filter (Thorlabs, cut-on wavelength
450 nm) to remove any residual excitation light and a second pinhole (= 50µm), also mounted in
an xyz translation stage, onto the fluorescence photo-multiplier tube (PMT) detector (Hamamatsu
photonics part number H9306-04, multialkali cathode type, peak sensitivity 530 nm, dark current
0.1 mV at a control voltage of 1 V). The data is recorded using an analogue to digital converter
(ADC) (Measurement Computing). The position of the scanning stage, the laser intensity, the
control voltage of the photo-multiplier, the reflection and the fluorescence signal are recorded si-
multaneously. To couple the data sampling to the position of the scanning stage, a conversion is
triggered every 20µm that the stage has moved by using the pulsed signal from the internal op-
tical encoder of the scanning stage as described below. This way, the speed of the stage which is
influenced by acceleration and deceleration at the beginning and end of travel does not corrupt
the data. If not for this arrangement it would be impossible to determine the position within the
sample at which the measurements were taken.
The instrument is currently run by the electronics supplied by the manufacturers of the various
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components. These will in a future version be combined into purpose-built in-house electronics
to reduce the number of cables and move the electronics to the inside of the instrument’s casing.
Plans for the new electronics have been submitted, but unfortunately they were not finished by
the time this thesis was submitted which is why no improvement can be reported here. The home
built electronics will include power supplies for all components and control electronics for the
photo-detectors and the photo-multiplier tube. The laser is driven by a generic blue laser diode
driving printed circuit board (Thorlabs) and the scanning stage is controlled using the controller
supplied by the manufacturer. Only three cables will connect the final version of the F410 to the
outside world - a cable for supplying power, a USB cable for communication with the ADC and a
RS232 cable that is used to communicate with the controller of the scanning stage. The instrument
will be able to be either run off the European standard voltage or off the voltage supplied in the
United States of America. This feature was added since the instrument is ultimately to be used in
trials at Allergan Inc., California. The reference voltage of the PMT will be settable in four discrete
steps of 0.25, 0.50, 0.75 and 1.00 V to change the overall gain of the instrument. This ensures good
resolution over a large range of concentrations. Currently, the reference voltage can be set to any
value between 0 and 1V.
Figure 4.6: A photograph of the F410 showing the laser source (1), the laser
safety monitor (2), the scanning stage (3), the sample (4), the reflection de-
tector (5) and the fluorescence detector (6).
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Figure 4.7: Axial point-spread function of the reflection arm of the F410. The
full-width half-maximum of the response is 285µm.
4.2.3 Lateral and Axial resolution
The pinholes chosen for the confocal reflection and confocal fluorescence detection may seem quite
big. However, as discussed in chapter 3, a trade off has to be made between pinhole size and signal
strength and thus signal to noise ratio. Since the photo diode used for the detection of the reflection
from the sample is not enhanced for UV detection and thus has low yield for short wavelengths
a comparatively big pinhole had to be used in this arm of the instrument to improve the intensity
of the detected light. The fact that this decreases the axial resolution is not a problem in this case
since the reflection is only used as a landmark feature to determine the start of the sample and
not for specific thickness measurements. The FWHM in this arm as measured by scanning the
focus of the beam through a mirror is 285µm. The measurement and a gaussian fit is shown in
figure 4.7. Theoretically, as determined by using equation (3.17), the axial resolution in a confocal
microscope with the properties of the F410 (a wavelength of 402 nm and a numerical aperture of
0.187) is as good as 16µm. The corresponding FWHM equals 14.08µm as calculated from equation
(3.19). The reason why no comparable value is achieved with the F410 lies partly in the fact that
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the pinhole diameter is above the optimal size as discussed in [67], and partly in the fact that the
beam is quite aberrated and the focus thus slightly blurred. The aberrations have been minimised
as much as possible by replacing the original dichroic mirror with a thicker version but residual
aberrations remain which decrease the axial and lateral resolution. The lateral resolution has not
been determined since it was less important to this project and is a lot harder to measure in the
current system. It would have required an external lateral scanning target to have been built
as the instrument only scans in the axial direction. This target would then have to have been
moved exactly perpendicular to the axially scanning beam, and the resulting axial measurements
would then have to have been analysed to remove the possibility of axial defocus from affecting
the lateral measurement. This procedure would have lead to large measurement errors and the
lateral resolution was thus not determined. The theoretical lateral resolution of the instrument as
calculated from equation (3.16) is 0.9µm with an associated FWHM of 0.756µm.
The axial resolution of the fluorescence detection arm was determined in the same way as the axial
resolution of the reflection arm. The emission filter was removed for this measurement to allow
for a residual amount of excitation light reflected by the mirror to pass through the dichroic mirror
onto the PMT. The obtained PSF is shown in figure 4.8. Due to the fact that the pinhole in the
fluorescence arm is only half the diameter of the pinhole in the reflection arm, the axial FWHM is
increased to 124µm. The axial resolution in this arm of the instrument was originally even further
improved by using a smaller pinhole of 25µm diameter, however to increase the intensity of the
collected fluorescence signal for the measurements of Brimonidine which has a very low intensity
as discussed in section 4.1 it was decided to increase the pinhole size. As described in chapter
3 the actual axial resolution in a fluorescence confocal microscope is dependent on the excitation
and the emission wavelength of the system as the excitation and the emission PSFs cannot be
assumed to be the same. The emission detected by the F410 is not a single wavelength band but
all wavelengths longer than 470 nm to the cut-off of the PMT. Both Fluorescein and Brimonidine
are not excited at their ideal wavelength - Fluorescein’s absorption maximum is at 493.5 nm and
Brimonidine’s absorption maximum is in the UV-A band - but for the purpose of the calculation of
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Figure 4.8: Axial resolution of the fluorescent arm of the instrument. The
full-width half-maximum of the point-spread function is 124µm.
the theoretical axial resolution the maximum emission wavelength (510 nm) of Fluorescein when
excited with a wavelength of 402 nm was used. The theoretical axial FWHM thus increases from
14.08µm to 18µm and the lateral FWHM from 0.756µm to 1µm.
As discussed in chapter 3, the FWHM describes the width of the PSF at the 50% signal level.
However, to be able to compare the F410 with other fluorophotometers, the axial resolution has
to be expressed as the half width of the PSF at the point where the signal has fallen to 3%. This
resolution was therefore determined for the fluorescence arm and found to be 280µm, which is
slightly worse than the resolution of the Fluorotron MasterTM when using its anterior chamber
adapter, but an order of magnitude better than the Fluorotron’s resolution without the adapter.
4.2.4 Noise
Since the fluorescence intensity of Brimonidine is very low as described in section 4.1, the signal
coming from the PMT has to be amplified and filtered in order to increase the signal to noise ra-
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Figure 4.9: The relationship between the reference voltage of the photo-
multiplier and the dark noise produced by the detector.
tio and make the measurements of Brimonidine samples more reliable. The PMT itself provides
some amplification through the variable reference voltage that changes the internal gain, how-
ever this method of amplification does not provide enough gain to make lower concentrations of
Brimonidine visible. Increasing the reference voltage on the PMT furthermore increases the dark
noise of the detector which is caused by the flow of thermal electrons from the photocathode and
the dynodes. The dark noise increases exponentially with the reference voltage as shown in figure
4.9. Other probable sources of noise are unwanted background signal (e.g. from room lights or flu-
orescence within the optics) that is registered by the PMT, especially at higher gains, and statistical
variations in the number of photons hitting the detector from the emitted fluorescence in the sam-
ple during the integration, also called photon or shot noise. To determine the main contributor of
additional noise, measurements were taken with the laser switched on but no sample in place, and
with samples of Fluorescein of different concentrations. It was found that very little background
signal is registered by the PMT when no sample is present, provided that either the instrument is
in a black box or the room lights are switched off (figure 4.10). The main contributer of noise to the
measurements is the variation in the number of photons hitting the detector. This particular type
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Figure 4.10: The unwanted signal intensity shows an exponential relation-
ship with increasing PMT reference voltage.
of noise is governed by Poisson statistics, which describe the occurrence of independent random
events. The shot noise is thus equivalent to the square root of the amplitude of the detected signal.
The fluctuation is greatest if high concentrations are measured at high reference voltages as shown
in figure 4.11. The shot noise created by a 100µM solution of Fluorescein at a reference voltage
of approximately 700 mV for example is ≈0.21 V, compared to a background signal of ≈0.012 V
and a dark noise of ≈0.008 V, showing that random fluctuations in photon arrival are the main
contributer of noise to the measurement. Therefore, some electronic filtering had to be introduced
into the set up to reduce the noise in the measurement before amplification. This was achieved
by connecting the PMT output to an active low pass filter with a corner frequency of 88 Hz and
an amplification of 1800 V/V. The corner frequency has to be chosen carefully since a trade-off
between noise rejection and rejection of actual measurement data has to be found. Theoretically,
the signal can change with a very high frequency if it is assumed that for each "step" of the scan-
ning stage the signal changes from 0 to 100%. The length of a step will have to be defined as the
stage scans continuously and thus the returned signal changes continuously. If a step of the stage
is defined as 1µm and the stage is run at the maximum possible speed (40 mm s−1), the highest
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Figure 4.11: The dependency of the fluctuation of the photon count with
PMT reference voltage and concentration of the sample.
frequency the signal could change with is 40kHz. To confirm if this frequent change can occur in
a real measurement situation, calculations of the diffusion speed of a drop of Fluorescein in water
were made.
Fluorescein has a diffusion coefficient of (4.25± 0.01)× 10−6cm2s−1 at 25 degrees centigrade [83].
Although the temperature in the research laboratory is usually lower at about 20 degrees centi-
grade, the value for 25 degrees centigrade was used because no value for lower temperatures
could be found in the literature. To calculate how much Fluorescein will have diffused over a spe-
cific distance within a given time the one-dimensional diffusion equation (Fick’s second law) has
to be used. The diffusion equation states that the concentration change dC with time t is depen-
dent on the diffusion coefficient D (which in turn is dependent on the mass of the compound), the
initial concentration C at position zero and the distance x from position zero:
dC
dt
= D
d2C
dx2
. (4.2)
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According to the literature [84], the solution to this equation is given by
c (x, t) =
M√
4piDt
exp
(
− x
2
4Dt
)
, (4.3)
with c being the concentration at position x and time after the release t, M being the total mass
of the substance released per unit cross-sectional area, and D being the diffusion coefficient. This
solution is a fundamental solution that only applies for specific boundary conditions which state
that no initial concentration is to be present except from a localised release that takes the form of
a Dirac function (i.e. an infinitely tall and infinitely narrow peak) which in the case considered
here would be the initial drop of Fluorescein, and that the substance will take an infinite time to
reach the infinitely far away end of the mathematical domain. Therefore this solution provides the
means to calculate the spreading of an instantaneous localised release of a substance in an initially
substance free medium.
For the release of a drop of Fluorescein in an infinitely wide volume of water the mass of the
released Fluorescein has to be calculated first. Therefore, some assumptions have to be made.
First of all it was assumed that a concentration of 1 M was released, and secondly that 1µl of this
concentration would be released over a 1µm diameter area. Thus the total mass per unit area of
released Fluorescein would be 4.2 × 106g cm−2. Since the step width was defined as 1µm for the
consideration of the theoretically maximum possible frequency of change above, the same value
was used for the consideration of the actual diffusion speed. To scan 1µm, the scanning lens
needs 0.025 ms when operating at a speed of 40 mm s−1. Thus, using the solution to the diffusion
equation given in equation (4.3), the amount of Fluorescein that would have spread this distance
within the given time frame would be 7 g cm−2. This is a reduction in concentration of more than
99% compared to the position before. This shows that Fluorescein diffuses very slowly and thus
the maximum signal change of 40 kHz is theoretically possible in a real measurement situation.
However, any frequency higher than 1000 Hz will not be measurable by the system. This is due to
the fact that the sampling speed of the ADC is 2 kHz and thus according to the Nyquist criterion no
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frequencies above 1 kHz can be resolved. This upper frequency limit defines how steep a concen-
tration gradient the F410 is capable of measuring if no low pass filter is applied. Therefore, either
no filter or a low pass filter with a corner frequency of 1 kHz and a steep cut-off should be applied
to make sure that none of the possible signal change is lost. This however creates a problem due
to the sensitivity of the system to any stray light entering the outer case which will fluctuate at
a frequency of 50 Hz and multiples thereof. It would thus be desirable to filter out any frequen-
cies at and above 100 Hz to remove as much of the influence of noise created by mains voltage
and external light as possible (a corner frequency of below 50 Hz is not feasible). It was therefore
decided that using a low-pass filter with a corner frequency below 100 Hz would be necessary to
increase the signal to noise ratio, even if this also means rejecting any signal change above 100 Hz.
It was furthermore experimentally confirmed that a filter with such a low corner frequency would
not influence the signal for the calibration measurements which rely on a fast response of the data
acquisition system. Therefore, while waiting for the home build electronics to be designed and
made, a simple single-stage active low pass filter with a corner frequency of 88 Hz and a gain of
1800V/V was used to increase the signal to noise ratio. The more refined electronic control system
will incorporate a 5 stage Chebychev low pass filter with an amplification of 1000 V/V, a pass band
frequency of 75 Hz and a stop band frequency of 95 Hz. Additional amplification of 1000 V/V is
added in a separate stage before the filter so that the total amplification of the filtering system will
be 2000 V/V.
4.2.5 Control software
The F410 is controlled via purpose-written software (see appendix B). All software was pro-
grammed using Python. The software includes the calibration of the instrument and the mea-
surement routine as well as the data analysis and display. It was written for functionality rather
than practicality and has not been combined into a single control programme yet. It is currently
split into four master programmes and several smaller routines. The four master programmes
control the calibration, the data acquisition, the analysis of the data and the display of the data in
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various ways. Even though it would obviously be better if the software was combined into one
single programme with a graphical user interface the available software can still be used easily by
a trained person. A short description of the different software parts is provided below.
1. Calibration
The calibration software is currently split in several sub-programmes. In the first programme,
parent2.py, the data sets are first shifted for every concentration such that the reflection peaks
are in the same place. In the next step the signal is averaged over the complete data set. The
averaged signal is then scaled to a gain of one in the PMT to make sure that the measure-
ments are comparable even when originally taken at different gains. After this step, the
unnecessary part of the array is truncated (i.e. any data before the inside of the cuvette or
eye) to ensure a good fit to the data. The fitting is slightly different for Brimonine than for
Fluorescein. As described in chapter 5, the data for Fluorescein follows an exponential decay
due to high absorbance, whereas the data for Brimonidine follows a linear trend. Therefore,
a selection for Fluorescein or Brimonidine calibration has to be made in the software and
the appropriate fitting functions are then used for the data. The obtained fitting parameters
are subsequently saved into a text file. A second programme, a-of-c.py, associated with the
calibration is used to read the fitting parameters from the file and create a linear fit to the
fitting parameters. This second fit is the important one since using the obtained parame-
ters in the data analysis software allows for concentrations with unknown parameters to be
determined.
2. Data acquisition
The data acquisition (AD converter control v12.py) is controlled via the ADC and the scan-
ning position of the motorised stage. The ADC is armed by the programme before the stage
is started. The position of the stage is controlled by an optical encoder which returns a TTL
pulse every 0.5µm. This signal is picked off and divided using a counter so that a pulse is
given to the trigger of the ADC every 20µm the stage has moved. The ADC trigger re-arms
automatically after each measurement point collection. The number of collected measure-
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ment points is checked by reading the status of the ADC which returns the index of the last
data point of the data array. Once the set number of samples has been collected for one
scan (i.e. one movement of the stage from starting to stopping position or from stopping to
starting position), the triggering loop is stopped and the collected values are converted from
internal units to voltage. If the recorded scan was a backward scan starting movement at the
position defined as stop and moving to the position defined as start, the obtained data array
is flipped to resemble a forward scan. The array that was collected from a single scan is then
appended to an array that holds the data for all scans from that measurement session. After
the data of one scan has been appended to the measurement array the trigger of the ADC is
re-armed by the software and the cycle repeated until the defined number of scans has been
collected. Once all scans have been appended the measurement array is written to a text file
for further analysis. Figure 4.12 shows a simplified flow chart of the data acquisition process.
3. Data analysis
The data analysis software (recover.py, conc-det.py) calculates the concentration of the sub-
stance in the sample from the obtained fluorescence intensity file. For this, the signal is first
scaled to gain one of the PMT and the background signal subtracted. In the next step, the
calibration parameters for the specific substance (i.e. either Brimonidine or Fluorescein) are
loaded from the calibration file. Using the calibration parameters, the concentration is re-
covered as described in chapter 5 by following a five-step procedure where in the first step
the concentration is determined from the current intensity, in the second step the decay rate
for that concentration is found, in the third step the expected intensity at the next position
is calculated using the determined decay rate, in the fourth step the expected intensity is
compared to the actual intensity at the next position and in the fifth step the intensity at
the next position is corrected by the difference determined in step four (unless the change is
smaller than a certain error band). This process is repeated until the end of the data array
has been reached. In the case of Brimonidine, no decay rate is used to calculate the intensity
at the next position since the decay caused by Brimonidine is so small that it vanishes in the
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noise as described in section 5.1.3. The array with the determined concentration values is
then returned to the data analysis programme and saved as a text file as well as a graphical
representation.
4. Data display
This very simple programme (DAV5.2.py) loads the fluorescence intensity data or the con-
centration data from the measurement file and saves a graphical representation for each sin-
gle scan. A second programme is available which saves a three-dimensional representation
of the data so that diffusion patterns are more easily visible to the untrained person.
4.3 Laser safety
Since the F410 is the prototype of an ophthalmic instrument that will be used on human volunteers,
the consideration of the safety for the human eye regarding to exposure to the laser beam of the
instrument is of great importance. Several points have to be considered which will be discussed
in this section.
In general, the thermal and photochemical hazards for the eye caused by the laser beam have to
be investigated. This includes the hazard to the retina and the hazards to the cornea and lens
which are particularly sensitive to blue and UV light. According to the British Standard [85], the
retinal hazard region ranges from a wavelength of 400 nm to 1400 nm. This includes retinal thermal
hazard from 400 to 1400 nm, with the risk being quite low at the shorter wavelengths, and blue-
light photochemical hazard from 400 to 550 nm. Light below 400 nm is filtered out by the human
cornea and lens, and thus causes a hazard to those regions rather than the retina (photokeratitis in
the cornea and cataract in the lens). However, the transition between UV and blue light is much
less defined in nature than in science - some people might respond with the same effects to light
of slightly longer wavelength as others do to UV. Therefore, it is important to not only follow the
suggestions of the standard as given by the laser wavelength but to also take into account the
damage the light might do to cornea and lens, especially since the beam is focused into a small
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Figure 4.12: Simple flow chart of the data acquisition process.
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spot and has a high irradiance (power density) in the focus.
4.3.1 The British standard for the safety of laser products
The British standard for the safety of laser products describes and defines the characteristics of
the different laser classes (1, 1M, 2, 2M, 3R, 3B, 4). The classes are defined by how much power
or energy is emitted from the laser at a point that is accessible to humans (this power or energy
is also called accessible emission). A laser or a laser system can be classified by measuring the
output power as described in section 9 of BS-EN60825-1 and then comparing the obtained value
with the values given for the respective laser classes. Conversely, from the values given in the
standard, a laser system can be forced into a specific class by applying neutral density filters or
other appropriate beam attenuation.
Two values relevant to the safety of the eye can be extracted from the standard; the maximum
permissible exposure (MPE) and the accessible emission limit (AEL). The MPE describes the max-
imum limit above which damage of the eye might occur. It includes correction factors to not only
prevent damage to the retina but also to the cornea and lens, which are especially susceptible to
damage from UV, blue and infrared light. Therefore, no further precautions have to be taken to
consider damage to the cornea and lens when operating at short wavelengths when the conditions
the standard applies to are given. The values given in the standard have been determined using
experimental data from studies and are rather conservative to ensure that they can be used safely;
the actual damage threshold lies up to fives times above the given limit. Furthermore, the MPE is
only a guideline value, so common sense has to be applied if values slightly higher than the MPE
are encountered (e.g. if the MPE is exceeded by only very little a system might still be considered
eye safe). The second value, the AEL, is the limit of emission that is allowed to be accessible to
humans for a particular laser class.
The British standard assumes either collimated or divergent light viewed at a distance of 100 mm
from the apparent source (e.g. the exit of a fibre) so that an almost diffraction limited spot of the
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size of 10 to 25µm is formed on the retina. With decreasing distance to the apparent source the
image size on the retina increases because the eye cannot accommodate for such a close source,
and thus a higher radiation level than the AEL may be taken by the eye without causing damage
to the retina. In the case of the F410, the beam will only focus on the back of the retina if the eye
is far enough away from the exit aperture, however the pupil (even if dilated) will block out most
of the highly divergent light and thus decrease the irradiance drastically (see figure 4.18). If the
eye is close to the scanning lens (i.e. within the measurement range), the focus will not reach the
retina due to the design of the illumination system. This is quite a big deviation from the standard
which will be discussed below.
The BS-EN60825-1 has not been derived for intentional viewing of the beam, and although medical
applications of lasers (for surgery) are mentioned very briefly, no guidelines for intentional intra-
beam viewing with typical illumination arrangements for ophthalmic instruments (such as e.g.
Maxwellian illumination, fig. 4.13) are given. Safety factors for cornea and lens are incorporated
into the standard, however they only apply to collimated and divergent beams. The AEL and
the MPE include these safety considerations, but they are only valid if the beam is focusing on the
retina leading to comparatively low irradiances in the cornea and the lens. Therefore, the standard
cannot apply for an instrument such as the F410 where high irradiances occur in the cornea and
the lens, but not on the retina.
Nonetheless, the British standard can be used to assess the safe limit of retinal irradiance for a
Class 1 (and thus inherently eye-safe) laser system. For this purpose, the AEL and the MPE for
a Class 1 system have to be calculated. To calculate the appropriate values, it has to be assumed
that the beam is collimated when hitting the cornea and thus will focus on the retina. The second
assumption that is inherent in the standard is that if the diameter of the beam is smaller than the
limiting aperture which is set to the size of the dilated pupil (7 mm), the diameter of the beam is
set to the size of the limiting aperture. This is done to account for the smallest possible spot size on
the retina, meaning that the measured power has to be averaged over a 7 mm diameter aperture.
The AEL for a Class 1 or Class 1M collimated laser at a wavelength of 400 to 450 nm and a viewing
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Figure 4.13: A schematic diagram showing Maxwellian illumination of the
eye.
time of 10 to 100 s can then be taken from table 4 [85]:
3.9× 10−3 J. (4.4)
Depending on the viewing time, the corresponding emission limit ranges from 390µW for 10 sec-
onds and 39µW for 100s. The MPE can be taken from table A.1:
100 Jm−2, (4.5)
again with the viewing time being the deciding factor since at 10 s the MPE would equal 10 Wm−2
whereas at 100 s it equals 1 Wm−2.
Both these values are to be measured at the access point (i.e. the cornea). The AEL is derived from
the MPE and thus yields an irradiance of 1.01 Wm−2 at the cornea when averaged over the 7 mm
diameter pupil for an exposure time of 100 s. Both values only apply at the cornea and not at the
retina. The standard specifies this by stating that the equations for the MPE give the "maximum
permissible exposure [...] at the cornea". If the AEL derived for an exposure duration of 100 s
(39µW) is used to calculate the safe retinal exposure limit, assuming that the light entering the eye
is subsequently focused down to a 180µm diameter spot on the retina (corresponding to a viewing
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angle of 11 mrad as defined in the standard for longer viewing periods), the result is
EAEL,R = 1532.6 Wm−2.
This is the MPE at the retina and the relevant number for the instrument presented in this thesis
since every plane within the eye (cornea, lens, retina) needs to be considered separately to evaluate
the safety due to the unconventional illumination geometry and the scanning of the lens. The
retinal MPE from the standard can then be compared to the actual values encountered in the F410.
Figure 4.14: Snapshot of the Zemax model that was used to determine the
spot sizes on the retina as the focus of the measurement beam scans through
the eye.
4.3.2 Simulation of the illumination pattern of the F410
To evaluate the safety parameters of the system at hand it is important to calculate the irradiance
at the relevant surfaces of the eye for different positions of the focus. This enables the comparison
CHAPTER 4. INSTRUMENTATION 72
Figure 4.15: Simulation of the spot size and the irradiance as produced by
the F410 on the retina as the focus scans through the eye.
of predicted irradiance values with the limits set by the standard and other relevant sources. To
help with the evaluation of the measurement system, a model of the scanning lens and the eye
was created in Zemax (Radiant Zemax LLC, Version 2011). The scanning lens is a combination of
a doublet and a meniscus lens, both supplied by CVI Melles Griot and glued into a home made
holder using UV cure glue. The lenses are sold together for a fixed focal length and can thus
be imported into Zemax from the CVI lens catalogue in that exact same combination. The eye
used for the Zemax simulation was the Liou & Brennan 1997 eye model as supplied by the Zemax
knowledgebase article "How to Model the Human Eye in Zemax" which is considered the best
currently available model for the living eye since it takes into account the different curvatures of
the anterior and posterior surfaces of the lens and also provides a different refractive index for
the lens core which other models omit [86]. The scanning lens was then moved in respect to the
position of the eye from a distance of 0 mm from the cornea to a distance of 100 mm in steps of
5 mm and the RMS spot size on the retina simulated using Zemax’s spot diagram. Figure 4.14
shows a diagram of the simulation optics.
A distance of 0 mm to the cornea will never occur in a real measurement situation, but for the
purpose of the model it was included. The data obtained from this model confirms the assumption
made above that the beam will never focus on the retina unless the scanning lens is quite a distance
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Figure 4.16: The scanning lens positioned such that the focus is in the an-
terior chamber of the eye. With rL being the radius of the scanning lens, α
being the convergence angle, d being the distance of the lens from the eye,
f being the focal length of the lens, x being the depth of the focus in the
anterior chamber and dC being the diameter of the beam on the cornea.
away from the eye. The retinal spot size and irradiance is shown in figure 4.15.
The retinal spot size starts to decrease once the scanning lens is more than approximately 60 mm
away from the eye. At this point, due to the focal length of 47 mm and the resulting high di-
vergence of the beam, the pupil starts clipping parts of the beam and thus reduces the possible
irradiance on the retina as shown in the graph. According to the model, the highest retinal irra-
diance is encountered at a distance of approximately 39 mm from the eye; however this is most
likely not the case since it is a well known fact that the simple ray tracing mode in Zemax is not
capable of accurately modelling the system when the focus of the beam happens to be exactly on
the surface of an optical object. The spike in irradiance in figure 4.15 can therefore be disregarded
as an artefact of the modelling, as it follows from logical consideration of the beam path that the
spot size and thus the irradiance on the retina at this distance of the scanning lens from the eye
will be similar to the spot sizes encountered adjacent to this position. However, for the reason of
added security, three times the irradiance predicted by Zemax was used to evaluate the hazards
to the retina. The factor of three was considered to be a reasonable safety margin.
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Figure 4.17: The focus inside the anterior chamber of the eye. With rL being
the radius of the scanning lens, α being the convergence angle, d being the
distance of the lens from the eye, f being the focal length of the lens, lA being
the depth of the anterior chamber, x being the depth of the focus in the eye, y
being the distance of the focus from the pupil plane and rP being the radius
of the beam at the pupil plane.
The irradiance on the retina can be calculated by dividing the incident power by the retinal spot
size. The incident power was assumed to be 39µW which is the AEL for a Class 1 laser for a view-
ing period of 100 seconds as defined by the British standard. To calculate the correct irradiance,
the beam diameter at the pupil plane needs to be taken into account. The retinal spot size as given
by Zemax was calculated using a 7 mm diameter pupil as defined in the standard for the smallest
spot size on the retina. Even though the pupil will constrict in the measurement conditions pre-
sented by the F410 and the spot size on the retina will thus be smaller than predicted by the Zemax
model, a smaller percentage of the absolute power of the beam will be let through the pupil and
thus the irradiance on the retina will be smaller than when measured with a 7 mm diameter pupil.
Therefore it was considered appropriate to use a 7 mm diameter pupil as the limiting aperture for
the simulation. In any situation where the beam diameter at the pupil plane is larger than the
limiting aperture the irradiance on the retina therefore has to be corrected by the factor that the
beam is overfilling the pupil with. This can theoretically be done by dividing the incident power
by the clipping factor and then calculating the irradiance for the non-clipped area to account for
the decrease in irradiance. However, for the retina the non-clipped area is not known due to the
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Figure 4.18: The focus outside the eye. With rL being the radius of the scan-
ning lens, α being the convergence angle, d being the distance of the lens
from the eye, f being the focal length of the lens, x being the distance of the
focus from the eye and rC being the radius of the beam on the cornea.
fact that a 7 mm diameter pupil was used in the Zemax model and thus only the clipped spot sizes
are known. Therefore, the retinal irradiance in cases where the beam is overfilling the pupil has to
be calculated from the clipped irradiance directly after the pupil.
To calculate the irradiance at cornea and lens (or in this case directly after the 7 mm limiting pupil),
simple geometric approximation was used. Two general lens positions were considered, one with
the focus inside the eye (figures 4.16 and 4.17) and one with the focus outside the eye (figures
4.18 and 4.19). Using the diagram provided in figure 4.16, the spot size and thus the irradiance
on the cornea can be calculated for positions of the scanning lens where the focus is inside the
eye (0 to 48 mm distance of the lens from the cornea). The spot size is calculated using the law of
proportionality:
rC =
rL
f
× (f − d) . (4.6)
The same principle is used for calculating the spot size at the pupil plane for positions where the
focus is inside the eye as depicted in figure 4.17:
rP =
rL
f
× (lA − (f − d)) . (4.7)
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Figure 4.19: The focus outside the eye. With rL being the radius of the scan-
ning lens, α being the convergence angle, d being the distance of the lens
from the eye, f being the focal length of the lens, x being the distance of the
focus from the eye, lA being the depth of the anterior chamber and rP being
the radius of the beam at the pupil plane.
For positions where the focus is outside the eye, the spot size at the cornea is calculated by
rC =
rL
f
× (d− f) (4.8)
as derived from figure 4.18, and the spot size at the pupil plane can be calculated by
rP =
rL
f
× ((d− f) + lA) , (4.9)
as shown in figure 4.19. The values for the pupil plane are for the full beam size and have to be
corrected by dividing them by the factor by which the beam is larger than the pupil size. For any
beam sizes that are smaller than 1 mm in diameter the beam size has been set to 1 mm according
to the paper discussed in the next section. The spot sizes and respective irradiances for the cornea
and the lens (i.e. directly after the pupil) are shown in figures 4.20 and 4.21. The highest irradiance
that can theoretically be encountered in the cornea and the lens occurs when the focus is incident
on the respective surface. The lateral radius of the focus can be calculated from equation 3.8 which
describes the spread of the focus and thus the image in a conventional microscope. The size of the
focal spot in the F410 would therefore theoretically be as small as (1.3µm)2, thus giving a possible
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Figure 4.20: Model of the spot size and irradiance produced by the F410 as
the beam scans through the cornea. The irradiance shows a flat cut-off at
approximately 50 Wm−2 due to the fact that the power was averaged over a
1 mm aperture rather than the theoretical spot size.
irradiance of 7.22 × 106 Wm−2. However, due to aberrations and misalignment in the system it
is safe to say that this irradiance will never be reached. Furthermore the power of the beam will
be spread over a much greater area than the theoretical focal spot size by small eye movements.
Thus the averaging over a 1 mm aperture for small beams as described in section 4.3.3 was used
for the calculations. Using this averaging, the highest possible irradiance encountered in the focus
and thus in the cornea and the lens is 49.7 Wm−2 as shown by the hat-shaped irradiance cutoff in
figures 4.20 and 4.21.
4.3.3 Guidelines for ocular safety with the use of ophthalmic instruments
As discussed above the BS-EN60825-1 does not explicitly state any limits for the irradiance of
cornea and lens. Limits are inherent in the values given by the standard but since the standard
does not consider the focusing of the light in any part of the eye other than the retina, it is not
applicable to the F410. Therefore, another source to define those limits had to be found. Even
though it incorporates a section on ophthalmic instruments that recommends an adjusted MPE for
the retina, the Amercian standard does not cite any limits for the cornea and lens neither. There
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Figure 4.21: Model of the spot size and the irradiance produced by the F410
in the lens. The flat cut off in the irradiance is due to the averaging of the
beam power over a 1 mm aperture.
is, however, a task group of the International Commission on Non-Ionizing Radiation Protection
(ICNIRP) around Dr. David Sliney who has been looking at damage to the eye from ophthalmic
instruments. This group has published at least two relevant papers [87][88] which describe the
hazards and limits for the cornea and the lens and are considered guidelines for the American
standard. Since the British standard does not apply to the F410, but best practice has to be fol-
lowed for health and safety reasons, these two papers were considered valid references. The first
paper, "Adjustments of guidelines for exposure of the eye to optical radiation from ocular instru-
ments: statement from a task group of the International Commission on Non-Ionizing Radiation
Protection (ICNIRP)" [87], is the more relevant one in this case since it does not only adjust the
retinal MPEs but discusses the implications for lens and cornea. This paper, which was also rec-
ommended to the author of this thesis to evaluate the limits for the F410 by personnel of the British
Health and Safety Agency, includes several tables which state the exposure limits for cornea, lens
and retina for photochemical and thermal hazards. According to both the British standard and
the papers, a wavelength of 402 nm falls in the visible range and does not create any hazard to
the cornea, however for the evaluation of the system a long UV-A operating wavelength was as-
sumed. For the lens, a thermal hazard applies for wavelengths of 360 to 450 nm, and for the retina
the blue light hazard applies for similar wavelengths. Table 1 states the "exposure guidance and
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Ocular surface Exposure guideline Aperture Maximal exposure duration
Cornea 3 mJ cm−2 1 mm 0.6 s
Lens 1 J cm−2 1 mm 201 s
Retina 2.2 J cm−2 1 mm 1517 s
Table 4.1: Exposure guidelines and damage thresholds at relevant ocular
planes.
hazard thresholds at each relevant ocular plane". Assuming a wavelength of 400 nm and a maxi-
mum irradiance of 49.7 Wm−2, the maximal exposure duration for cornea, lens and retina can be
calculated (table 4.1). The calculations show that the guideline limit for the cornea is below the
actual exposure occurring in the F410. According to the paper, the cornea should be exposed for
only 0.6 s within one day; the exposure duration by the F410 is longer. After careful consideration
it was chosen to ignore this safety guideline. The first reason for this decision is that the F410 does
not actually operate in the UV but rather in the very short blue wavelength range and thus the
cornea should not be affected at all according to both the British standard and the ICNIRP paper.
The second reason is that the most dangerous wavelength for the cornea is in the short UV at
270 nm which is a reasonable distance away from a wavelength of 402 nm. Considering these two
facts it was decided that the probability for damage to the cornea in healthy individuals is low.
The averaging aperture for the calculations of the actual irradiance is given as 1 mm due to small
eye movements which will spread the power over such an area in a very short time, even when the
actual focus is smaller than 1 mm diameter. This averaging aperture takes into account head re-
striction and eye stabilisation. However, the paper states in section 3C ("Applying Infrared Limits
to Protect the Cornea and Lens") that the area over which the energy should be averaged in the
lens needs further investigation and that it is possible that the aperture should be smaller than
1 mm diameter. It is mentioned several times that 1 mm is the maximum applicable aperture. This
aperture was derived from mathematical models of heat dissipation and corneal injuries from in-
frared lasers. In the case of the F410 a head- and chin-rest is used to help the subject position
their eye. However, the head is not restrained and the eye not stabilised and can move freely. It
is therefore believed that an averaging aperture of 1 mm is applicable. The British Standard con-
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firms that it is rare to get a spot size as small as 135µm in diameter when the exposure duration
is 100 s (Annex C). However, the BS-EN60825 applies correction factors for eye movements for
long exposure durations so that the numbers from the paper and the standard are not directly
comparable.
If the maximal exposure duration that will actually occur in any point of the eye is known, the
maximum permittable exposure can be calculated reversely from the equations given in table 4.1.
The probing beam exiting the F410 is scanning through the patient’s eye on the optical axis with
a speed of 40 mm s−1, over a scanning distance of 10 mm. Since the averaging aperture is 1 mm
and the convergence angle of the beam is 0.189 mrad, the length of the beam that has the highest
irradiance of 49.7 Wm−2 is 5.22 mm. Therefore, the focal volume spends approximately 0.13 s per
scan within any part of the eye. If it was assumed that one measurement session included 100
scans, and that 10 measurements were taken every day, this would mean that the focus spends a
total of 130 s in any part of the eye in one day. This is an exaggeration of the number of scans that
will occur in a real life situation; however for the reason of safety margins this was the assumed
total exposure duration. If an exposure duration of 130 s is assumed, the maximum permissible
exposure for lens and retina can be calculated by dividing the exposure guideline by the exposure
duration. Multiplying the smallest resulting irradiance by a 1 mm aperture then gives the total
permissible power that may enter the eye, which in this case would be 60µW.
The second paper, "Maximum permissible exposures for ocular safety (ANSI 2000), with empha-
sis on ophthalmic devices" [88], contains a guideline on how to use the section of the ANSI 2000
standard that is devoted to ophthalmic instruments. However, similar to the British standard, this
section only evaluates the irradiance on the retina. The paper provides guidance on how to use
the standard and worked examples for several common ophthalmic instruments. It explains how
the assumptions made in the original standard for the viewing of collimated and extended beams,
i.e. free head and eye movement, natural constriction of the pupil and natural aversion reflexes
of the eye such as lid-closure, were removed from the relevant equations. The paper introduces
a corrected MPE for the pupil plane (MPΦ) which is derived from the corneal MPE given in the
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standard by removing the response of the pupil to bright light to account for artificially dilated
pupils which might occur in an ophthalmic measurement situation. Following the corrected equa-
tions from the paper, the thermal and photochemical limits for the power entering the natural or
dilated pupil are (from table 3 [88]):
MPΦth = 6.93× 10−4 CT CE P−1 t−0.25 = 9.6 mW (4.10)
MPΦph = 5.56× 10−6 CB α2 t−1 = 1.99 mW, (4.11)
with MPΦth being the thermal maximum permissible exposure and MPΦph being the photochemi-
cal limit. The constantsCT , CE , P andCB are taken from table 2 for α = 189 mrad, λ = 402 nm and
t = 100 s. Since the MPΦph yields the lower number this value has to be used as the safety limit.
The maximum permissible irradiance on the retina is also given in table 3 and can be calculated
from
MPEr,th = 2.04CT P−1 t−0.25 = 1186 Wm−2 (4.12)
MPEr,ph = 2.45CB t−1 = 245 Wm−2. (4.13)
Again, the more restrictive value has to be used as the upper limit. It is furthermore recommended
in section 9 ("Additional safety issues") that if repetitive testing of volunteers is to take place in the
same session, the photochemical limit divided by the number of exposures over a 24 hour period
should not be exceeded. In addition to this it is also explained that due to the nature of the original
Standard which assumes that the beam is overfilling the pupil, protection for light damage in the
anterior segment of the eye is included for the visible spectrum. For wavelengths between 380 and
1400 nm a spectrally unweighted limit was introduced that recommends a maximum permissible
corneal irradiance of 4.0× 104 Wm−2 for exposure durations above 10 s.
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4.4 Discussion and conclusion
In the first section of this chapter it has been shown that Brimonidine, the compound of interest for
Allergan Inc., fluoresces very little with a quantum yield of approximately 0.41%. As a compar-
ison, Fluorescein which is a well known fluorescence standard fluoresces about 170 times more.
The instrument was therefore conceptualised to detect very low fluorescence intensities by using
a photo-multiplier tube detector with a peak sensitivity at 530 nm which is very close to the emis-
sion maximum of Brimonidine (around 535 nm). To increase the signal to noise ratio, electrical
filtering and amplification was added to the set up using an active low pass filter. Unfortunately,
since the home-build electronics were not provided in time to test them before the submission of
this thesis, no comment can be made about the performance of the instrument when using pro-
fessional electronics. The expectation is that the performance will increase drastically due to the
fact that much less noise will be induced in the signal itself (shorter and better screened cables)
and in the post-processing of the signal, leading to a better signal to noise ratio. Furthermore the
instrument did not have a light-tight outer casing for most of the measurements presented in this
thesis because the casing was made to fit the instrument once the home-build electronics had been
added. This also is believed to have lead to an increase in the measurement noise since unwanted
background signal from without the instrument could reach the detector. The photo-multiplier is
mounted in a separate light-shielding casing but measurements of noise levels showed that this
was not sufficient to block out all of the background light. Therefore some problems with noise
remain even though measures have been taken to reduce the noise as much as possible.
The analysis of the axial resolution shows that the instrument can be improved in this region since
the reflection arm and fluorescence arm FWHMs are rather big with 285µm and 124µm respec-
tively. However, having near theoretical resolution is not as crucial in the F410 as it would be in
for example a confocal microscope. Currently, the concentration of the drug can only be measured
very crudely by extracting the relevant tissues and analysing the counts from the radioactively la-
belled medication. No fine depth discrimination is possible with this method and gradients across
the aqueous humour will not be detected at all since the whole aqueous is extracted and measured.
CHAPTER 4. INSTRUMENTATION 83
Therefore the depth discrimination offered by the F410, even if not perfect, is a huge improvement
compared to the currently used method. The lateral resolution of the instrument is of little impor-
tance for the current version since only a one-dimensional scan along the optical axis of the eye is
performed. The lateral resolution thus only plays a role when assessing the volume of light that
is being collected but not in terms of distinction between neighbouring features. The specification
for the F410 states an axial resolution of 100µm as measured by the FWHM to be acceptable. The
resolution measured in the fluorescence arm is slightly above this value and thus needs improving
in a final version of the instrument if Allergan are interested in developing it further. However for
the purpose of the proof of concept this resolution is good enough and shows that the gradient
of the concentration of both Brimonidine and the reference standard Fluorescein can be measured
accurately. When expressed as the half width of the PSF at the 3% signal level, the axial resolution
of the F410 is currently slightly worse than that of the gold-standard instrument, the Fluorotron
MasterTM. This is only true for the version of the instrument that is adapted for anterior chamber
measurements, however, and the axial resolution of the F410 is one order of magnitude better than
the unmodified version of the Fluorotron.
For the consideration of the laser safety of the instrument, the different limits for cornea, lens and
retina as they can be taken from the BS-EN60825-1, the ANSI 2000 and the ICNIRP guidelines were
presented. First of all the retinal safety was considered since this is the value obtained from the
standards. According to the British standard, the retinal exposure limit applying to the conditions
encountered in the F410 is 1532.6 Wm−2. The Zemax simulation of the spot size and irradiance on
the retina shows that the maximum irradiance that is ever encountered on the retina when using
the F410 is 14 Wm−2. Unfortunately, this value is not to be trusted due to ray tracing difficulties in
Zemax and the maximum irradiance is likely to be lower and thus more eye safe. For additional
security reasons however it was decided to use the value obtained from the simulation. The max-
imum permissible exposures for the retina given in the ANSI 2000 ophthalmic instrument section
and the ICNIRP paper are below the value given in the British standard. This is due to the fact
that in these documents the natural aversion reactions like pupil contraction and lid closure have
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been removed from the calculation, whereas both the British standard and the original ANSI stan-
dard rely on those reactions to make their calculations valid. According to both these documents,
which are more applicable to the measurement situation at hand than the British standard, the
maximum permissible irradiance on the retina ranges from 220 Wm−2 to 245 Wm−2. This value is
drastically reduced compared to the value given by the British standard. However, even for the
reduced value the F410 is below the limit by an order of magnitude and can thus be said to be very
safe for the retina for prolonged viewing periods.
For the cornea and lens the situation is more difficult. According to all the sources cited above, a
wavelength of 402 nm falls within the visible region and should thus not cause any photochemical
damage to either the cornea or the lens. However, in nature no clear dividing line can be drawn
between UV light and blue light, and for the lens thermal damage can still occur for the used
wavelength. Since the used wavelength is at the limit to wavelengths defined as being UV, it was
considered sensible to evaluate the harm that might be caused by UV light of long wavelengths
(UV-A). The ICNIRP guidelines and the ANSI ophthalmic paper contradict each other in the safety
guidelines for the cornea. The ICNIRP guideline states a limit of 0.3 Wm−2 for a viewing period
of 100 s, whereas the ANSI 2000 states a limit of 4× 104 Wm−2 for viewing times above 10 s. This
discrepancy can possibly be explained by the fact that the corneal limit from the ICNIRP paper ap-
plies to the whole UV range of wavelengths, including those that peak in the damage curve, while
the ANSI 2000 only considers wavelengths above 380 nm which are less harmful for the cornea.
It was thus considered safe to use the value obtained from the ANSI. The theoretical irradiance
encountered in the focal spot of the F410 (i.e. 7.22× 106 Wm−2) would exceed this limit by two or-
ders of magnitude. However due to aberrations in the beam the real focal spot will be larger than
the theoretically possible spot size. Additionally, the irradiance will be spread over a larger area
by involuntary eye movements, even if the head of the volunteer is stabilised in a head rest. For
those reasons an averaging aperture of 1 mm diameter as defined in the ICNIRP guidelines was
first used for the calculation of the irradiance in the focal area which yields 49.7 Wm−2. However
since this is the maximum aperture that should be used for the calculation and the ICNIRP states
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that the area should probably be smaller, the area was later assumed to be only 50µm in diameter.
For this case, the irradiance in the focal spot of the F410 would be approximately 2 × 104Wm−2
which is at half the safe limit given by the ANSI 2000. Therefore, the instrument can also be said
to be safe for the cornea for long viewing periods, although the safety margin is probably reduced
compared to the retinal safety margin.
For the lens the limit for thermal injury applies. This is set to 100 Wm−2 for exposure times of
100s. This limit applies to a 24-hour period, meaning that the additive exposure should not exceed
the given value. Since the focus of the F410 is scanning through the eye, it was still considered
to be safe for the total duration that the focal volume spends in any part of the eye within one
day. However, this only applies if the power is averaged over a 1 mm diameter aperture, not if it
was averaged over a smaller aperture. It therefore is disputable if the F410 is safe for the lens for
extended viewing periods. However since no power above the AEL of 39µW is used during any
measurement of volunteers and since the actual exposure time is much shorter than assumed for
the calculations, the instrument was still considered safe for the lens as it falls into laser Class 1
and the limits given in the ANSI 2000.
Concluding it can thus be said that the safety for the eye has been evaluated thoroughly and
that even though the irradiance occurring in the focal spot of the F410 may be close to some of
the exposure limits (which are very conservative experimental limits and by no means a division
between safe and unsafe) the instrument falls within all known limits for cornea, lens and retina
and is therefore completely safe for extended periods of intentional intra-beam viewing.
Chapter 5
Calibration
The F410 has to be calibrated such that the concentration of a natural fluorophore or other fluores-
cent compound can be determined from the fluorescence intensity at a specific position within the
eye. To be able to do this the relationship between the intensity of the fluorescence, the concentra-
tion of the fluorophore and the measurement depth has to be found. In the real-world application,
the fluorescent compound will not be distributed equally throughout the eye due to chemical
processes such as e.g. binding of the compound to certain molecules within the eye or aqueous
flow within the anterior chamber which create situations of inhomogeneous distribution. For the
calibration, however, well defined homogeneous solutions are needed. The concentration of the
compound at any position within the solution needs to be known to guarantee a reliable calibra-
tion of the instrument. Therefore the whole system was first modelled to predict the behaviour of
several concentrations of Fluorescein in a cuvette where a homogeneous solution is guaranteed.
Measurements were then carried out in the cuvette to demonstrate the validity of the model and
to have a standard means of calibrating the instrument using Fluorescein which is one of the most
commonly used compounds in ophthalmic research [89][90][70][91] and can thus be regarded as
a reference standard. Measurements using the pharmaceutical compound Brimonidine were also
carried out in a cuvette to get a better understanding of the concentrations that would be suitable
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for the calibration of Brimonidine in the eye. As a last step, homogeneous solutions of Fluorescein
concentrations were measured in in vitro porcine eyes by first removing as much of the aqueous
humour as possible using a syringe and then refilling the anterior chamber with a known concen-
tration of Fluorescein. By comparing the measurements obtained for Fluorescein in in vitro eyes
to the measurements taken in the cuvette the F410 can also be calibrated to the measurement of
fluorescent compounds within the eye. Measurements were both taken with the highest avail-
able laser power (approximately 0.6 mW) and a lower laser power of 39µW that is eye safe for
the current configuration of the instrument as determined in chapter 4. The higher laser power
was included to initially test the system and to show the performance at better signal levels which
might be reached in the future if the improvements suggested in chapter 8 are implemented into
the system.
5.1 Calibration in the cuvette
A set of curves as shown in figure 3.10 can be used to find all the parameters needed to calibrate the
instrument. For the most important step, i.e. for determining the concentration from a measured
intensity value, the relationship between the unattenuated intensity measured by the instrument
for various concentrations and the concentration has to be found. The unattenuated intensity (the
maximum intensity at the very start of the cuvette which is not influenced by attenuation through
absorption) has to be used since there are uncertainties in the concentration determination if atten-
uated intensities were used due to the fact that the attenuation curves for different concentrations
cross after a certain depth, creating points were one intensity could refer to several concentrations.
This means that to be able to calculate the concentration of a given sample at any depth, the in-
tensity has to be "restored" to its unattenuated value before converting it into a concentration. For
this restoration, one other parameter is needed: The rate at which each concentration decays with
the measurement depth in the solution. To find an equation for this concentration-dependent de-
cay parameter the set of recorded calibration curves has to be analysed. After all the necessary
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Figure 5.1: The intensity modelled at position 0 (i.e. no depth-attenuation)
as a function of the concentration of the sample solution with no noise. The
correlation coefficient R2 is 1.0.
parameters have been found from the calibration curves, the concentration at any depth of a given
sample can be calculated using an iterative approach that is explained below.
5.1.1 The model
To determine its suitability, the calibration routine was first carried out using the modelled Fluorescein
decay curves from section 3.3. Ten modelled curves of the concentrations 100, 90, 80, 70, 60, 50,
40, 30, 20 and 10µM were used, the same ones as depicted in figure 3.10. First of all, the rela-
tionship between the unattenuated intensity and the concentration was determined by finding the
maximum intensity value for each concentration and fitting a linear regression to the maximum
intensity as a function of the concentration. Obviously, since the calibration data in this case comes
from a model, the correlation coefficient R2 is 1.0! Both the unattenuated intensity and its linear
regression as a function of the concentration are shown in figure 5.1. As expected, the measured
(or in this case, the modelled) intensity behaves linear with concentration. Therefore the fit is of
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the form
I(C) = mC · C, (5.1)
where I(C) is the unattenuated intensity and C is the molar concentration, with the gradient mC
being 4.476588 × 1006. Using this calibration equation, the concentration can accurately be calcu-
lated for any given unattenuated intensity. Therefore, in a second step, the intensity measured at
a specific location within the sample has to be restored to its unattenuated value. This restoration
is carried out to remove the influence of depth on the signal as predicted by the Beer-Lambert
law and to thus make it easier to identify changes in intensity that are caused by real changes in
concentration. To be able to remove the depth dependent attenuation of the fluorescence intensity,
the relationship between the extinction coefficient and the concentration of the fluorophore has to
be found. For that purpose, the decay rates for the set of measurement curves the calibration is
based on have to be known. The measurement curves follow an exponential decay of the form
I(x,C) = I0(C) · exp(−(C)x) as described in section 3.3, where I(x,C) is the intensity of the
fluorescence for the concentration C at position x, I0(C) is the concentration-dependent offset (i.e.
the unattenuated intensity value), (C) is the concentration-dependent extinction coefficient (i.e.
the decay rate) and x is the position of the focus in the sample. The parameter I0(C) does not
have to be found because it is equal to the unattenuated intensity for the respective concentration,
and the actual intensity rather than the parameter is used in the calculation of the concentration
to account for small differences in the fitting procedures and to thus make sure that the calculated
concentration matches the measurement data. To find how the extinction coefficient  relates to
the concentration C, the exponential data was first linearised to
ln(I(x,C)) = (C)x+ ln(I0(C)),
where (C) and I0(C) are the decay rate and the unattenuated intensity as above, and x is the
measurement depth in the cuvette. The data is linearised since a fitting routine might find more
suitable fitting parameters for a linear regression fit rather than for an exponential decay fit where
a small change in the decay rate results in a big change in intensity. Furthermore this enables the
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Figure 5.2: The parameter (C), the attenuation coefficient or decay rate,
as a function of the concentration of the fluorophore in an ideal, noise-free
measurement. The correlation coefficient of the fit is R2 = 1.0.
researcher to spot any concentration that behaves in an unusual way more easily by eye. After the
linearisation of the data, the parameter (C) is found for each concentration in the set of calibration
curves. This gives the decay rates for the concentrations that were measured for the calibration.
For the calculation of the concentration from any intensity, however, the decay rate for any possi-
ble concentration needs to be known. Therefore, the relationship between the extinction coefficient
and the concentration has to be found. The coefficient is, in the case of the model, linearly depen-
dent on the concentration of the fluorophore in the sample. Therefore, another linear regression
of the format (C) = m · C is calculated for the extinction coefficient. The extinction coefficient
and the linear regression are shown in figure 5.2. The determined parameter for the gradient in
this case was m = −1.781 × 10−06. Knowing the relationship between the unattenuated intensity
and the concentration and the extinction coefficient and the concentration now makes it possible
to calculate the concentration at any measurement position within the sample by following a five
step approach for every measurement point:
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In the first step, the concentration C at the current position x is found from the unattenuated
intensity Irec(x,C) (either determined in the step before or taken from the measurement file if it is
the first measurement point):
C(x) =
Irec(x,C)
mC
. (5.2)
Then, the decay rate (C) for this concentration is found using the parameters determined from
the calibration measurements:
(C) = m · C. (5.3)
In the third step, the intensity expected at the next position for the determined concentration and
decay rate Ith(x+ 1, C) is found by applying the Beer-Lambert law of absorption:
Ith(x+ 1, C) = Imeas(x,C)× exp [−(C)∆x] , (5.4)
where ∆x is the step width between the current position x and the next position x + 1. After the
expected intensity of the signal has been determined, the actual (i.e. measured) intensity at the
next position Imeas(x + 1, C) is compared to the expected intensity Ith(x + 1, C) to find out if the
signal has changed by more than just the expected value. The change in signal is calculated as a
percentage of the expected intensity:
%∆I =
Ith(x+ 1, C)− Imeas(x+ 1, C)
Ith(x+ 1, C)
. (5.5)
The difference between the actual and the expected intensity is measured in percent of the ex-
pected intensity because it can then be directly translated to the corrected intensity. This is due
to the fact that the fluorescence intensity is linear with both the intensity of the excitation light
and the concentration of the sample. Since the difference in expected and actual intensity, if above
a certain error band, is assumed to be due to a change in concentration, the change in intensity
of an unattenuated measurement point would be equal in percentage to the change detected in
the attenuated measurement point if the same change in concentration was present. Thus, the
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unattenuated (or recovered) intensity has to change by the same value to account for the detected
change in concentration. Therefore, in the fifth step, the recovered intensity determined in the pre-
vious cycle for the current measurement point Irec(x,C) is changed by the determined percentage
to set the recovered intensity for the next position (i.e. position x+ 1):
Irec(x+ 1, C) = Irec(x,C)− Irec(x,C)×%∆I. (5.6)
If the percentage change is within the error band, the recovered intensity from the measurement
point before is set as the recovered intensity for the current measurement point without changing
it:
Irec(x+ 1, C) = Irec(x,C). (5.7)
The whole process is then repeated until the last data point has been recovered. A flow chart of the
procedure is shown in figure 5.3 for clarity. The abbreviations used in the equations are defined as
follows:
Abbreviation Definition
Imeas(x) Measured intensity at position x
Ith(x) Expected intensity at position x
Irec(x) Intensity recovered for position x
To illustrate this process, a sample calculation was carried out in table 5.1. The first column shows
the depth of the measurement position in the sample in micrometers. The second column holds
the intensity measured (or in this case, modelled) at each depth in scaled units (all measurements
were scaled to a gain of one on the photo-multiplier). The third column contains the expected
intensity values, calculated for the next position using the measured intensity of the current po-
sition (column two) as described in step three above. The fourth column indicates the difference
between the expected and the actual (measured) intensity at the next position in percent of the
expected intensity. If the measured intensity is greater or smaller than the expected intensity, this
change is registered here. The restored intensity is calculated in column five using the percentage
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Figure 5.3: A flowchart showing the procedure of the recovery of concentra-
tion.
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Depth [µm] Imeas(x,C) [s.u.] Ith(x+ 1, C) [s.u.] ∆I [%] Irec(x,C) [s.u.] C(x) [M]
0 357.60 – 0 357.60 8 · 10−5
1000 310.31 310.31 0 357.60 8 · 10−5
2000 269.28 269.28 0 357.60 8 · 10−5
3000 233.67 233.67 0 357.60 8 · 10−5
4000 202.77 202.77 0 357.60 8 · 10−5
5000 175.95 175.95 0 357.60 8 · 10−5
6000 152.69 152.69 0 357.60 8 · 10−5
7000 132.49 132.49 0 357.60 8 · 10−5
8000 114.97 114.97 0 357.60 8 · 10−5
9000 99.77 99.77 0 357.60 8 · 10−5
10000 86.58 86.58 0 357.60 8 · 10−5
Table 5.1: Exemplary calculation of the concentration of a homogenous so-
lution of Fluorescein.
determined in column four. If there is no difference between the expected and the measured inten-
sity, it is assumed that the measured loss in intensity is only due to the attenuation of the excitation
light and not due to a change in concentration, leaving the unattenuated intensity unchanged. If
there is a difference between the expected and the measured intensity, it is assumed to be due to
a change in concentration and the recovered intensity is changed by the same value as explained
above.
The result of the determination of the concentration for all modelled intensities is shown in figure
5.4. This graph clearly shows that for the model the concentration can be accurately determined for
any depth within the cuvette. It also shows that the crossing over of intensities in the measurement
curves after a specific depth in the sample as shown in figure 3.10 does not influence the calculation
of the concentration since only the decay rate is used to restore the intensity. The decay rate follows
a linear trend with concentration and thus has a unique value for each concentration, preventing
any uncertainties in the process.
In a second step, the calibration routine was used on a modelled sample where the concentration
changes by a known value throughout the data set. Again, the data set was created using the
actual calibration data from Fluorescein calibration measurements to make it resemble an actual
measurement. The intensities in the data set were set to change from the equivalent concentrations
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Figure 5.4: A plot of the determined concentration values from the calibra-
tion. The values given in the legend are the modelled concentrations, the
values on the y-axis are the determined concentrations. They are an exact
match.
Figure 5.5: Restored concentrations of a modelled inhomogeneous sample.
As above the determined concentrations are an exact match with the input
concentrations.
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of 1 to 20µM at 400µm, from 20 to 10µM at 1500µm, from 10 to 1µM at 2500µm, from 1 to 5µM at
3500µm, from 5 to 15µM at 4500µm, from 15 to 10µM at 5500µm and from 10 to 1µM at 6500µm
depth. The appropriate attenuation introduced by each concentration was included in the cal-
culation of the intensities. The resulting determined concentrations match the set concentrations
perfectly as shown in figure 5.5. This second test of the calibration routine shows that unknown,
changing concentrations can also be accurately recovered from the given intensity values using
the calibration algorithm described in this chapter.
5.1.2 Fluorescein
High-power measurements
As a next step, homogeneous solutions of known concentrations of Fluorescein were measured in a
cuvette of known path length to confirm that the calibration routine is valid for real measurements.
The instrument was first configured such that an optical chopper (Thorlabs) was modulating the
beam at a frequency of 1 kHz after the last lens of the system, and the modulated fluorescence
signal was then locked to the reference signal from the chopper and amplified by a lock-in am-
plifier (LIA) (LIA MV 150S, Laser Components) to remove unwanted background signal from the
measurement data. It was, however, found that the integration time of 3 ms on the LIA was too
short for the frequency of the chopper to effectively reject noise from the system. In fact, noise
was actually added due to aliasing effects between the chopping frequency, the integration time
and the sampling frequency of the ADC. To run the chopper/lock-in system effectively, either the
chopping speed or the integration time would have to be increased. Unfortunately, the chopper
that was used in this set up was not capable of running at a higher frequency. A blade with thinner
sections and thus a higher frequency could theoretically have been used, but since the blade was
not in the focus of the beam this would have meant that not the whole beam would have been
blocked by a dark section of the blade. This then would have lead to incomplete modulation of
the signal and the introduction of more noise. The only options would therefore have been to
CHAPTER 5. CALIBRATION 97
ε
Figure 5.6: The relationship between the decay rate and the concentration as
measured with the optical chopper.
either re-design the system such that an additional focal spot was provided where the chopper
blade could be placed or to increase the integration time. Adding a second focal spot would mean
adding more lenses and thus more aberration, reflection and auto-fluorescence to the system, and
it was decided not to follow this route. A longer integration time, on the other hand, was also not
feasible since this would influence the shape of the measurement curve so that only slow tempo-
ral changes in concentrations would be detectable and the amplitude of the fluorescence would
thus be falsified and a wrong concentration detected. Nonetheless, calibration measurements were
taken with the chopper and lock-in set up to gain a data set for comparison with the active low-
pass filter described in section 4.2.4. Figure 5.6 shows the relationship between  (the decay rate)
and the concentration. The error bars for  were calculated from the variance-covariance matrix
provided by the fitting routine. The variance is found by calculating the square root of the main
diagonal in the matrix, i.e. of the values at position 1,1.
The solutions of Fluorescein used for all calibration measurements discussed in this chapter were
diluted in series from a stock solution of Fluorescein. The stock solution was made by weighing
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Figure 5.7: Linear fit to the unattenuated intensity of samples of different
concentrations as measured with the optical chopper in place.
the needed amount of Fluorescein into an Eppendorf-tube using chemical scales and then adding
the appropriate volume of water. Theoretically, to avoid cumulative errors from the dilution of
the solution, each desired concentration should be weighed and mixed individually. However the
available scales did not have high enough measurement resolution to measure the low weights
of Fluorescein required which is why the serial dilution technique was chosen. The concentra-
tions therefore have an error attached to them which was estimated by error propagation from
the standard error of the pipetting volume and the standard error of the scales as given by the
manufacturers. The estimated error in the mixed solutions is however at least two orders of mag-
nitude smaller than the target concentration which is why it is not shown in the graphs. The
measurement of each individual concentration was averaged over 20 consecutively taken scans
to obtain the standard deviation of the measured intensity. All solutions were measured consec-
utively using the same reference voltage on the PMT to ensure minimal influence from external
parameters. The measurements were repeated several times to confirm that the calibration pa-
rameters did not change from day to day. The most successful measurement (i.e. the one creating
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Figure 5.8: Concentrations calculated from the measurements taken with the
optical chopper. The original concentrations are shown in the legend.
the most linear calibration curves) was used for the determination of the final set of calibration
parameters.
Due to the non-linear behaviour of Fluorescein with concentration through mechanisms of self-
quenching [92][93] only the linear part (up to a concentration of 20µM) of the measurement data
was used for the determination of the calibration parameters as shown in the graphs. The fit to
the offset of the exponential decay fit is not used for the calibration and was thus omitted here. In
the calibration, the fit to the unattenuated intensities as shown in figure 5.7 is used as described
in section 5.1.1. The error bars on the data points in figure 5.7 show the standard deviation of the
average maximum value for each concentration. The concentration can then be recovered from the
measured intensities using these calibration parameters by removing the depth-dependency of the
signal. The result of the recovery of the concentration from the measurement data is presented in
figure 5.8. The graph clearly shows the aliasing effect introduced by the lock-in amplifier in the
higher concentrations. This effect always occurs if the input signal is high enough, so that even
though the lower concentrations seem fine in this graph, the effect would be visible there as well if
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Figure 5.9: Linear regression fit to the decay rate versus concentration as
measured by the low pass filter.
a higher gain on the PMT was used. It is, however, also visible that the concentrations calculated
from the signal intensity are a very close match to the concentrations as they were mixed (given in
the legend).
Due to the aliasing effect it was decided to remove the chopper from the system and use an active
low pass filter instead as described in section 4.2.4. The resulting fit to the decay rate (C) is
shown in figure 5.9, and the fit to the initial intensities in figure 5.10. For the fit to the decay rate
the lower concentrations were omitted as is shown in the figure since they were clearly wrong
whereas the higher concentrations show a good linearity with an intercept at zero as expected.
The reason why the lower concentrations do not fit the linear trend is unknown. It is possible
that due to the lower signal to noise ratio of the low concentrations the decay is not measured
correctly by the instrument. Another reason might be that the absorption is so small that its effects
are hidden by the random fluctuations in signal caused by the photon count on the detector. With
the arrangement of using only the higher concentrations for the determination of the calibration
curve the correlation coefficient as measured in R2 is 0.96. It can of course be disputed if the
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Figure 5.10: Fit to the unattenuated intensity of the measurement samples
versus concentration as measured using the active low pass filter.
approach of not using the lower concentrations to find the relationship between the decay rate
and the concentration is valid. Since this method showed good results for the recovery of the
concentration from the measured intensities and no other data set recorded showed a better or
rather more clear linear relationship between the decay rate and the concentration it was assumed
that this measurement was valid. In addition all other measurements show a similar gradient for
the decay rate. If only the higher concentrations are considered, the correlation is better for the set
up with the low-pass filter than for the lock-in amplifier. Furthermore the error in the decay rate
for the higher concentrations has been reduced compared with the measurements from the lock-in
amplifier; however, the measurement points of the low concentrations do stray from the linear
regression. The amplification provided by the electronic filter is much higher than with the lock-in
amplifier and thus allows for better measurement resolution in terms of concentration. The most
important point, however, is that no aliasing occurs and thus the signal is cleaner.
Figure 5.11 shows the recovered concentrations from the calibration with the low-pass filter. Again,
the calculated concentration matches the mixed concentration as given in the legend very closely.
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Figure 5.11: Concentrations recovered from the original measurement files.
The input concentrations are shown in the legend.
It can be seen that the concentration of the 20µM solution is estimated too low at approximately
16µM. As the fit to the initial intensities of the samples shows this is due to the fact that Fluorescein
starts self-quenching at this point and thus the emitted fluorescence is below the value which
would be expected if the relationship between the unattenuated intensity and the concentration
was completely linear for all concentrations. Apart from this quite high deviation from the true
concentration value the error in the recovered concentrations lies below the 20% goal defined in
the specifications for the instrument (see table 5.2). The four measurement points that show less
good accuracy in terms of the average deviation from the true concentration value (i.e. 40 nM to
1µM) are some of those points that do not match the fit of the decay rate in figure 5.9. However,
even though the point for 2µM also does not match the linear regression it is recovered quite well
by the algorithm, so other factors seem to be influencing the calculation. It is for example possible
that the correlation coefficient of the original exponential decay fit to the data set of the 2µM was
poor and thus the detected decay rate does not actually match the data set. The error on the deter-
mined decay rate for each concentration was calculated using the covariance matrix provided by
the fitting routine and does therefore only show the standard deviation of the determined decay
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Actual Average Standard deviation Highest deviation Average deviation
concentration recovered of average from from
(M) concentration recovered concentration true value true value
(M) (M) (% of actual value) (% of actual value)
1e-07 1.02e-07 9.47e-09 27.8 2.1
2e-07 2.04e-07 1.17e-08 11.3 2.2
4e-07 4.45e-07 1.50e-08 20.5 11.2
6e-07 6.94e-07 2.00e-08 20.7 15.6
8e-07 9.05e-07 2.72e-08 18.4 13.1
1e-06 1.14e-06 2.59e-08 18.7 13.8
2e-06 2.02e-06 8.84e-08 8.1 0.8
4e-06 3.97e-06 2.57e-08 2.7 0.8
6e-06 5.91e-06 4.73e-08 4.2 1.6
8e-06 8.18e-06 5.38e-08 3.3 2.2
1e-05 9.51e-06 7.70e-08 7.5 4.9
2e-05 1.62e-05 1.90e-07 22.3 18.8
Table 5.2: Accuracy of the recovered concentration values for the high-
power measurement.
rate from the final value but not the deviation from any true value which is obviously unknown.
The reason why the calculated concentration suddenly drops in the last few micrometers of the
scan is that the focus of the beam is getting closer to the back wall of the cuvette and thus signal
is lost. The scanning depth of the focus is 10 mm but the data shown in figure 5.11 is cropped
such that position zero in the graph is at the point in the cuvette where the signal is highest (i.e.
immediately behind the front wall of the cuvette plus a little bit of distance into the cuvette to
account for the wall influencing the signal level). Furthermore the position as displayed in the
graph has not been corrected for the refractive index of the water and does thus not reflect the
true depth in the cuvette. Since the focal volume is rather large due to aberrations the back wall
of the cuvette starts influencing the signal at the depth shown in the graph although it is in truth
still a couple of micrometers away. Since this signal decrease is not due to expected attenuation of
the laser light by absorption it is picked up by the programme as genuine change in concentration
and thus depicted here. Since it would be very hard to judge where this signal decrease begins in
a real measurement situation where the concentration might change towards the back wall of the
cuvette no attempt has been made to remove it from the measurement files.
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Figure 5.12: Fit to the unattenuated intensities as measured with low laser
power.
Low-power measurements
As mentioned above data was also taken with the beam attenuated to a power of equal to or below
39µW to assess the performance of the instrument at a power level that is safe for the human eye.
It has to be kept in mind that the permitted exposure is dependent on the exposure duration and
thus the results described in section 5.1.2 should not be considered to have been taken with a
completely non eye safe laser power. In contrary, if the data acquisition speed would be increased
(by e.g. increasing the scanning speed), the laser power used for the high-power measurements
would become eye safe since the duration of exposure would be shorter. Therefore the results
presented in this section are valid as an indicator to the sensitivity of the instrument only for the
current measurement configuration where the exposure duration is comparatively long.
To obtain the low-power level measurements the same procedure as described above for the high-
power measurements was followed. Several solutions of known concentrations of Fluorescein
were measured and the decay rate and initial intensity found for each. The fit to the initial inten-
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ε
Figure 5.13: Fit to the decay rate of the exponential fit (parameter ) with
concentration. The data was measured with the low-power laser.
sity is shown in figure 5.12. As with the high-power measurements, the intensity shows a clear
linear trend with concentration. It is, however, visible that the relationship between the decay
rate (parameter ) and the concentration is much less clear (figure 5.13) and the variance in the
determined decay rate much larger. The returned fluorescent signal is very sensitive to the correct
alignment of the cuvette which for the low-power measurements has to be done by eye since no
reflection data is available due to the low power. Therefore some of the cuvettes might have been
misaligned, thus leading to an incorrect calculation of the decay rate. The measurements which
were clearly misaligned were omitted for the sake of the calibration but some residual error will
have remained in the data set. Furthermore the signal to noise ratio is much lower for the low-
power measurement and thus the exponential decay fits to the original measurement data have
lower correlation coefficients which also leads to a falsification of the trend of the decay rate with
concentration. This deficit of the instrument will be addressed in a future version, however for
this dissertation the proof of the concept is what matters. The concentrations can still be recovered
with an error of under 26% as shown in table 5.3 which is comparable to the high-power measure-
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Actual Average Standard deviation Highest deviation Average deviation
concentration recovered of average from from
(M) concentration recovered concentration true value true value
(M) (M) (% of actual value) (% of actual value)
1e-07 1.22e-07 3.28e-08 102.9 22.4
2e-07 2.51e-07 3.74e-08 78.7 25.7
4e-07 4.78e-07 3.45e-08 45.4 19.5
6e-07 7.16e-07 4.01e-08 43.7 19.3
8e-07 9.69e-07 5.50e-08 43.0 21.1
1e-06 1.20e-06 5.40e-08 33.1 20.4
2e-06 1.98e-06 2.25e-07 35.1 1.2
4e-06 4.03e-06 2.21e-07 15.1 0.7
6e-06 6.23e-06 1.32e-07 10.4 3.7
8e-06 8.71e-06 1.86e-07 14.2 8.9
1e-05 9.53e-06 6.01e-07 18.5 4.7
2e-05 1.75e-05 2.49e-07 15.9 12.7
Table 5.3: Accuracy of the calculated concentration values from the low-
power measurement.
ments. The recovered concentrations are shown in figure 5.14. It is visible here that both 2 and
10µM were misaligned when measured and thus the wrong concentration is recovered. Again,
as with the high-power measurements, the lower concentrations are recovered with less accuracy
than the higher concentrations due to the degradation of the signal to noise ratio with the low
intensities.
It is clear from figure 5.14 that even with the very low power that can be used safely on the human
eye the instrument is still capable of measuring Fluorescein solutions of low concentrations (the
lowest concentration on this plot is 100 nM) with a reasonable accuracy. The reason why the accu-
racy is slightly less good than with the high-power measurement lies in the fact that the internal
amplification of the PMT was higher due to the lower signal level, leading to a decrease in the
signal to noise ratio.
The calibration with homogeneous solutions in a cuvette and the resulting recovered concentra-
tions therefore show that the calibration routine is working correctly not only with the modelled
intensities but with real measurement data. It is possible to accurately extract concentrations rang-
ing from 2 nM to 10µM using the current, calibrated instrument. Concentrations above 20µM can
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Figure 5.14: Concentrations recovered from the low-power measurement.
theoretically be extracted but will have an increasing error with higher concentrations due to the
non-linearity of the initial intensity curve of which only the linear part for the low concentrations
was used for the calibration of the instrument. The lowest measurable concentration that is within
the 20% error band when using the higher laser power is 2 nM. For the lower power measure-
ment, the lowest accurately detectable concentration is 100 nM. This is not necessarily due to the
lower signal to noise ratio but might also be because the actual concentration of the measurement
sample might not match the assumed concentration. The error propagation predicts that the er-
rors for the nano-molar solutions are still very small (two orders of magnitude below the assumed
concentration) but it cannot be ruled out that other errors in pipetting might have occurred which
are not included in the error analysis. For a true calibration, the concentration of the samples
therefore have to be confirmed with alternative methods before using them for the measurement.
Unfortunately no alternative methods were available to accurately measure the concentration of
the samples which is why they were used as is. Another approach would be to buy standard stock
solutions for calibration purposes which are offered by some suppliers.
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5.1.3 Brimonidine
High power measurements
After it was established that the calibration was working well with the reference standard Fluorescein,
it was attempted to calibrate the instrument for Brimonidine. The calibration was at first carried
out as for Fluorescein by fitting an exponential decay to the measured concentrations. However
it then became clear that the determined decay rates for the individual concentrations had a big
error associated with them due to the fact that the signal to noise ratio is poor for these low-
intensity measurements. Furthermore the decay rate did not seem to follow an obvious trend with
the concentration as expected; in fact the data showed very little decay at all. For the purpose of
calibration comparatively high concentrations of 1µM to 1 mM were used. Substantial decay rates
were expected for these. Therefore, a model of the Brimonidine decay for these concentrations was
created using the absorption coefficient that was measured as a by-product of the quantum yield
measurements (see chapter 4). The modelled curves in figure 5.15 show that even at the highest
concentration the decay is almost negligible. This is due to the fact that the excitation wavelength
used in the instrument is at the very edge of the absorption spectrum of Brimonidine which ab-
sorbs mainly in the UV region and thus the extinction coefficient at a wavelength of 402 nm is low
( 0.00064 compared to 0.631 for Fluorescein). A shorter wavelength was not used for reasons of
eye safety; As described in chapter 4 the risk to the cornea and lens increases dramatically for UV
wavelengths. Once a similar level of noise as present in the measurement data had been added to
the model (figure 5.16) it became clear that the data is too noisy to extract any information about
the decay rate. It was therefore decided to assume that the signal did not attenuate with depth.
Thus only the fit to the intensity of the unattenuated signal is needed for the calibration. Since the
data is so noisy, this value was obtained by taking the mean value of the complete data set (i.e.
the intensity averaged over the whole depth of the sample) for each concentration. The calibration
curve is shown in figure 5.17. For a reason unknown, the calibration curve does not intercept the y-
axis at zero. The intensity should obviously be zero if no concentration is present. However there
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Figure 5.15: Modelled decay rates of different concentrations of
Brimonidine. The concentrations are given in the legend.
Figure 5.16: The same modelled decay rates with noise added similar to that
encountered in the real measurement.
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Figure 5.17: Unattenuated intensities extracted from the high-power
Brimonidine measurement.
is an offset in the measurement which cannot be explained since the water background was sub-
tracted from the measurement to remove the influence of any offset coming from either the cuvette
or the instrument. It is interesting to note that a similar offset occurred when taking the measure-
ments with the professional spectrophotometer to determine the quantum yield of Brimonidine,
again after the background signal had been subtracted. This offset might be due to self-quenching
of Brimonidine at high concentrations which would lead to the low concentrations fluorescing
more than predicted by the high concentrations. However, no information on the spectroscopic
and fluorescence properties of Brimonidine could be found in the literature.
Even though this recurring phenomenon cannot be explained, it was decided to use the calibra-
tion curve as it is to try and determine the concentrations of known solutions of Brimonidine. As
expected from the noise in the measurement, the calculated concentration is also very noisy and
has a standard deviation of approximately 500µM as can be seen in figure 5.18. This is obviously
not ideal since the poor signal to noise ratio prevents the software from recovering the concentra-
tion as accurately as it needs to be. Changes in concentration can however still be detected using
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Figure 5.18: Concentrations recovered from the original Brimonidine data
set.
the current set-up of the instrument as will be shown in chapter 6. To improve the signal to noise
ratio of the measurements several steps could be taken as described in chapter 8. Although the re-
sults presented here are not ideal they show that the current version of the instrument is sensitive
enough to detect comparatively high concentrations of Brimonidine and extract the concentra-
tion value from the average of the measurement. The lowest measurable concentration currently
is 500µM. This proves that the measurement concept is working well. The author of this thesis
therefore believes that the instrument will be capable of measuring very weak fluorescent signals
with a good signal to noise ratio with few improvements to the instrument.
Low power measurements
Since the signal to noise ratio and thus the accuracy of the recovered concentrations for the mea-
surements of Brimonidine with the high laser power was poor, no measurements were taken for
the low-power configuration of the instrument.
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5.1.4 Repeatability of the measurement results
To determine the temporal stability of the instrument and its calibration the repeatability of the
high-power Fluorescein measurements was assessed. The high power Fluorescein measurements
were selected for this task because it was assumed that the repeatability for all measurements
will be the same. This assumption is based on the fact that the samples will not change during
one week (the same set of samples was used for every repeatability measurement) and that the
spread in the detected concentration for a specific sample is due to instrument parameters. These
parameters will change within the same range, no matter what compound or at what laser power
is measured. The repeatability values presented here are therefore considered to be valid for all
measurements taken in the cuvette.
The repeatability was assessed by measuring the same set of samples several times throughout
one day and then once a day for a week. For each measured sample, the average of the detected
concentration was taken. The mean and standard deviation of the averages for the respective con-
centration was then used to determine the repeatability. It was found that during one day, the
standard deviation in the measurements was smaller than 11% of the average value. In the course
of one week, however, the standard deviation increased to being below 23% for concentrations
down to 400 nM and then increasing drastically. The specifications for the F410 state that a re-
peatability of not worse than 10% should be reached. Over the course of one day, this value is
almost met by the current instrument. However, over one week, the repeatability is not sufficient
to meet the requirements. The instrument therefore needs improvement in stability of the laser
and the electronics to ensure a good repeatability of the measurement results.
5.2 Calibration in in vitro porcine eyes
Since the F410 is ultimately to be used on animal or even volunteer’s eyes for pharmacokinetic
studies of Brimonidine and other fluorescent ophthalmic compounds, the instrument was also cal-
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ibrated for measurements in the eye. The measurements were performed on in vitro porcine eyes
which were obtained from a wholesale meat supply in the area. Since that company only slaugh-
ters pigs on a Tuesday morning, eyes could only be obtained once a week. They were collected by
car at 2pm in the afternoon, keeping them fresh in a Styrofoam box with a cooling pad. They were
however not cooled in store and thus depending on when in the morning the eyes were removed
from the pigs they were sometimes not very fresh when they were collected. Unfortunately, there
was no way of determining the freshness of the eyes (the amount of aqueous humour left in them
might have been an indication as described below), and it is likely that most of the time they
were not fresh enough to use them as valid prediction to any in vivo eyes. Nonetheless measure-
ments were carried out to better understand the background fluorescence levels that will occur in
in vivo measurements and to show that the instrument is capable of measuring the concentration
of Fluorescein as well as Brimonidine in a less-than-perfect measurement situation. It is assumed
that if the instrument performs well with the in vitro eyes it will not be a problem to measure phar-
maceuticals in in vivo eyes since the measurement conditions will be much better due to the fact
that the cornea will be thinner and less attenuating than in the in vitro porcine eyes.
5.2.1 Calibration using Fluorescein
To measure the calibration curve for the in vitro eyes, a similar method as described for the mea-
surements in the cuvette was used. First, the background fluorescence of the respective eye
was measured after the eye had been aligned to the instrument by maximising the reflection
from the cornea using the commercial control software of the ADC (Measurement Computing’s
"TracerDAQ"). In a second step, the eye was removed from its position in front of the instrument
and as much of the aqueous humour as possible extracted using a BD Microfine insulin syringe
(0.3 and 0.5 ml models were used). Due to the fact that the animals the eyes were from had been
dead for a while and the corneal pump had thus stopped working, it was not uncommon that only
very little or no aqueous humour could be extracted from the eye. The aqueous humour is primar-
ily made out of water and when the corneal pump ceases to work with death, the cornea swells
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up with the liquid from the aqueous [94][95][96]. This results in very thick corneas and very little
aqueous left in the anterior chamber. The volume of extracted aqueous can thus be used as a mea-
sure for the decay state of the eye. Once the aqueous had been removed, a solution of Fluorescein
of a known concentration was injected into the anterior chamber to replace the aqueous. The eye
was then re-aligned to the instrument using the reflection from the cornea and the intensity of the
Fluorescein solution was measured.
Since the signal that was returned from the Fluorescein was lower than expected, both the corneal
thickness and the value by which the cornea attenuates the incoming excitation light were mea-
sured to assess the measurement parameters. According to the literature, the average porcine
corneal thickness is approximately 666µm in living eyes [97] and 0.83 to 1.12 mm in in vitro eyes
[98][99]. It was however found that the corneal thickness of the eyes used in this experiment was
at least five times as much as the thickness reported in in vivo eyes due to the breakdown of the
corneal pump. The thickness was measured by slicing the cornea as thinly as possible, placing
the slices sideways on a microscope slide and then measuring the length of a line that was drawn
across the cross-section of the cornea using a microscope with inbuilt measuring function (SteREO
Discovery.V12, Zeiss). A sample picture of the obtained measurements is given in figure 5.19. The
average measured value of the corneal thickness was found to be (3570±340)µm.
The attenuation of the excitation light by the cornea was measured by removing the whole cornea
from the eye and placing it onto a microscope slide. First, the transmission of the microscope
slide without the sample present was measured using a photodiode. The transmission was then
re-measured after the cornea had been placed on the slide. Four porcine corneas were measured
this way and it was found that they attenuate the excitation light by a mean value of (88 ± 1)%.
This means that the laser power inside the sample eye is significantly lower than the incident light
and thus will influence the lowest measurable concentration. Furthermore the return light will
also be scattered and attenuated by the cornea so that the total signal loss is significant. A cornea
in a living eye will however never scatter or absorb the light as much as the measured in vitro
corneas since otherwise vision would be very inefficient. It is of course of highest importance in
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Figure 5.19: An image showing the measurement of the corneal thickness of
in vitro porcine eyes.
a living eye that the cornea is very clear and does not attenuate the incoming visible radiation.
As described in chapter 2, this is achieved by the very ordered structure of the cells in the cornea
as well as the tearfilm which is covering its comparatively rough surface. Therefore the high
attenuation of the light in the in vitro eyes is not only due to the absorption of light but mainly due
to scattering on the surface and within the rough structure of the cornea, which is increased by the
fact that without the tearfilm to protect it the corneal epithelium dries out and develops cracks.
This creates a further problem for the F410 since the focus inside the in vitro porcine eye is much
bigger than it should be due to scattering and thus less signal will reach the confocal detector. It
is therefore clear that in a living, healthy eye the instrument will perform much better than the in
vitro results presented in this thesis might imply.
Due to the varying freshness of the eyes and varying thicknesses of the cornea, the standard error
of the measurement points is quite large. Figure 5.20 shows that the linear relationship between
unattenuated fluorescence intensity and concentration can however still be detected. As a result
of the problems mentioned above only a couple of eyes in every measurement session yielded us-
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Figure 5.20: The unattenuated intensity of Fluorescein fluorescence versus
concentration in in vitro porcine eyes. The correlation coefficient as measured
in R2 is 0.73
able data which is why only a limited number of eyes could be used for obtaining the calibration
curve. It would have been desirable to measure more eyes to obtain smaller error bars and a more
accurate calibration curve but the restriction of only being able to measure eyes once a week added
a time limit to the measurements. Even so about 200 eyes were measured to obtain the results pre-
sented in this thesis, partly since the design of the instrument changed from the chopper/lock-in
amplifier combination to using the active low pass filter which involved complete re-measurement
of the calibration curve, and partly because only about 50% of the eyes actually yielded any use-
able results. The data points shown in figure 5.20 were obtained by first calculating the average of
the maximum value measured in all scans of each eye after the background had been subtracted
and then taking the mean of the averages of all eyes measured for that concentration. The error
bars show the standard error of the mean of the maximum.
As described in section 5.1, two calibration parameters are necessary to enable the software to
extract the concentration from the measured intensity: The relationship between the unattenuated
intensity and the concentration and the relationship between the decay rate and the concentration.
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For the eyes, however, no relationship between the decay rate and the Fluorescein concentration
could be found. This is due to the fact that the fits found for the exponential decay of the intensity
with depth in the eye were mostly rather poor. Several explanations can be found for this. First
of all, the exchanging of the aqueous humour for Fluorescein solutions changed the shape of the
cornea since the anterior chamber was filled completely rather than being empty or just half full,
thus adding structural support to the cornea. This lead to the auto-fluorescence measured from
the cornea having a different shape and/or amplitude in the Fluorescein measurement compared
to the reference measurement, thus altering the shape of the fluorescence decay curve when the
background was subtracted in the data analysis. Furhtermore the amplitude of the corneal auto-
fluorescence was very dependent on the alignment of the eye to the instrument. A very small
change in alignment would result in a major change in the fluorescence intensity. Thus removing
the eye from its position in front of the instrument to exchange the aqueous humour, even when
taking care to re-align the eye using the reflection measured off the cornea, lead to a change in
alignment and thus a change in auto-fluorescence levels. This again influenced the shape of the
fluorescence decay curve when the background was subtracted. Another reason might be that
the measurement was influenced by other factors in the eye such as the Fluorescein binding to
proteins in the eye [100]. Due to these reasons and the fact that the signal to noise ratio was poor
for the low concentrations most of the exponential decays fitted to the measurement data had a
rather low correlation coefficient and it is thus no surprise that the decay rates do not follow a
clear trend with concentration.
The recovery of the measured concentrations was first attempted by assuming no decay of the
intensity with depth as it was done with Brimonidine in the cuvette as described in section 5.1.3.
It was however found that this was not sufficient since the signal does indeed decay, especially at
the higher concentrations. Thus in a second attempt to recover the concentrations the best fit to
the decay rate versus concentration was used to find the respective decay rate for each concentra-
tion. This approach improved the results marginally but shows very clearly that the decay rates
extracted from the original measurement data are not very accurate since the high concentrations
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Figure 5.21: An exemplary graph showing the concentration determined
from a scan through a 10µM solution in an in vitro porcine eye.
(i.e. 10 and 20µM start increasing when recovered, ultimately reaching infinity, whereas the lower
concentrations still show the decay of the signal. An example of the concentration recovered from
the measurement of an eye with 10µM injected into the anterior chamber is shown in figure 5.21.
This phenomenon does not only indicate that the extracted decay rates are incorrect, but also that
some other mechanism than just the absorption of the excitation light is influencing the decay of
the signal with depth.
The recovered data furthermore shows that even though the concentration at the front of the eye
matches the actual injected concentration more closely than further into the eye, it is not estimated
very accurately. This is due to the fact that the data points for the calibration curve are the average
values from all eyes measured for that concentration and have large errors. Thus none of the
measured eyes will fit the calibration curve exactly. It is therefore necessary to improve the method
of calibration for future versions of the instrument by either using perfused eyes (i.e. eyes that
are being kept "alive" artificially by pumping saline solution through them), by performing the
calibration routine on in vivo animal eyes or by using an artificial eye.
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5.2.2 Brimonidine
Since it was not possible to calibrate the F410 for measurements in in vitro eyes using Fluorescein
due to too large divergences in signal level from the eyes for each concentration, no calibration for
Brimonidine in in vitro eyes can be performed. This is because the Brimonidine calibration would
have been achieved by using the relationship between the Brimonidine and Fluorescein signal
levels known from the calibration in the cuvette and applying it to the Fluorescein calibration in
in vitro eyes.
5.3 Discussion of calibration results
The results of the calibration presented in this chapter highlight some problems of the F410. The
calibration works very well for measurements that have a high signal to noise ratio such as the
high-power measurements of Fluorescein in the cuvette, and the accuracy of the results obtained
for this measurement lies within the 20% error band defined in the specifications. Due to changes
in laser power, sensitivity to the alignment of the cuvette and poor measurement resolution of
the ADC, the repeatability is however not very good (23% error within one week). The poor
repeatability is caused by the high amplification of the system which increases the sensitivity of
the instrument to small fluctuations in signal levels. This shows more obviously in the low-power
Fluorescein measurements in the cuvette where the internal amplification of the PMT is higher,
thus leading to higher deviations in the number of photons detected by the PMT for the same
concentration in different measurement sessions. Furthermore the internal amplification was set
to different values for different measurements to assure that the full range of the ADC input (0 to
+10 V) was used. The obtained values for the intensities therefore had to be scaled to a common
amplification so that the measurements became comparable. This scaling was done using the PMT
transfer function which was measured by the author and thus also had an error attached to it.
In addition to the fact that there were small fluctuations in the signal levels coming from the PMT,
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the laser intensity was changing slightly in the course of a day due to unknown reasons. Since the
laser intensity was monitored by the external photo diode it was attempted to remove this change
of excitation intensity from the data but it was found that this actually decreased the accuracy
and repeatability. It is not exactly known if the change in laser intensity between different mea-
surements had any influence on the performance of the instrument. The largest recorded change
within one day was 3.5% of the highest measured intensity. This measured change in intensity,
however, could also have been due to the resolution of the ADC which is 11 bit. Therefore, the
lowest resolvable voltage is 4.9 mV which means that if there was a smaller change in the measured
intensity the ADC might have jumped up to a higher voltage value. Furthermore the accuracy of
the used ADC is only 4 times the least siginificant bit which in this case means an average accuracy
of 19.5 mV which decreases to 39.5 mV at the full scale of the measurement (i.e. -10 V or +10 V) due
to non-linearity in the gain of the ADC. It is thus quite possible that the laser intensity was actually
only fluctuating very little or not changing at all and the error was introduced by the ADC. This
poor accuracy possibly also lead to comparatively high fluctuations in the measured signal levels
of the fluorescence coming from the samples, thus decreasing the accuracy and the repeatability
of the measurement since any small error in the intensity reading gets amplified significantly by
the low pass filter.
Another factor that introduces error to the concentration value determined from the measured
intensity is that the F410 is very sensitive to the correct alignment of the sample. A small mis-
alignment leads to a comparatively large error in the measured intensity and the shape of the
measurement curve and thus an error in the recovered concentration which in turn influences the
accuracy of the measurement. This is especially visible in figure 5.14 in the data sets for 10 and
2µM where the concentration at the front of the cuvette seems much lower than at the back. This
is purely due to an error in alignment since the same samples measured at another time yielded
correct results.
It is furthermore obvious that the signal to noise ratio of the measurement holds an important role
in the determination of the correct decay rate for each concentration, which in turn is important for
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the accurate recovery of the concentration. The decay rates are comparatively well recovered from
the Fluorescein measurements taken with the higher laser intensity as shown in figure 5.9, but for
the low power measurements and the low intensity fluorescence the determination of the decay
rate is not very accurate as shown by the large error bars in figure 5.13. This leads to a decrease in
accuracy to 26% compared with 20% for the higher power measurements. The signal to noise ratio
does of course also influence the recovered concentration directly - if the noise level is too high the
noise will be detected by the algorithm as genuine concentration change, thus directly translating
the noise of the measured fluorescence intensity to the noise of the recovered concentration.
Despite all the problems discussed above the instrument could still be calibrated to measure the
concentration of Fluorescein in a cuvette with an accuracy that is within the value set in the spec-
ification. The described problems influence the calibration extensively but since they are all in-
strumentation issues they will be easily reduced or removed with further improvement of the
instrument. The calibration routine presented in this chapter therefore is considered to be work-
ing well enough to prove that the measurement concept presented in this thesis is working. It
furthermore shows that with future versions of the instrument the error in the accuracy can be
reduced significantly.
The reason why the calibration in in vitro porcine eyes does not work well is due to several factors
that are sample-related rather than instrument-related. First of all the porcine cornea scatters the
incoming excitation light quite badly so that the fluorescence from the volume of light measured
by the confocal detector is very low. However, due to varying states of decomposition of the eyes
the scattering coefficient varies quite extremely so that very different signal levels were measured
for the same concentration of Fluorescein in different eyes. The state of decay of the eye also in-
fluenced the absorbance of the cornea; corneas that had decomposed more were generally more
absorbent and showed higher autofluorescence. Another factor was that sometimes not all the
remaining aqueous humour could be removed from the eye, thus diluting the concentration of the
injected Fluorescein solution. It is possible that the accurate concentration could have been de-
termined by re-sampling the solution from the anterior chamber of the eye. However since it has
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been reported that Fluorescein molecules bind to compounds within the eye [100] the re-sampled
concentration would not necessarily have been an indicator of the concentration measured by the
instrument, especially since the instrument only measures in a very localised area. Furthermore
the alignment of the sample to the instrument again played a very important role, especially be-
cause the autofluorescence of the cornea was very high. Small changes in alignment thus lead to
large changes in background signal which then caused an error in the shape of the measurement
curve once the background had been subtracted. All these things resulted in large error bars and
thus a poor correlation coefficient both for the fit to the unattenuated intensity versus concentra-
tion and for the decay rate versus concentration. Another method has thus to be found in the
future to calibrate the instrument for eyes. This could for example involve perfusing the in vitro
eyes to keep them quasi-alive artificially and thus reducing the decay [101], or by using living
animal eyes. Another approach might be to transfer the calibration from Fluorescein in a cuvette
directly to the eye as has been done before [52]. It might also be possible to use the calibration
obtained from an artificial eye for the measurements of real eyes.
Chapter 6
Experiments and results
In this chapter the results of the experiments carried out during this research project are presented.
At the very beginning of the project, some interest in measuring the thickness of the human tear
film and the influence of medication for treating dry eye syndrome on the cornea and tear film
was expressed by Allergan. Therefore, measurements were carried out with a different version
of the instrument, a prototype (called the V370) built by Lein AD, to compare the performance of
the measurement principle presented in this thesis to a commercially available instrument (Haag-
Streit’s LenStar). It however became clear after a short while that Allergan was more interested in
being able to measure the pharmacokinetics of Brimonidine, ideally both in the anterior and the
posterior chamber of the eye. For this work, the measurement area was restricted to the anterior
chamber of the eye since measuring behind the crystalline lens is an additional challenge. After the
F410 was calibrated as described in the previous chapter, the diffusion of unknown concentrations
of Fluorescein and Brimonidine was measured both in the cuvette and in in vitro porcine eyes.
These measurements not only show that the instrument and its software are capable of tracking
the distribution of the fluorescent compounds over time but also that the concentration can be
recovered from rapidly changing samples. Last but not least, the background fluorescence of
healthy volunteers was monitored both over the course of a day and over the course of a week to
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Figure 6.1: Schematic diagram of the V370.
assess the amplitude of the background signal that will occur in a real-life measurement situation.
6.1 Measurement of tear film thickness
As described in chapter 2, the tear film plays an important role in keeping the cornea healthy and
nourished. If the production of the tear film is disturbed in any way it can lead to a condition
called keratoconjunctivitis sicca, also known as dry eye syndrome. If the condition cannot be
cured by removing the cause (for example long term wear of contact lenses) it is usually treated
by giving artificial tear drops. Since Allergan produces such artificial tears, they were interested
in measuring the influence of the eye drops on the tear film thickness and break up time at the
beginning of this project. This is of interest because it is not fully understood how, and for how
long, the artificial tear drops influence the tear film and thus gaining better understanding of the
factors and timings involved would enable Allergan’s pharmacologists to improve the eye drops.
For this purpose, the central corneal thickness (CCT) including the tear film of the author’s left
and right eye was measured over time with and without the application of the artificial tear drops
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Figure 6.2: A typical scan through the cornea as produced by the V370.
to the right eye. Since these measurements were taken before the F410 was built, and since the
measurement principle of the F410 is roughly based on the instruments built by Lein AD, one of
their prototypes (the V370) was used to measure the CCT. A schematic diagram of the V370 is
given in figure 6.1. The measurement principle is very similar to that of the reflection arm of the
F410. The light leaving the laser (670 nm, Laser 2000, UK) is focussed by a lens to create a reference
focal spot before expanding through a polarising beam splitting cube (PBSC) and a second beam
splitting cube which diverts a small fraction of the light returned from the sample onto a web cam
to enable the operator to monitor the alignment of the sample to the instrument. The light is then
consequently collimated to a 12 mm diameter beam by an achromatic lens combination and passes
through a quarter wave plate before being focussed onto the sample by a final lens that is mounted
on a scanning stage (SMAC Europe Ltd., UK). As in the F410, this motorised scanning stage moves
the focus of the beam along the optical axis of the eye, thus creating a one dimensional profile of
reflection intensities on the detector. The light reflected by the sample is re-collimated and passes
through the quarter wave plate again before being diverted by the PBSC and focussed through a
pinhole and a relaying lens onto a photo diode. The double pass through the quarter wave plate
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Figure 6.3: Measurement of central corneal thickness (CCT) in the right and
left eye with the LenStar. Artificial tear drops were applied to the right eye
at 15:20 hours.
in combination with the PBSC reduces unwanted reflections reaching the detector. After the light
passes the last lens a fixation target is projected onto the beam, helping the patient to align their
eye to the instrument. The full system has also been described by us in [102].
Figure 6.2 shows a typical scan produced by this instrument. The first peak at approximately
1000µm scanning depth is the reflection from the anterior surface of the cornea, whereas the
much lower intensity peak at approximately 1400µm depth is the reflection from the posterior
surface of the cornea. The graph has been cropped such that the posterior peak is clearly visible.
The intensity from the anterior peak is much higher due to the fact that the change of refractive
index is larger at the boundary between air and the anterior corneal surface than between the pos-
terior corneal surface and the aqueous humour in the anterior chamber of the eye, leading to a
higher Fresnel reflection. To compare the results with a commercially available instrument, mea-
surements were carried out simultaneously with the LenStar produced by Haag Streit which is
an interferometer based instrument and thus follows a different measurement principle than the
V370. As mentioned above, the artifical eye drops (OptiveTM, Allergan Inc.) were applied to the
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Figure 6.4: The corneal thickness (CCT) as measured with the V370 after the
application of artificial tears.
author’s right eye while the left eye was used as a reference. Measurements were taken quasi-
simultaneously by first measuring the CCT of both the left and the right eye with the LenStar and
then measuring the right eye using the V370 immediately afterwards. As shown in figure 6.3, the
application of the artificial tear drops at 15:22 leads to an increase in the CCT of 9µm, whereas
no increase is visible in the left eye. The increase in corneal thickness is also visible in the mea-
surements taken with the V370 (figure 6.4, however the measured change in thickness was only
4µm.
This discrepancy in thickness is most likely due to the fact that it takes up to a couple of minutes
to obtain one measurement with the LenStar and thus the measurement point taken with the V370
was collected 10 minutes after the application of the eye drops. During this time the CCT has de-
creased almost to its original value as the next data point taken by the LenStar shows. This point
was taken 1 minute after taking the measurement with the V370 and the CCT had decreased to
being only 2µm thicker than the original value before the application of the eye drops. The reason
why the corneal thickness as measured with the V370 is slightly higher lies in the fact that the
CHAPTER 6. EXPERIMENTS AND RESULTS 128
Figure 6.5: Repeat measurement of the increase in CCT after the application
of eye drops.
instrument was not calibrated before use, and therefore the accuracy might have been compro-
mised. For the measurement of the relative change of CCT the absolute thickness is however not
of importance. Both instruments show a similar level of increase in thickness and thus it is clear
that the V370 is capable of measuring the relative change of the CCT that is induced by the eye
drops.
To show that the increase in corneal thickness was due to the eye drops and not some other un-
defined influence the measurements were repeated the next day using only the LenStar since this
instrument was calibrated. Again an increase of the CCT of 7µm was measured while the refer-
ence eye did not show any increase in thickness as shown in figure 6.5. As a second confirmation
that the measurement was valid both eyes were measured in the afternoon without applying the
eye drops, showing no increase in thickness whatsoever (figure 6.6).
Unfortunately, neither of the instruments were able to resolve the tear film from the cornea. It is
thus impossible to say whether the application of the eye drops lead to an increase in the tear film
thickness or to an effect called corneal plumping where the cornea swells slightly due to external
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Figure 6.6: Measurement of the CCT with the LenStar. No eye drops were
applied.
influences. The measurements presented here do however show that the combined effect can be
detected as a relative change in thickness compared to the previously measured value. The initial
plan for this PhD project was therefore to improve the prototype built by Lein AD so that the tear
film would become resolvable and then monitor the influence of artificial tears on the corneal and
tear film thickness and tear film break up time. The instrument would have been further improved
by adding the capability to detect fluorescent light and the polarisation of the reflected light so that
the instrument could provide information on the internal structure of the cornea.
It then became clear that Allergan was more interested in measuring the pharmacokinetics of
Brimonidine which lead to a slightly different design of the instrument. Since the F410 was de-
signed to measure the autofluorescence of weakly fluorescent compounds more attention was paid
to collecting as much fluorescent signal as possible and increasing its signal to noise ratio than to
having an axial resolution good enough to resolve the tear film. In principle the instrument for
measuring the tear film thickness and break up time would however have been very similar to
the F410, and there is no reason why the F410 cannot be developed into such an instrument in the
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future. The beauty of the F410 lies within the fact that it is a very versatile instrument that can
easily be adapted for different applications.
6.2 Determination of unknown concentrations in a cuvette
As described above the focus of the research changed quite soon after the start of the project
from measuring the tear film thickness and break up time to measuring the pharmacokinetics
of Brimonidine in the anterior chamber of the eye. The instrument was thus changed to the design
described in chapter 4 and built and calibrated as described in chapter 5. After the instrument
had been calibrated successfully to recover the concentrations from fluorescence intensities mea-
sured in a cuvette and it had been shown that the calibration routine theoretically also works on
changing concentrations, the dispersion of a drop of both Fluorescein and Brimonidine in water
was monitored over time. The results show that the F410 is not only capable of recovering the
concentration from a static solution but also from solutions of concentrations that change rapidly
with time. The temporal resolution of the instrument is currently approximately 0.6 s.
6.2.1 Fluorescein
High laser power
First of all, the diffusion measurement was carried out with a laser power that is slightly above
the calculated safe level for human exposure to ensure a good signal to noise ratio. A drop of
20µM Fluorescein (50µl) was released into a cuvette filled with 2 ml of water. The diffusion of
the Fluorescein into the water was consequently monitored for approximately 4.3 minutes. A
three-dimensional representation of the diffusion of the drop with time is shown in figure 6.7.
The scanning depth is shown along the x-axis, the recovered concentration along the y-axis and
the measurement time in seconds along the z-axis. It has to be pointed out here that the figure
does not show a three-dimensional representation of the cuvette but rather is a representation of
CHAPTER 6. EXPERIMENTS AND RESULTS 131
Figure 6.7: Three-dimensional represenation of a drop of Fluorescein diffus-
ing in a cuvette.
how the two-dimensional scan changes over time. The concentration is colour-coded for ease of
reading. At the beginning of the measurement the drop is released and falls through the focus of
the beam while spreading in the water, leaving an interesting localised distribution of quite high
concentration. It then diffuses through the cuvette over time and becomes less localised. At the
end of the scan it is quite evenly distributed throughout the whole measurement volume. The
average concentration of the last scan in the measurement is (495 ± 246) nM. The high standard
deviation is due to the fact that diffusion was not completed by the time the measurement was
stopped and thus localised small changes in concentration are still present. The expected concen-
tration after complete diffusion for a 50µl drop of 20µM in 2 ml of water is 500 nM. These results
therefore show that the concentration measured by the F410 is very close to the actual value, and
it is assumed that if the diffusion had been monitored for longer the final measured concentration
would have met the actual concentration even more accurately. The same measurement is shown
in a different representation in figure 6.8 as temporal snapshots for clarity. Figure 6.8 (a) shows the
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(a) (b)
(c) (d)
(e) (f)
Figure 6.8: A drop of Fluorescein diffusing in a cuvette. (a) The background
signal before the drop is released. (b) The drop has been released and is
falling through the focus. (c) - (f) The Fluorescein is diffusing through the
cuvette until a more equal distribution has been reached.
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(a) (b)
(c)
Figure 6.9: Measurement of a drop of Fluorescein diffusing in a cuvette filled
with water. The measurement was taken at an eye safe laser power.
cuvette at time zero before the drop of Fluorescein is released. No concentration is present in the
water. In (b), the drop has just been released and is falling through the focus of the beam into the
cuvette while spreading sideways through the water. It then starts spreading more and more side-
ways while the concentration equalises throughout the length of the cuvette as is visible in scans
(c) to (e). In scan (f) after which the measurement was stopped the Fluorescein has diffused almost
completely and levelled at a concentration of approximately 500 nM. The time of measurement in
seconds after the start of scanning is given in the top left hand of the respective graph.
Low laser power
The same measurement of a drop of Fluorescein diffusing in a cuvette of water was then carried
out using the lower laser power that is safe for human exposure for this configuration of the instru-
ment to show that even with such a low incident power the concentration of a rapidly changing
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solution can be monitored with the F410. A three-dimensional representation of the diffusion of
the drop of Fluorescein in the cuvette over time is given in figure 6.9. The three scans were taken
consecutively in the order (a), (b), (c). As with the higher power measurement, the drop first falls
through the focus of the instrument while starting to diffuse sideways. It then starts spreading
more and more throughout the cuvette until a state close to final equilibrium is reached as can be
seen in the last scan of figure 6.9(c). The same parameters as in the higher laser power measure-
ment were used, i.e. a 50µl drop of 20µM Fluorescein in a cuvette filled with 2 ml water. The final
concentration after complete diffusion will therefore be 500 nM as before. As can be seen in the
snapshots taken from the measurement (figure 6.10) the final concentration measured is slightly
below 500 nM, however this might be due to the fact that the Fluorescein had not diffused com-
pletely before the end of the measurement. The time of the measurement is shown in the top left
hand corner of the graph. In figure 6.10(a), the drop has not yet been released. In (b) the drop falls
through the focus while spreading slightly to the sides. The Fluorescein then diffuses throughout
the cuvette through (c) to (e) until it is almost in equilibrium in scan (f).
It is obvious that the signal to noise ratio of the low power measurements is lower than for the
higher power measurements. However it is also clear that even though the accuracy is slightly
worse, the concentration is still measured correctly.
6.2.2 Brimonidine
Even though the calibration for recovering the concentration of Brimonidine from the measured
signal does not work as well as with Fluorescein due to the lower intensity of the fluorescence and
thus the lower signal to noise ratio, the same measurement as for Fluorescein was carried out. The
diffusion of a drop of Brimonidine in a cuvette filled with water was monitored over time. When
trying to recover the concentration from the measured data it however became clear that more
research is needed to find why Brimonidine has an offset in the calibration curve and to generally
better understand its fluorescent behaviour. The set of calibration solutions is recovered more or
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Figure 6.10: A drop of Fluorescein diffusing in a cuvette measured at eye safe
laser power. (a) Before the drop has been released. (b) The drop has been
released and falls through the focus. (c) to (f) The Fluorescein is diffusing
through the cuvette.
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less correctly as shown in figure 5.18, but the recovery of the measured diffusion does not work
due to the fact that any signal that is below the offset is set to the offset by the algorithm so that no
negative concentrations are measured. Since the offset found in the calibration is 1 V and most of
the signal change measured during this experiment was below 1 V the concentration was thus set
to zero. Therefore, the intensity of the measurement scaled to a gain of 1 on the PMT rather than
the recovered concentration is shown in the graphs presented here.
Figure 6.11 shows temporal snapshots of a 50µl drop of 10 mM Brimonidine diffusing in a cuvette
filled with 2 ml of water. The time of measurement in seconds after the measurement start is shown
in the top left hand corner of the graph. In (a), no Brimonidine is present and thus the average
signal is zero. In (b), the drop of Brimonidine has been released and is falling through the focus
of the instrument. The drop of Brimonidine then bounces of the bottom of the cuvette and starts
diffusing sideways (scan (c) to (e)). After that the Brimonidine leaves the focus of the instrument
until it has diffused throughout the whole cuvette (scan (f)). No three-dimensional representation
of this measurement is included here since no interesting profiles are visible in the focus after the
first 30 scans and the gradual increase in intensity is not visible in the three-dimensional image
due to the poor signal to noise ratio.
These measurements show that although there is an issue with the calibration which needs fur-
ther investigation the instrument is capable of measuring the change in intensity induced by the
diffusion of a comparatively high concentration of Brimonidine in water. The final concentra-
tion after complete diffusion was calculated to be 250µM which according to the calibration is
below the resolvable limit due to the noise in the measurement. It is however clearly visible
from graphs (a) and (f) that the average intensity has increased after the diffusion of the drop
of Brimonidine. Therefore, even though the concentration cannot currently be extracted from
the measurements, the change in intensity is measured and relative changes in concentration can
thus be extracted. The instrument will therefore add valuable knowledge about the distribution
properties of Brimonidine. Without doubt with the improvements suggested in chapter 8 a fu-
ture version of the instrument will be capable of resolving and calculating the concentration of
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Figure 6.11: A drop of Brimonidine diffusing in a cuvette filled with water.
(a) The background signal before the drop is released. (b) The drop has been
released and falls through the focus. (c)-(e) The drop is starting to spread in
the cuvette. (f) The Brimonidine has diffused almost completely.
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Brimonidine with an accuracy similar to that already achieved for Fluorescein.
6.3 Determination of unknown concentrations in in vitro porcine
eyes
6.3.1 Fluorescein
After it had been determined that the concentration of samples of unknown, rapidly changing
concentrations can be recovered and monitored over time in the cuvette the same was attempted
in in vitro porcine eyes. For this experiment, an arbitrary volume of Fluorescein was injected into
the unknown volume of the aqueous humour of the porcine eye. The concentration injected was
20µM but since the volume of the aqueous humour in the eye is unknown no predictions towards
the final concentration after diffusion can be made. Figure 6.12 shows the very slow distribution
of the injected drop of Fluorescein with time. The four measurements (a) to (d) were taken con-
secutively in that order. The eye was only monitored for approximately six minutes due to time
restrictions - since the eyes were degrading very quickly it was of crucial importance to measure
the next eye as soon as possible. Figure 6.12 (a) shows the eye at the point of injection. The high
peak in fluorescence intensity at a depth of approximately 3750µm comes from the degrading
proteins in the cornea. The Fluorescein was injected at approximately 10 seconds into the first
measurement, as can be seen by the peak of the cornal auto-fluorescence shifting about its po-
sition due to the deformation of the cornea by the needle of the syringe. The fluorescence from
the Fluorescein is then very quickly visible at 12 seconds into the measurement and then starts
becoming more and more intense with time.
Figure 6.13 again shows a selection of measurement scans at different time points in the same
measurement. The time the scan was recorded at is indicated in the top left hand corner of the re-
spective graph. Graph (a) shows the background fluorescence from the eye before the Fluorescein
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(a) (b)
(c) (d)
Figure 6.12: 3D representation of Fluorescein diffusing in an in vitro porcine
eye.
was injected. Graphs (b) to (f) show the distribution of the Fluorescein over time. It is noticeable
that unlike in the cuvette no distinctive profile of fluorescence intensity with depth is visible. This
is most likely due to the fact that the aqueous humour has a different consistency to the water
in the cuvette and thus the Fluorescein distributes more slowly. Furhtermore, since the eye is a
closed system (in contrast to a cuvette), the slower and more even diffusion might also be due
to smaller thermal and atmospheric influences that would mix the fluorescein with the solvent in
unpredictable patterns. It might also be that due to the injection of the Fluorescein with a syringe
it has more velocity than the drop released into the cuvette and thus distributes faster and more
evenly throughout the measured volume than in the cuvette. That the properties of the diffusion
are different in the eye from the cuvette can also be seen in the later scans where the intensity of
the fluorescence rises very slowly and smoothly in the focus of the beam and does not seem to
distribute further into the eye. Since no reflection from the lens is measured by the instrument due
to the low signal level it is impossible to tell how deep the anterior chamber actually is. From the
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author’s experience of working with the eyes it seems however likely that the anterior chamber
is not deeper than the 2 mm the depth of the Fluorescein distribution in scan (f) suggests. The
anterior chamber of a human eye has an average depth of 3.5 mm [11] and since porcine eyes are
similar in size it is likely that in their normal (i.e. living) state they have a similar depth. However
as mentioned before the corneas of the eyes used for these experiments were swollen with the
water from the aqueous and it is thus quite likely that the depth of the anterior chamber decreased
with the increasing decomposition of the eyes.
Since the calibration for the measurement of the concentration of Fluorescein in in vitro porcine
eyes did not yield satisfying results it was not attempted to calculate the concentration of the data
presented here. It is however clearly visible that small changes in intensity are measured by the
F410 and it is thus clear that once a better way of calibrating the instrument to the eyes has been
found it will be possible to accurately recover the concentration from the measured intensity.
6.3.2 Brimonidine
The same measurements as described above for Fluorescein were carried out with a high concen-
tration (1 mM) of Brimonidine to assess whether the change in intensity can be measured by the
instrument at such low signal levels. Figure 6.14 again shows a three-dimensional representation
of the whole data set split into four consecutive measurements. In graph (a) the Brimonidine is in-
jected between 10 and 20 s after the measurement was started. This can be seen by the peak of the
corneal auto-fluorescence shifting its position due to the deformation of the cornea by the needle.
The Brimonidine concentration then starts increasing behind the cornea, but unlike the Fluorescein
it does not seem to distribute throughout the length of the anterior chamber. This phenomenon
has been observed in all measurements taken with Brimonidine and is confirmed by the literature
[103][82]. Brimonidine binds to specific compounds and structures within the eye, one of which is
the cornea. The measurements taken of Brimonidine diffusing in porcine eyes therefore show that
the F410 is capable of accurately measuring the position of the drug in the eye.
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Figure 6.13: Snapshots of Fluorescein diffusing in a porcine eye. (a)
Background fluorescence from the cornea before injection. (b) The
Fluorescein has been injected into the anterior chamber. (c)-(f) The
Fluorescein is diffusing through the anterior chamber.
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(a) (b)
(c) (d)
Figure 6.14: Brimonidine diffusing in the anterior chamber of an in vitro
porcine eye.
Selected time points of the measurement are presented in figure 6.15. It is more clearly visible
in these graphs than in the three-dimensional representation that Brimonidine does bind to the
cornea. The depth of the distribution is only approximately 1 mm. It is again visible as in the
measurements with Fluorescein that the diffusion in the eye takes place slower than in the mea-
surements of a drop of Brimonidine diffusing in a cuvette. This is probably due to the fact that the
components in the eye have started decomposing and the aqueous humour is thus more viscous
than it would be in living eyes were it will have a viscosity close to that of water.
6.4 Fluorescent background in volunteers
After it had been confirmed that the F410 is capable of measuring rapid changes in concentration
in cuvettes and in vitro porcine eyes the next logical step was to measure the background fluores-
cence in in vivo eyes. Ethics permission to measure the autofluorescence in healthy volunteers was
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Figure 6.15: Temporal snapshots of Brimonidine diffusing in the anterior
chamber of a porcine eye. (a) The background fluorescence from the cornea.
(b) After the injection. (c)-(f) The Brimonidine is diffusing slowly through
the anterior chamber.
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Figure 6.16: Typical scan of the F410 through a human eye.
subsequently granted by the departmental ethics committee. The ethics application and selection
criteria for volunteers is given in appendix C. The autofluorescence of cornea and lens were thus
monitored first over the course of one day and then twice a day over the course of one week. It
seems to be the general convention in the literature to express the fluorescence intensity in terms of
equivalent Fluorescein concentration; This has not been done here but will be added in the future
prior to the publication of these results.
A typical scan through a human anterior chamber is shown in figure 6.16. The autofluorescence
both from the cornea and the lens is clearly visible. The cornea fluoresces significantly less than
the lens, with the fluorescence of the lens being age-dependent [49][104]. The fluorescence of the
cornea does not seem to be age dependent and the intensity was within the same range for all
measured volunteers. It is noticeable in the graph that no reflection from the eye is measured.
This is due to the low power of the laser used in this experiment and its wavelength for which the
detector is not optimised. The home-build electronics mentioned in chapter 4 include a detector
with better sensitivity in the blue wavelengths to increase the signal from the reflection from the
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Figure 6.17: The level of human corneal autofluorescence measured over a
day.
eye. The detection of correctly aligned scans could therefore not be done using the reflection.
Instead, a combination of the amplitude of the corneal peak and the lens peak being above a
threshold value was used to define a well aligned scan.
The autofluorescence of cornea and lens was then monitored in seven volunteers in total in two-
hourly intervals on two consecutive days. It was found that the fluorescence of the cornea dropped
within one day on both measurement days which contradicts other findings published in the lit-
erature [105][106]. These measurements were taken at slightly longer wavelengths than the one
presented in this dissertation (430-490 nm excitation wavelength for both studies, and 530-630 nm
detected emission). The excitation wavelength might thus have an influence on the autofluores-
cence of the cornea. Further investigation in this area would be very interesting to find if by
choosing an appropriate excitation wavelength different corneal metabolic changes can be mea-
sured.
The peak fluorescence of the cornea versus the time of day is shown in figure 6.17 for the first
measurement day and in figure 6.18 for the second measurement day. The drop in intensity was
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Figure 6.18: The human corneal autofluorescence changing over the course
of a day.
found to be statistically significant on both days in all measured volunteers but one (paired t-test,
P < 0.0005). No significant drop in intensity was found in the lens as can be seen in figures 6.19
and 6.20. It is however well known that the lens in patients with diabetes fluoresces more than
in healthy subjects [107][108]. It was therefore no surprise to find that the lens of a volunteer
with diabetes fluoresced significantly more than the lenses of other volunteers of the same age
(unpaired t-test, P < 0.005). After it had been established that the fluorescence of the cornea seems
to drop throughout the day it was decided to measure the autofluorescence of the anterior chamber
over a week to find any cycles that might be present. The fluorescence intensity for the cornea is
shown in figure 6.21 and the autofluorescence for the lens in figure 6.22. It can be seen that the
corneal intensity seems to be decreasing on all days except Wedneday and except for volunteer
H where in fact it seems to be increasing most of the days. In general there seems a lot of spread
of decreasing and increasing so that no definite conclusions can be drawn. More volunteers and
more repeats would be necessary to gain enough data for a meaningful analysis.
As with the corneal measurements the autofluorescence from the lens does also not seem to follow
CHAPTER 6. EXPERIMENTS AND RESULTS 147
Figure 6.19: The autofluorescence of the human lens monitored over the
course of one day.
Figure 6.20: The diurnal change in autofluorescence of the lens of human
volunteers.
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Figure 6.21: The autofluorescence of the human cornea monitored twice
daily for a week.
a clear trend or cycle. It is however clearly visible that the lenses of older subjects (F and H, age:
30-35 years) fluoresce more than the lenses of younger volunteers (B and D, age: <30 years).
These results show that the F410 cannot only be used to monitor the diffusion of inherently flu-
orescent compounds within the anterior chamber of the eye but that a by-product of the design
creates the ability to measure the autofluorescence of the cornea and lens. This feature can pos-
sibly be used to indicate the health status of either of these components. The fluorescence from
the cornea, for example, can be used as an indicator for diabetic retinopathy and for the general
evaluation of the corneal metabolism [50][105], whereas the fluorescence from the lens can be used
to monitor for cataract and diabetes.
Once the detector in the reflection measurement arm has been changed the instrument will fur-
thermore be capable of measuring the dimensions in the anterior chamber simultaneously which
will provide valuable information on the exact location of the fluorescence source.
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6.5 Discussion of measurement results
The measurements presented in this chapter show that the instrument is not only capable of mea-
suring the concentration of static, homogeneous samples but also of rapidly changing concentra-
tions of both Fluorescein and Brimonidine in a cuvette and in in vitro porcine eyes. Measurements
were presented that show a drop of Fluorescein diffusing in a cuvette, both at a high and at a low
laser power that is eye safe at the current configuration of the instrument. The final concentration
measured in these experiments was close to 500 nM which is the expected concentration after com-
plete diffusion of the drop. Although the concentration could not be recovered from a single drop
of Brimonidine diffusing in a cuvette due to issues with the calibration, the measurements show
that small changes in intensity are measured by the instrument. These changes in intensity can be
used to determine a relative change in concentration even when the absolute concentration is not
known. The measurements of Brimonidine diffusing in a cuvette also have poor signal to noise
ratio. It is however not doubtable that once the improvements discussed in chapter 8 have been
implemented the signal to noise ratio will be better and the instrument will thus be able to recover
the concentrations from Brimonidine as accurately as it is currently working with Fluorescein.
In addition to having shown that the distribution of a drop of either Fluorescein or Brimonidine
can be monitored in a cuvette, the results presented here also show that the distribution of both
Fluorescein and Brimonidine can be monitored in in vitro porcine eyes. Unfortunately the con-
centration for these measurements cannot currently be recovered due to the problems with the
samples as discussed in chapter 5. As with the measurements of the Brimonidine diffusion in the
cuvette, however, the change in intensity caused by the diffusion of the fluorophore is measured
by the instrument. Thus even though the absolute concentration is not known, relative changes in
concentration can be recovered. It is thus clear that once a better calibration routine for the porcine
eyes has been found the absolute concentration will also be recoverable.
As well as being able to measure small changes in intensity at such low laser power as is present
in the porcine eyes, the F410 can also measure the position of the fluorescence accurately and
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Figure 6.22: The change in autofluorescence of the human lens in a week.
confirms measurements that were published in the literature before of Brimonidine binding to the
cornea of the eye. It is therefore clear that with the improvements suggested in chapter 8, the F410
will be able to measure the concentration and distribution of both Fluorescein and Brimonidine
accurately both in cuvettes and in vivo eyes. The measurement conditions in in vivo eyes will be
much better than in in vitro eyes since the autofluorescence of the cornea will be lower and the
cornea much less absorbing and scattering than in the measurements presented in this chapter. It
therefore has been proven that the measurement concept presented in thesis is working.
Further to being able to measure the diffusion of fluorescent compounds both in cuvettes and in in
vitro porcine eyes the instrument is also capable of monitoring the autofluorescence of the human
eye. This is an obvious side-effect of the measurement principle that opens doors into other areas
of research such as cataract research. Furthermore a slightly modified version of the instrument
that was briefly presented at the beginning of this chapter could be used to monitor the tear film
and its break up properties. The tear film thickness and break up time are also commonly assessed
by measuring the clearance time of Fluorescein eye drops. A potential application of an instru-
ment that combines fluorescence and reflection is the monitoring of the health of the cornea, for
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example in long-term contact lens wearers. Another potential application is using the instrument
for monitoring the health of the lens which is related to monitoring the auto-fluorescence in dia-
betics because it is well known that patients with diabetes are more prone to getting early onset
cataract [109][110][111].
The results presented in this chapter therefore show that the instrument is not only capable of
measuring the pharmacokinetics of fluorescent ophthalmic compounds non-invasively in the eye
with high temporal and spatial resolution but that it also has the potential to be used in other
applications related to the measurement of fluorescence and reflection in the eye.
Chapter 7
Discussion and conclusion
The work presented in this dissertation deals with the design of a novel, non-invasive instrument
to measure the fluorescence of inherently fluorescent drugs in the anterior chamber of the eye.
Instruments that measure fluorescence in the eye are usually referred to as ocular fluorophotome-
ters, and they have been in use since the late first half of the 20th century [35][36]. The accepted
gold standard instrument, the Fluorotron MasterTM (Coherent Inc., California, USA), has however
been primarily designed for measuring the fluorescence in the vitreous humour (e.g. to assess the
function of the blood-retinal barrier) and can only be used in the anterior chamber by adding a spe-
cial adapter to the instrument. Its axial resolution using the anterior chamber adapter, measured as
the distance from the peak of a signal to the point where the signal has fallen to 3%, is 0.2 mm [52],
and without the adapter the resolution decreases to 2 mm [55]. The need for an instrument with
higher axial resolution is thus obvious and has been expressed in the literature [32][52][56][57].
Furthermore, to the author’s best knowledge none of the instruments that have been discussed in
the literature have been used to measure the diffusion of an inherently fluorescent drug directly
without the use of fluorescent markers or indirect measurement methods. The instrument pre-
sented in this thesis is capable of measuring the diffusion of Alphagan-P (Brimonidine), a drug
that is used to lower the IOP in patients with open angle glaucoma, directly and without the use
152
CHAPTER 7. DISCUSSION AND CONCLUSION 153
of fluorescent markers. In addition the instrument discussed here does not only measure the fluo-
rescence but also the reflection from the eye so that valuable information about the exact position
of the fluorescence can be obtained.
The investigation was started by modelling the depth dependent decay of the fluorescent signal
of Fluorescein solutions of different concentrations. This was done to predict the behaviour of a
real sample and to be able to compare the obtained measurements of real samples with the mathe-
matical model to confirm that the instrument is working correctly. For this purpose, the extinction
coefficient for Fluorescein sodium salt in water of pH 7 and when excited with a wavelength of
402 nm was measured. It was found that the decay curves for different concentrations cross after a
specific depth and thus cannot be used directly to remove the depth dependency of the signal since
there is a point of uncertainty where a specific signal can be attributed to several concentrations.
The intensity at the first position within the sample (i.e. where the laser beam and thus the fluo-
rescence has not yet been attenuated by absorption) was found to increase linearly with increasing
concentration. It was furthermore determined that the decay rate was also linearly dependent on
the concentration, with larger concentration having higher decay rates as expected.
As a next step the quantum yield of the compound of interest, Brimonidine, was measured to as-
sess its fluorescent properties. The quantum yield was measured against two standard fluorphores
with known quantum yields, Rhodamine B and Fluorescein, and was found to be approximately
0.41% which is very low. In comparison, Fluorescein has a quantum yield that is 170 times higher.
Knowing the quantum yield is important so that the instrument can be designed accordingly. A
low quantum yield means that a very sensitive instrument with a good signal to noise ratio is
needed to be able to measure the fluorescence of low concentrations of that compound. After the
magnitude of the quantum yield had been established, a novel measurement concept for mea-
suring the fluorescence and reflection from the anterior chamber of the eye was introduced. The
performance of the instrument was assessed by measuring the axial resolutions of the two distinct
detection arms which were found to be 285µm for the reflection detection arm and 124µm for the
fluorescence detection arm. These values are larger than the values predicted by the theoretical
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value due to aberrations in the beam produced by slight misalignment of optics and astigmatism
introduced by the dichroic mirror, and due to the fact that comparatively large pinholes were cho-
sen to collect more signal. To compare the instrument presented in this thesis with the gold stan-
dard ocular fluorophotometer, the Fluorotron MasterTM, the axial resolution was also measured as
the width from the peak of a signal to the 3% point and was found to be 280µm, which is below
the axial resolution achieved by the competing instrument. It is however clear that once the pro-
totype presented here has been developed further and issues with aberrations have been resolved
the axial resolution will increase beyond the value achieved by the Fluorotron. The perfomance
of the instrument was then futher analysed by measuring several types of noise that influence the
measurement. It was found that the dark noise, although increasing with the reference voltage,
was small compared to the unwanted background signal that reaches the detector. The type of
noise that creates the highest fluctuation in the measurement was found to be the shot noise cre-
ated by the random arrival of photons from the sample. This random fluctuation increased both
with the reference voltage and with the concentration of the measured solution.
After the discussion of the instrument and its performance and limitations the control software
was briefly introduced. The instrument is currently controlled by four major programmes which
control the data acquisition, the calibration, the analysis of the data and the presentation of the
data. It would obviously be better if all code was combined into one master programme that
also incorporates a graphical user interface. This is an addition that is planned for the future
development of the instrument. The currently available programmes are however clear enough
for a trained person to use them.
Since the instrument was to be used on healthy volunteers the laser safety for exposing the eye to
laser radiation was then assessed. According to the British standard, the maximum permissible
exposure for an exposure time as given by the instrument presented here is 39µW. The British stan-
dard, however, has not been designed for intentional viewing of the beam and does not consider
the focussing of the beam in the anterior chamber of the eye. Instead, it assumes that the beam
will focus on the retina and thus no danger is posed to the cornea and lens. To be able to assess
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the danger for cornea and lens the illumination of the F410 was therefore simulated using Zemax.
It was found that the measurement beam used in the instrument will never focus on the retina un-
less the eye is more than 60 mm away from the last lens of the instrument, in which case the beam
will be overfilling the pupil and the irradiance on the retina will thus be reduced significantly. The
highest irradiance on the retina was found to be 14 Wm−2 which is below the safety limit. The
highest irradiance on the cornea and in the lens will obviously occur when the beam is focussed
on the respective component. The theoretical irradiance in the focal spot as determined from the
theoretical spot size (1.69µm2) and the incident laser power (39µW) is 7.22×106 Wm−2. It is how-
ever very unlikely that this irradiance will ever occur due to the aberration of the beam and the
resulting blur of the focus. Furthermore, according to guidelines published by the International
Commission on Non-Ionizing Radiation Protection, the power of the beam can be averaged over
an area as big as 1 mm to account for involuntary eye movements that occur even when head
movements are restricted. Therefore, the irradiance can be said to be 49.7 Wm−1, although an av-
eraging over a smaller area is possibly more accurate. Averaging over an area of 50µm diameter
yields an irradiance of 2× 104 Wm−2. This value is at half the safe limit as given by ANSI 2000. It
was found that for the lens the instrument is only just within the safe limit as long as a 1 mm area
is used for averaging. Since the actual exposure time is shorter than assumed for the calculation
the instrument was however still considered to be safe for human exposure.
After it had been established that the instrument was safe for human use it was calibrated for the
use of Fluorescein and Brimonidine in both cuvettes and in vitro porcine eyes. The calibration was
first carried out using a set of modelled decay curves to show the validity of the calibration routine.
As a second step, the instrument was then calibrates for the use of Fluorescein and Brimonidine
in cuvettes at both a laser power too high for human viewing (to guarantee a good signal to noise
ratio) and a laser power safe for human viewing. It was found that the calibration works very well
for measurements that have a high signal to noise ratio, but that for measurements with low signals
the accuracy of the recovered concentrations is not very good. The accuracy of measurements of
high concentrations of Fluorescein is within a 20% error band as set by the specifications. The
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repeatability was however found to be rather poor with an error of 23% within one week. This
is most likely due to the high amplification in the system which increases the sensitivity of the
instruments to fluctuations in the signal. Unfortunately, the calibration in in vitro porcine eyes was
found not to work due to the different states of decomposition of the eyes. Another method to
calibrate the instrument to in vitro eyes therefore has to be found in the future.
As a last step, measurements of diffusing drops of Fluorescein and Brimonidine were taken both
in cuvettes and in in vitro porcine eyes. It was shown that the instrument can track the diffu-
sion of the compound of interest with a temporal resolution of 0.6 s which is much faster than
the Fluorotron, which needs 20 s for one complete scan through the anterior chamber. Due to is-
sues with the calibration, the concentration of a single drop of Brimonidine diffusing in a cuvette
could not be recovered, but it is shown that the change in intensity and thus the relative change
in concentration can still be measured by the instrument. Results were also presented that show
a drop of Fluorescein and Brimonidine diffusing in porcine eyes. Again, the concentration for
these measurements cannot be recovered due to the fact that the calibration for in vitro eyes failed.
However, as with the Brimonidine diffusing in a cuvette, the change in signal and thus the relative
change in concentration is tracked by the instrument. It was found that the Brimonidine concen-
tration is higher in areas close to the cornea than deeper in the aqueous humour which confirms
findings discussed in the literature [103][82]. Further results that show the diurnal change in the
autofluorescence of the eyes of healthy volunteers were presented. It was found that the peak
fluorescence intensity of the cornea decreased over the course of one day which contradicts find-
ings from slightly longer excitation wavelengths published in the literature [105][106]. No clear
pattern was found in the change of autofluorescence in the lens. Furthermore, no clear change in
fluorescence was found over the course of a week.
Concluding it can thus be said that a novel, non-invasive instrument has been presented in this
dissertation which has the potential to become the new gold standard fluorophotometer. Its axial
resolution is currently not quite as good as that of the current gold standard instrument but it is
without doubt that once the improvements suggested in the last chapter of this thesis have been
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implemented the instrument presented here will perform at least as good as the Fluorotron Master.
The advantage of the novel instrument is the use of pinholes rather than confocal slits which al-
lows for an increase in the resolution of the system. Furthermore a laser rather than a filtered lamp
is used as the excitation source which increases the irradiance and thus the signal to noise ratio.
In addition, the instrument described here records the reflection from the eye simultaneously with
the fluorescence which increases the accuracy of the determination of the source of the fluorescent
signal. A measurement point is taken every 20µm in comparison to every 250µm in the commer-
cially available instrument. A better positional resolution is thus achieved. Another advantage
of the F410 is that it only takes 0.6 s to acquire a complete scan through the anterior chamber of
the eye whereas the Fluorotron takes 20 s for one scan. The diffusion of fluorescent compounds
can thus be tracked with much higher temporal resolution than before. Other instrument that are
faster than the Fluorotron Master exist [44], but to the best of the author’s knowledge they have
not been developed any further and have not extensively been used in research. As a last point it
should be mentioned that the instrument presented here is comparatively low-cost and that it can
easily be made smaller and lighter and thus find applications in home monitoring systems.
Chapter 8
Outlook
The F410 is only a prototype and therefore still harbours a number of problems that need im-
proving. The most crucial limitation of the instrument currently is its signal to noise ratio which
needs improvement before the concentrations of compounds with low signal levels or low quan-
tum yields can be measured accurately. The author is convinced that with an improved design,
the instrument will have the potential to become the new gold standard ocular fluorophotometer.
The first step to improve the instrument will be to use better optics (lenses that are anti-reflection
coated in the specific wavelength region and achromatic) and to apply more sophisticated optical
engineering to the existing instrument to decrease the optical aberrations currently present in the
set-up. A decrease of the aberrations will lead to a tighter focal spot in the sample and thus an
increased signal strength, which in turn will facilitate a higher signal to noise ratio. A tighter focal
spot will also mean that the pinhole size can be reduced, thus improving the axial and lateral
resolution of the system.
After these improvements have been made, the next important step will be to increase the speed
of the data acquisition. A faster data acquisition will decrease the scanning time and thus the
time the eye is exposed to the laser, which in turn means that the laser intensity can be increased
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which leads to a direct increase in the signal to noise ratio. To make the data acquisition faster,
the analogue to digital converter has to be exchanged for a model that can acquire more samples
per second. The scanning speed of the motorised translation stage can then be increased as well
to make the scanning time shorter. Eventually, a different translation stage that can scan at higher
frequencies will have to be used. Increasing the data acquisition speed will also reduce the error
introduced into the measurements by blinking and involuntary eye movements.
Then, it will be important to be able to further increase the laser power incident on the eye. This
can be achieved by using a pulsed rather than a CW laser since the pulse durations are so short that
the exposure time will decrease drastically. Again, this improvement will lead to a better signal to
noise ratio which will in turn lead to a better measurement resolution of the instrument in terms
of detected concentrations. Furthermore, if a pulsed laser source is used, it can become part of
a lock-in amplification circuit which can replace the currently used active low-pass filter, further
increasing the signal to noise ratio and probably reducing the size of the control electronics.
Another important improvement to make is the generation of a graphical user interface for ease
of use of the software. Currently, all components of the software have to be run individually from
the Python Shell so that it would be very hard for an untrained person to use them. Therefore a
graphical user interface is needed to increase the usability of the system.
Lastly, reevaluation of the laser safety with the help of an expert would be required to ensure that
the maximum possible laser power is used while staying within safe limits.
Less important for the immediate improvement of the instrument but also desirable for the future
will be the decrease of the size of the instrument to make it less heavy and easier to transport. It
can even be developed into a hand-held instrument for e.g. a home monitoring system. Another
addition might be to use a different detection method like for example fluorescence life-time mea-
surements which would allow for better distinction between the compound of interest and other
fluorescent signals that might be detected, as well as adding the possibility to detect different
ophthalmic compounds simultaneously. This might however be hard to combine with the current
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spatial scanning technique and require more computing power, thus slowing down the acquisition
speed.
With all the improvements suggested above it is expected that the instrument will perform better
than currently available commercial instruments. It will thus not only fulfill the requirements set
by Allergan but also has the potential to become the new gold standard of ocular fluorophotome-
ters in specific areas of research.
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List of Acronyms
ADC: analogue to digital converter
A device that digitises an analogue input quantity. 53, 54, 62, 64, 96, 113, 119
AEL: accessible emission limit
The maximum accessible emission permitted within a particular laser class. 68–70, 73, 85
CCT: central corneal thickness
The thickness of the cornea at its apex. 124, 126–128
FWHM: full-width half-maximum
The full width of the point-spread function at half intensity. 29, 30, 36, 55, 57, 58, 82
IOP: intra-ocular pressure
The pressure within the anterior chamber of the eye. Normal IOP ranges from 8 to 21 mm Hg.
14–16, 152
MPE: maximum permissible exposure
The level of laser radiation to which persons may be exposed without causing damage to
their eyes or skin. 68–71, 77, 80
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NA: numerical aperture
A physical property of a lens related to the semi-angle of the aperture and the refractive
index of the medium the light beam is travelling through. 25
PMT: photo-multiplier tube
A very sensitive detector in which the photo current is amplified over several internal stages.
53, 54, 57, 58, 64, 65, 97, 99, 106, 119, 134
PSF: point-spread function
A function describing the lateral or axial intensity distribution created by the focus of a lens.
25–30, 35, 36, 57, 58, 82
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Specifications for the F410
-a fluorescence based system for the quantitative measurement of ophthalmic drugs in the eye-
Aim
The aim of this project is to determine the best technologies and solutions for a non-invasive optical instrument
capable of quantitative concentration measurements of naturally fluorescing ophthalmic drugs in the eye. It will
record one-dimensional depth concentration profiles along the optical axis of the eye through the aqueous cham-
ber using confocal fluorescence microscopy.
This specification defines the targets for a device that is to be tested first on glass objects (in vitro), on perfused
sheep’s or pig’s eyes (in vitro) and last on human eyes (in vivo).
Introduction
This specification defines target performance limits of the F410.
Detection and excitation wavelengths
This system is being designed to measure the fluorescence of Brimonidine which fluoresces in the region of 425
to 625nm when excited with 408nm. The excitation wavelength was chosen because the absorption curve of
Brimonidine shows that a wavelength as short as possible while still being eye safe is needed to excite enough
fluorescence for the detector to pick up in the lower concentration range. These factors define the detection and
excitation wavelengths of the system as given below.
– Wavelength of detection: ≤470 nm to 700 nm
– Wavelength of excitation: 408 nm, Laser Class 1 as defined in IEC 60825-1
– Other wavelengths: White light source to illuminate the front of the eye for position detection with the web
cam
Accuracy
Accuracy is defined as the proximity of the measurement result to the true value.
– Drug detection in vivo: As agreed with Allergan an error of 20% should be allowed.
– Axial position in the eye in vitro: 1 µm (acceptable: 10 µm)
– Axial position in the eye in vivo: 5 µm (acceptable: 20 µm)
– The measurement accuracy will be constant within 20% over the course of a day if the instrument is not
being moved. The calibration will have to be checked on a day to day basis.
Repeatability
The capability of the measurement system to create repeatable results.
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– Drug detection in vitro: Better than 5% standard deviation (acceptable: 10% standard deviation)
– Drug detection in vivo: Better than 20% standard deviation as agreed with Allergan
– Axial position in the eye in vitro: 1 µm (acceptable: 10 µm)
– Axial position in the eye in vivo: 5 µm (acceptable: 20 µm)
– The measurement repeatability will be constant within 20% over the course of a day if the instrument is not
being moved. The calibration will have to be checked on a day to day basis.
Resolution
Resolution is defined as the smallest change in the underlying physical quantity that produces a response in the
measurement.
– Axial resolution: Better than 50 µm (acceptable: Better than 100 µm)
– Lateral resolution: Better than 100 µm (acceptable: Better than 200 µm)
– Chemical resolution: Better than 100 nM Brimonidine (acceptable: Better than 500 nM Brimonidine)
Speed
– Data acquiring: All data has to be acquired in under 100 seconds including alignment time.
– Data analysis: Near real time analysis and display of collected data.
Detection limit
The detection limit is dependent on the power of the laser which has to be eye safe. Currently, the laser is operating
at 660 µW. Therefore the target detection limit of the instrument is 100 nM Brimonidine currently, with better than
500 nM of Brimonidine being acceptable. The gain of the photo-multiplier will be switchable to detect different
concentration ranges.
Safety
– Laser safety
– The output of the instrument is that of a Class 1 laser device as defined by IEC 60825-1 under all condi-
tions of operation, maintenance, service and failure.
– The Class 4 laser used as a light source will be mounted within a protective box within the instrument.
– The instrument cover will be connected to an interlock that switches off the laser if the cover is opened.
– Electrical safety
– The device will be tested for electrical safety according to IEC 60601-1.
– Mechanical safety
– No moving parts will be accessible from the outside of the instrument without removing the cover.
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Mechanichal properties
– Dimensions and Weight: To be agreed, but suitable for easy handling and mounting on an ophthalmic stage.
Software
The software will perform the following functions:
– Turns on the light source and initialises the system for operation
– Checks that the light source power is within acceptable limits
– Runs the scanning function
– Collects acceptable data (discards poor data)
– Saves data in an appropriate format for post-processing in an electronic file
– Analyses data
– Saves the results of the analysis in a format appropriate for post-processing
– Stops the scanning function when the required quantity of data has been collected.
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parent2 v1.py -- Printed on 08/10/2012, 11:58:30 -- Page 1
from __future__ import division
from operator import itemgetter
import scipy.optimize
import fileopen, shift, average, norm, fit, conc_det, loadBack
import numpy, pylab, scipy, os
def lin_func(x, m, b):
return m*x + b
def exp_func(x, a, b):
return a*scipy.exp(b*x)
STEM = r'c:\Documents and Settings\kkb\Desktop\New Folder (2)\PhD\F410\PMT measurements\
         2012-08-24/'
files = [fname for fname in os.listdir(STEM) if fname[-5:] == 'M.txt']
C = []
backname = r'c:\Documents and Settings\kkb\Desktop\New Folder (2)\PhD\F410\
             PMT measurements\2012-08-24/water.txt'
p_back, m_back, r_back, f_back = loadBack.load_background(backname) #load background file
f_back = f_back
for fname in files:
print fname
pos, tim, mon, vref, ref, flu = fileopen.fopen(STEM+fname) #read columns from file
#shift arrays such that they are all aligned at the maximum reflection:
shift_pos, shift_mon, shift_vref, shift_ref, shift_flu = shift.shift(r_back, pos, mon,
vref, ref, flu)
shift_pos_2 = shift_pos[::2] #cut arrays such that only every 
#second entry is used-
shift_ref_2 = shift_ref[::2] #only one direction is used due to too 
#big position 
shift_flu_2 = shift_flu[::2] #discrepancies between the two scanning 
#directions
pos_av, pos_sd, pos_se = average.average(shift_pos_2) #average position over all scans
mon_av, mon_sd, mon_se = average.average((shift_mon)
ref_av, ref_sd, ref_se = average.average(shift_ref_2) #average reflection over all scans
flu_av, flu_sd, flu_se = average.average(shift_flu_2) #average fluorescence over all scans
vref_conc = shift_vref[0] #create new array for concatenation
for i in range(len(shift_vref)-1):
#concatenate all reference voltage values to find the correct (most common) one:    
vref_conc = numpy.concatenate((vref_conc, shift_vref[i+1]))
normed_flu_av = norm.norm(vref_conc, flu_av) #norm the fluorescence signal to gain 1
normed_flu_se = norm.norm(vref_conc, flu_se) #norm the fluorescence error to gain 1
normed_flu_cor = normed_flu_av #correct the data for fluctuations in laser 
#intensity
normed_se_av = normed_flu_se
normed_flu_cor = normed_flu_cor - f_back #subtract the background from the data
normed_flu_cor = flu_av
normed_se_av = flu_se
max_idx = scipy.where(ref_av == max(ref_av)) #find the index of the maximum value
max_idx = max_idx[0] #extract it from the variable
max_idx = max_idx[0]
thickness = int(1000/20) #thickness of the front wall 
max_idx = max_idx + thickness #set index to after the front wall
newpos_av = pos_av[max_idx:] #cut datasets to only display data from 
within 
#the cuvette
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newpos_se = pos_se[max_idx:]
newflu_av = normed_flu_cor[max_idx:]
newflu_se = normed_se_av[max_idx:]
ref_pos = newpos_av[0] #save reference position to re-set 
#position values
newpos_av = newpos_av-ref_pos #subtract the reference position from all 
#values to make the position start at 0
cut = -7
lny = scipy.log(newflu_av) #linearise the data for a linear fit
lnyerr = newflu_se/newflu_av #log the error too for the fitting function 
#weighted fit
p0 = [max(lny), -0.1]
##    p0 = [max(newflu_av),-0.5]
##    best_p, covar = scipy.optimize.curve_fit(exp_func, newpos_av[:cut], 
##                                             newflu_av[:cut], p0, sigma=newflu_se[:cut])
best_p, covar = scipy.optimize.curve_fit(lin_func, newpos_av[:cut],
lny[:cut], p0, sigma = lnyerr[:cut])
amp = scipy.exp(best_p[1])
print amp
exp = best_p[0]
amp_err = numpy.sqrt(covar[1][1])
exp_err = numpy.sqrt(covar[0][0])
flu_fit = lin_func(newpos_av[:cut], exp, scipy.log(amp))
SSerr, SStot = fit.SSq(lny[:cut], flu_fit) #find sum of squared errors and total sum 
of squares
##    flu_fit = lin_func(newpos_av[:cut], grad, offs)
##    SSerr, SStot = fit.SSq(newflu_av[:cut],flu_fit)
Rsq = 1-SSerr/SStot #calculate R^2 as indicator for goodness 
of fit 
print Rsq
maxFluIdx = scipy.where(normed_flu_av == max(normed_flu_av))
maxFlu = normed_flu_av[maxFluIdx]
maxFluErr = normed_flu_se[maxFluIdx]
conc = float(fname[1:-6])
conc = conc*1e-6
#write best parameters for each fit to a file:
newFile = open(STEM + '\\_params_21-09-2012.txt', 'a')
newFile.write('%.3e\t' %conc)
newFile.write('%.6e\t' %amp)
newFile.write('%.6e\t' %amp_err)
newFile.write('%.6e\t' %exp)
newFile.write('%.6e\t' %exp_err)
newFile.write('%.6f\n' %Rsq)
newFile.close()
mon = numpy.average(mon_av)
errMon = numpy.std(mon_av)
maxFlu = newflu_av[0]
errFlu = newflu_se[0]
C.append((conc, maxFlu, errFlu, mon, errMon))
print conc, maxFlu, errFlu
C_sorted = sorted(C, key = itemgetter(0))
X = []
Y = []
Yerr = []
for v in C_sorted:
C:\Documents and Settings\kkb\DATA\programmes\fitting\program collection\parent2 v1.py -- File date: 08/10/2012 -- File time: 11:53:30
parent2 v1.py -- Printed on 08/10/2012, 11:58:30 -- Page 3
X.append(v[0])
Y.append(v[1])
Yerr.append(v[2])
X = numpy.array(X)
Y = numpy.array(Y)
Yerr = numpy.array(Yerr)
best_init_params, init_fit, merr, berr = fit.lin_fit(X, Y, Yerr)
SSerr_init, SStot_init = fit.SSq(Y, init_fit)
Rsq_init = 1-SSerr_init/SStot_init
print Rsq_init
grad_init = best_init_params[0]
offs_init = best_init_params[1]
#write best parameters for each fit to a file
newFile = open(STEM + '\\_params_init_fit_21-09-2012.txt', 'w')
newFile.write('%.6e\t' %grad_init)
newFile.write('%.6e\t' %merr)
newFile.write('%.6e\t' %offs_init)
newFile.write('%.6e\t' %berr)
newFile.write('%.6f\n' %Rsq_init)
newFile.close()
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from __future__ import division
from operator import itemgetter
import numpy, scipy, pylab, os, fit
import scipy.optimize
def load_params():
fname = r'c:\Documents and Settings\kkb\Desktop\New Folder (2)\PhD\F410\
              PMT measurements\2012-08-23\Brimo/_params.txt'
fp = open(fname, 'r')
data = fp.readlines()
fp.close()
params = []
for line in data:
line =[float(n) for n in line.split(None)]
params.append((line[0], line[1], line[2], line[3], line[4]))
p_sorted = sorted(params, key = itemgetter(0))
return p_sorted
def go():
params = load_params()
C = []
A = []
A_err = []
B = []
B_err = []
for val in params:
c = val[0]
C.append(c)
A.append(val[3])
A_err.append(val[4])
B.append(val[1])
B_err.append(val[2])
C = numpy.array(C)
A = numpy.array(A)
A_err = numpy.array(A_err)
B = numpy.array(B)
B_err = numpy.array(B_err)
init_m_A = 1e7
init_m_B = -3
x = -len(C)
##    best_params_B, fit_B, m_err_B, b_err_B = fit.lin_fit(C, B, B_err)
best_params_B, fit_B = fit.lin_fit_0(C[x:], B[x:], B_err[x:], init_m_B) #fit: m1x+b1
##    best_params_A, fit_A = fit.lin_fit_0(C, A, A_err, init_m_A) #fit: m2x+b2
best_params_A, fit_A, m_err_A, b_err_A = fit.lin_fit(C[x:], A[x:], A_err[x:])
SSerr_B, SStotal_B = fit.SSq(B[x:], fit_B)
SSerr_A, StotalE_A = fit.SSq(A, fit_A)
Rsq_B = 1-SSerr_B/SStotal_B
Rsq_A = 1-SSerr_A/StotalE_A
print Rsq_A
print Rsq_B
m_A = best_params_A[0]
m_B = best_params_B
newF = open('_fit_to_params_21-09-2012.txt', 'w')
newF.write('%.3e\t' %m_A)
newF.write('%.3e\n' %Rsq_A)
newF.write('%.3e\t' %m_B)
newF.write('%.3e\n' %Rsq_B)
newF.close()
C = C*1e6
pylab.figure()
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pylab.subplot(121)
pylab.errorbar(C,A, A_err, fmt = '.b')
pylab.plot(C, fit_A, '--r')
pylab.xlabel(u'Concentration [\xb5M/l]')
pylab.ylabel('Parameter A [a.u.]')
pylab.subplot(122)
pylab.errorbar(C,B, B_err, fmt='.r')
pylab.plot(C[x:], fit_B, '--b')
locs, labels = pylab.yticks()
pylab.yticks(locs, map(lambda x: "%.1e" %x, locs))
pylab.xlabel(u'Concentration [\xb5M/l]')
pylab.ylabel('Parameter B [a.u.]')
pylab.show()
if __name__ == "__main__":
go()
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from __future__ import division
import UniversalLibrary as UL
import ctypes as ct
import numpy
import time
import serial
import pylab
import csv, winsound
### ---------------------------------Stage set up---------------------------###
### User dependent values: ###
START_POS = 0 # mm
STOP_POS = 10 # mm
SPEED = 40 # mm/s
ACC = 1000 # mm/s^2
### Internal constants stage: ###
COUNTS = 2000 # encoder counts per mm
K = 26214.4 # stage constant: k = 1*2000/5000*65536
### ----------------------------------A/D set up----------------------------###
# load DLL to memory:
cbw32 = ct.WinDLL('c:\\Program Files\\Measurement Computing\\DAQ\\cbw32.dll')
FuncType = 1
# set up for cbAInScan
BoardNum = 0
LowChan = 0
HighChan = 1
Count = 31*68 # collect 31*68 samples (integer multiple of packet size(31))
Rate = 3000 # will be ignored because set by trigger frequency
Range = UL.BIP10VOLTS # +- 10V range 
# convert AD data, run in background mode, re-arm the trigger automatically:
Options = UL.CONVERTDATA + UL.BACKGROUND + UL.RETRIGMODE
Values = numpy.zeros((Count*2,), dtype = numpy.int16) # array for backward scan data
#scan = []
# additional set up for cbALoadQueue
NumChans = 4 # collect samples from 4 channels
ChanArray = numpy.zeros((NumChans,), dtype = numpy.int16) # array of channel numbers 
# to be sent to the ADC
GainArray = numpy.zeros((NumChans,), dtype = numpy.int16) # array of gains to be sent to the ADC
ChanArray[0] = 1 # define channels
ChanArray[1] = 3
ChanArray[2] = 5
ChanArray[3] = 7
for x in range(NumChans):
GainArray[x] = UL.BIP10VOLTS # define gain for channels
### --------------------------------Sound set up----------------------------###
sound = r'c:\Documents and Settings\kkb\Desktop\New Folder (2)\PhD\F410\
          PMT measurements\2012-07-03\Click01.wav'
### -------------------------------Stage commands---------------------------###
class MyStage(object):
def __init__(self, COM):
# open COM port baudrate 19200, timeout .1s
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self.port = serial.Serial(COM, 19200, timeout = .1)
self.flush() # Echo on
def home(self):
# send stage home (gh - go home)
self.port.write('GH\n\r')
##        self.flush()
def sStart(self):
# write starting position to register 56
cmd = 'AL%i,AR56\n\r' %(START_POS*COUNTS)
self.port.write(cmd)
self.flush()
def sStop(self):
# write stopping position to register 89
cmd = 'AL%i,AR89\n\r' %(STOP_POS*COUNTS)
self.port.write(cmd)
self.flush()
def sVelocity(self):
# write velocity (scanning speed) to register 23
cmd = 'AL%i,AR23\n\r' %(SPEED*K)
self.port.write(cmd)
self.flush()
def mForward(self):
# Call Macro 100 (forward scan)
self.port.write('MC100\n\r')
##        self.flush()
def mBackward(self):
# call macro 110 (backward scan)
self.port.write('MC110\n\r')
##        self.flush()
def mAbsolute(self):
# move stage to position x
cmd = 'MA%i,GO\n\r' %(STOP_POS*COUNTS)
self.port.write(cmd)
self.flush()
def error(self):
# display any errors
self.port.write('TE\n\r')
self.flush()
def tPos(self):
# read encoder count from controller
self.port.write('TP\n\r')
pos = self.port.read(100) # save returned string in pos
##        print 'pos:',pos
s = pos.split() # split returned string
p = int(s[2]) # use 1st entry of s, turn into integer
return p
def flush(self):
# echo on (print command on screen)
print self.port.read(100)
def close(self):
# close COM port
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self.port.close()
def __del__(self):
# automatically close port when program terminates
print 'Auto-closing'
self.close()
### ------------------------------------------------------------------------###
def read_status(): # read I/O status from ADC
Status = ct.c_short(0) # busy or idle
CurIndex = ct.c_long(0) # index of last data point in array
CurCount = ct.c_long(0) # sample count of last data point in array
cbw32.cbGetIOStatus(ct.c_int(BoardNum), ct.byref(Status),
ct.byref(CurCount), ct.byref(CurIndex), ct.c_int(FuncType))
return Status.value, CurCount.value
def go():
time.clock()
# acquire 4 samples per trigger:
UL.cbSetConfig(UL.BOARDINFO, BoardNum, 0, UL.BIADTRIGCOUNT, 4)
# load channels and gains into queue:
UL.cbALoadQueue(BoardNum, ChanArray, GainArray, NumChans)
stage = MyStage('COM6') # open COM port
stage.sVelocity() # set stage velocity
stage.sStart() # set starting position
stage.sStop() # set stopping position
stage.home()
for x in range(20): # set number of scans - remember: range(2) 
#is one forward and one backward scan!
print x+1
scan = []
p = stage.tPos() # ask actual stage position to calculate 
#trigger points (in encoder counts)
p = p/2 # divide encoder counts by 2 to get micrometers
# start data acquisition (wait for trigger):
UL.cbAInScan(BoardNum, LowChan, HighChan, Count, Rate, Range, Values, Options)
time.sleep(0.1) # wait to make sure trigger is armed
if x%2 == 0:
t = time.time() # measurement date and time
stage.mForward() # if even loop count scan forward
else:
t = time.time() # record measurement date and time
stage.mBackward() # if odd loop count scan backward
while 1:
Status, CurCount = read_status() # read A/D status
time.sleep(0.1) # don't have to read status all the time 
# (eats up cpu time)
# if current data point index > 2000 stop the while loop:
if CurCount == 2000 or CurCount > 2000: break
# stop background data acquisition:
cbw32.cbStopIOBackground(ct.c_int(BoardNum), ct.c_int(FuncType))
Val = Values[:Count] # clip array to size of samples
for v in Val:
EngUnits = -10 + v*(20/4096) # convert a/d values to voltage
scan.append(EngUnits) # write voltage to list
Scan = numpy.array(scan) # turn list into array
Scan = numpy.reshape(Scan, (Scan.shape[0]/4,4)) # reshape list to have 4 columns
Scan = Scan[:499] # crop list to only have 499 entries (delete overshooting)
##        ref = Scan[:,2]
##        if max(ref) > 0.16:
##            winsound.PlaySound(sound, winsound.SND_FILENAME)
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l = len(Scan)
Sec = numpy.zeros(l)
Sec.fill(t)
Pos = numpy.zeros(l) # create empty array for position values
if x%2 == 0: # calculate position values
for c, v in enumerate(Pos):
p = p + 20 # position moves forward
Pos[c] = p
else:
for c, v in enumerate(Pos):
p = p - 20 # position moves backward
Pos[c] = p
Pos = numpy.reshape(Pos, (Pos.shape[0], 1)) # reshape position values to have 1 column
Sec = numpy.reshape(Sec, (Sec.shape[0],1))
Pos = numpy.append(Pos, Sec, 1) # append position values and data points 
# into 5 column array
Scan = numpy.append(Pos, Scan, 1)
if x%2 != 0: Scan = numpy.flipud(Scan) # flip data from backward scan
try: # if 'Data' exists do this:
Data = numpy.append(Data, Scan, 1) # append new scan to existing data
except NameError: # if 'Data' doesn't exist:
Data = Scan # Create new array named Data, write first 
# scan into it
print 'Data acquisition finished'
time.sleep(1)
stage.home() # send stage home
print time.clock()
return Data
try:
Data = go()
finally:
cbw32.cbStopIOBackground(ct.c_int(BoardNum), ct.c_int(FuncType))
fid = open('Fluo resolution test.txt', 'w')
csvWriterObject = csv.writer(fid, delimiter='\t')
csvWriterObject.writerows(Data)
fid.close()
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from __future__ import division
from operator import itemgetter
import scipy.optimize
import fileopen, shift, average, norm, fit, conc_det, loadBack
import numpy, pylab, scipy, os, csv, time
STEM = r'c:\Documents and Settings\kkb\Desktop\New Folder (2)\
 PhD\F410\PMT measurements\2012-07-05\non eye safe\Brimo calibration/'
files = [fname for fname in os.listdir(STEM) if fname[-5:] == 'M.txt']
backname = r'c:\Documents and Settings\kkb\Desktop\New Folder (2)\PhD\F410\
             PMT measurements\2012-07-05\non eye safe\Brimo calibration/Brimo background.txt'
p_back, m_back, r_back, f_back = loadBack.load_background(backname) #load background file
f_back = f_back
for fname in files:
print fname
#read columns from file:
position, tim, monitor, reference, reflection, fluorescence = fileopen.fopen(STEM+fname)
pos = numpy.array(position) #turn position, monitoring PD, reference voltage,
mon = numpy.array(monitor) #reflection and fluorescence values into arrays
vref = numpy.array(reference)
ref = numpy.array(reflection)
flu = numpy.array(fluorescence, dtype = numpy.float64)
#shift arrays to be aligned at the maximum reflection:
shift_pos, shift_mon, shift_vref, shift_ref, shift_flu = shift.shift(r_back, pos, mon,
vref, ref, flu)
vref_conc = shift_vref[0] #create new array for concatenation
for i in range(len(shift_vref)-1):
vref_conc = numpy.concatenate((vref_conc, shift_vref[i+1]))
C = []
t0 = tim[0]
t01 = t0[0]
for counter, entry in enumerate(shift_pos):
print 'Scan %i' %counter
t1 = tim[counter]
t11 = t1[0]
tm = time.strftime("%H:%M:%S",time.localtime(t11))
t = t1 - t0
t2 = t11 -t01
t2 = str(t2)
mon_av, mon_sd, mon_se = average.average(mon)
newpos = entry
newvref = shift_vref[counter]
newref = shift_ref[counter]
newflu = shift_flu[counter]
normed_flu = norm.norm(vref_conc, newflu) #norm the fluorescence signal to gain 1
normed_flu_cor = normed_flu
normed_flu_cor = normed_flu_cor - f_back
max_idx = scipy.where(newref == max(newref)) #find the index of the maximum value
max_idx = max_idx[0] #extract it from the variable
max_idx = max_idx[0]
thickness = int(1000/20) #thickness of the front wall 
max_idx = max_idx+thickness #set index to after the front wall
new_pos = newpos[max_idx:] #cut datasets to only display data from
#within the cuvette
new_flu = normed_flu_cor[max_idx:]
ref_pos = new_pos[0] #save reference position to re-set 
#position values
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new_pos = new_pos-ref_pos #subtract the reference position from 
#all values to make the position start 
at 0
conc = conc_det.calibrate_Brimo(new_pos, new_flu)
C.append(conc)
if counter < 10:
n = '00' + str(counter)
elif counter < 100:
n = '0' + str(counter)
else:
n = str(counter)
n_conc = numpy.array(conc[:-5])
n_pos = numpy.array(new_pos[:-11])
n_time = numpy.array(t[max_idx:-11])
Pos = numpy.reshape(n_pos, (n_pos.shape[0],1))
Tim = numpy.reshape(n_time, (n_time.shape[0],1))
Con = numpy.reshape(n_conc, (n_conc.shape[0],1))
Pos = numpy.append(Pos, Tim, 1)
Pos = numpy.append(Pos, Con, 1)
try: #if 'Data' exists do this:
Data = numpy.append(Data, Pos, 1) #append new scan to existing data
except NameError: #if 'Data' doesn't exist:
Data = Pos
n_conc = n_conc*1e6
##    lab = float(fname[11:-6])*1e-6
##    lab = '%.1e M/l' %lab
pylab.clf()
pylab.plot(n_pos[:-5], n_conc[:-5])#, label = lab)
pylab.ylim(-0.2, 2)
pylab.xlim(0,6000)
##    locs, labels = pylab.yticks()
##    pylab.yticks(locs, map(lambda x: "%.3f" % x, locs*1e6))
pylab.text(0.0, 1.01, t2, fontsize=12, transform = pylab.gca().transAxes)
pylab.grid()
pylab.ylabel(u'Intensity [scaled units]')
pylab.xlabel(u'Scanning depth [\xb5m]')
pylab.savefig(STEM + 'Fig_%s' %fname + '_scan_%s' %n +'_recovered_22-09-2012.png',
dpi = 100)
newF = open(STEM + '\\' + fname +'_recovered.txt', 'w') #write each fit to a file (pos, fit)
csvWriterObject = csv.writer(newF, delimiter = '\t')
csvWriterObject.writerows(Data)
newF.close()
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from __future__ import division
import numpy, os, scipy, pylab, norm
def load_fit_params():
'''Load the parameters for the fit to the exponential fitting parameters'''
LUTname = r'c:\Documents and Settings\kkb\Desktop\New Folder (2)\PhD\F410\
                PMT measurements\2012-08-23\Brimo/_fit_to_params.txt'
fp = open(LUTname, 'r')
data = fp.readlines()
fp.close()
##    params = []
m = []
for line in data:
line = [float(n) for n in line.split(None)]
m.append(line[0]) #gradient is second column in file
##        b = line[2]                              #y axis intersection is fourth column in file
##        params.append((m,b))
##        params.append((m))
return m
def load_Conc_Cal():
'''Load the parameters for the determination of
    the concentration from the corrected intensity'''
CalName = r'c:\Documents and Settings\kkb\Desktop\New Folder (2)\PhD\
                F410\PMT measurements\2012-08-23\Brimo/_params_init_fit.txt'
fp = open(CalName, 'r')
data = fp.readlines()
fp.close()
for line in data:
line = [float(n) for n in line.split(None)]
m = line[0]
b = line[2]
return m, b
def calibrate_Brimo(x,y):
params_att = load_fit_params()
params_det = load_Conc_Cal()
gradI = params_det[0]
offsI = params_det[1]
gradB = params_att[1]
print gradI, offsI, gradB
dpos = 20
C = []
X = []
for i in range(len(y)-1):
pos = x[i]
sig = y[i]
if sig <= offsI: sig = offsI
if i == 0:
Int0 = sig
else:
Int0 = newInt
c = (Int0-offsI)/gradI
param_B = gradB * c
I_1_th = sig + param_B * dpos
sig_1 = y[i+1]
if sig_1 <= offsI: sig_1 = offsI
prcnt_change = (I_1_th-sig_1)/I_1_th
if prcnt_change > 0.0001 or prcnt_change < -0.0001:
newInt = Int0 - Int0*prcnt_change
else:
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newInt = Int0
C.append(c)
return C
def calibrate(x,y):
params_att = load_fit_params()
params_det = load_Conc_Cal()
gradB = params_att[1]
gradI = params_det
dpos = 20
C = []
X = []
for i in range(len(y)-1):
pos = x[i]
sig = y[i]
if sig <= 0.0: sig = 0.1
if i == 0: #for the first entry in the file (i.e. zero attenuation):
Int_0 = sig #final intensity is equal to measured intensity
else: #for any other case:
Int_0 = newInt #final intensity is equal to intensity determined in 
#previous step
c = Int_0/gradI #calculate concentration from intensity (i=mc+b)
##        if c < 1e-9: c = 0
param_B = gradB * c #calculate parameter B for this concentration
#calculate theoretical intensity at next position:
I_1_th = sig * scipy.exp(param_B * dpos)
if I_1_th == 0: I_1_th = 0.1
sig_1 = y[i+1]
if sig_1 <= 0: sig_1 = 0.1
prcnt_change = (I_1_th-sig_1)/I_1_th #calculate the change in intensity in percent 
#of the theoretical intensity at that position
#if the change is bigger than the error margin:
if prcnt_change > 0.0001 or prcnt_change < -0.0001:
newInt = Int_0 - Int_0 * prcnt_change #the detemined intensity is the final 
#intensity from the step before minus
#the percent change
else:
newInt = Int_0
C.append(c) #append determined concentration to list
return C
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from __future__ import division # make sure all divisions work properly
import _csv, numpy, os, time
import matplotlib.pyplot as plt
import sys
import fileopen
def FWHM(pos, ref):
maxAmp = 0.0
maxPos = 0.0
# for the counter and all values in ref do the following:
for c, v in enumerate(ref):
if v > maxAmp: # if value is greater than the maximum amplitude:
maxAmp = v # set value as new maximum amplitude
maxPos = pos[c] # save stage position of new maximum amplitude
maxIndex = c # save index in arrayof new maximum amplitude
halfM = maxAmp/2 # find half maximum amplitude
dOld = 100
# initiate counter and for all values in ref up to maximum amplitude:
for c, v in enumerate(ref[:maxIndex]):
dNew = abs(v - halfM) # find difference between value and half amplitude
if dNew < dOld: # if new difference is smaller than old difference
p1 = pos[c] # save stage position of closest value
h1 = v # save value of closest value
dOld = dNew # write new difference into old difference
dOld = 100
# do the same for values in ref after maximum amplitude:
for c, v in enumerate(ref[maxIndex:]):
dNew = abs(v - halfM)
if dNew < dOld:
p2 = pos[maxIndex+c]
h2 = v
dOld = dNew
# the fwhm is the difference of stage position 2 minus stage position 1:
#res = p2-p1                            
return maxAmp, maxPos#, res   
STEM = r'c:\Documents and Settings\kkb\Desktop\New Folder (2)\PhD\F410\
         PMT measurements\2012-09-18\Fluo es/'
files = [fname for fname in os.listdir(STEM) if fname[-4:] == '.txt']
for fname in files:
print 'processing '+fname
pos, tim, mon, vref, ref, fluo = fileopen.fopen(STEM + fname)
n = len(pos)
t0 = tim[0]
for k in range(150,200,1):
p = pos[k]
t = tim[k]
m = mon[k]
r = ref[k]
f = fluo[k]
maxamp, maxpos = FWHM(p, r)
print 'scan %i:'%k
tm = time.localtime(t[0])
tm = time.strftime('%H:%M:%S', tm)
fig = plt.figure()
ax = fig.add_subplot(111)
lns1 = ax.plot(p, r, '-b', label = 'Reflection')
ax2 = ax.twinx()
lns2 = ax2.plot(p, f, '-g', label = 'Fluorescence')
lns3 = ax2.plot(p, m, '-r', label = 'Laser Monitor')
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lns = lns1 + lns2 + lns3
labs = [l.get_label() for l in lns]
ax.legend(lns, labs, loc = 0)
ax.grid()
ax.set_xlabel(u'Depth (\xb5m)')
ax.set_ylabel('Intensity (V)', color='b')
ax2.set_ylabel('Intensity (V)', color ='g')
ax.set_ylim(0,10)
ax2.set_ylim(0,10)
plt.text(0.0, 1.01, tm, fontsize=12, transform = plt.gca().transAxes)
if k < 10:
n = '00' + str(k)
elif k < 100:
n = '0' + str(k)
else:
n = str(k)
plt.savefig(STEM + 'Fig_%s' %fname + ' scan_%s_100dpi.png' %n, dpi = 100)
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DURHAM UNIVERSITY 
 
ETHICS ADVISORY SUB-COMMITTEE in the DEPARTMENT of PHYSICS 
 
Application form for ethical review and approval of work which involves human 
participants and/or gives rise to ethical issues 
 
Note to applicants: information concerning the University’s ethical procedures, the 
Human Tissues Act, data protection, freedom of information and links to research 
council ethics policies can be found at 
http://www.dur.ac.uk/research.office/local/research_governance/research_ethics/ 
 
 
Status 
(tick one) 
Staff  Postgraduate 
project  
Undergraduate project  
 
Full scientific title of project:  
Tracking ophthalmic drugs in the eye using confocal fluorescence microscopy 
 
Short title of project (to appear on supporting documentation):  
Tracking drugs in the eye 
 
Name(s) of researcher(s): Kim K. Buttenschön  
Email address(es): k.k.buttenschoen@durham.ac.uk   
 
Name of supervisor (if applicable): Prof. John M. Girkin 
Email address:  j.m.girkin@durham.ac.uk 
 
Proposed start date: 01/10/2011 
Proposed end date: 31/10/2011 
 
Check boxes for supervisor (if applicable): 
 
The student has read the ethical guidance of the relevant research council  
  
The procedures for recruitment and obtaining informed consent are appropriate   
  
Comments from supervisor:  
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For the following questions, please delete the options (Yes/No/Not applicable) as appropriate. 
 
1. Will you describe the main procedures to participants in advance, so that they are 
informed about what to expect? Yes / No / Not applicable 
 
2. Will you tell participants that their involvement is voluntary, that they may withdraw 
from the research at any time (without their having to give any reason and without any 
repercussions) and that in such circumstances their data will be removed from the 
study? Yes / No / Not applicable 
 
3. Will you obtain written informed consent for participation and for all intended uses of 
the data arising from this study?  Yes / No / Not applicable 
 
4. If the research is observational, will you ask participants for their consent to being 
observed? Yes / No / Not applicable 
 
5. If recordings (video, audio etc.) are being made, will you explain how they will be kept 
and what will happen to them? Yes / No / Not applicable 
 
6. With questionnaires or interviews, will you remind participants of their option of 
omitting questions they do not want to answer? Yes / No / Not applicable 
 
7. Will you tell participants that their data will be treated with full confidentiality and that, if 
published, will not be identifiable as theirs? Yes / No / Not applicable 
 
8. Will you debrief participants at the end of their participation (i.e. give them a brief 
explanation of the study)? Yes / No / Not applicable 
 
9. If your project involves the use of archive data, has the appropriate approval 
previously been given?  (Please attach details of the approval.) 
 Yes / No / Not applicable 
 
10. Have you conducted a Risk Assessment ?  
  Yes / No 
 
11. Do you declare that your participants will not be given financial or other inducements 
(other than reasonable expenses and compensation for time) to participate? 
 Yes / No / Not applicable 
 
12. If the proposal involves an application for external funding, will it adhere to the ethical 
guidelines provided by the relevant funding body? Yes / No / Not applicable 
 
13. Will your project involve deliberately misleading participants in any way? Yes / No 
 
14. Is there any realistic risk of any participants experiencing either physical or 
psychological distress or discomfort?  If Yes, give details in the space at the end of the 
form and state what you will tell participants to do if they should experience any 
problems (e.g. who they can contact for help). Yes / No 
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15. Have you consulted the University’s Insurance Officer?  
(clare.robinson@durham.ac.uk ) Yes / No 
 
16. Does your project involve work with animals? Yes / No 
 
17. Are drugs, placebos or other substances (e.g. food substances, vitamins) to be 
administered to the study participants or will the study involve invasive, intrusive or 
potentially harmful procedures of any kind? Yes / No 
 
18. Will blood or tissue samples (including saliva and waste products) be obtained from 
participants (refer to the document on the Human Tissue Act, posted on Duo)? 
 Yes / No 
 
19. Will the study involve recruitment of patients or staff through the NHS? Yes / No 
 
20. Do participants fall into any of the following special groups? Note that you may also 
need to obtain satisfactory CRB clearance (or equivalent for overseas students). 
 
Children under 16 years of age No 
Children aged 16 or 17 years No 
The elderly (aged 75 or over) No 
People with learning or communication difficulties No 
People in custody No 
People engaged in illegal activity (e.g. drug-taking) No 
 
There is an obligation on the lead researcher (or Supervisor, in the case of 
undergraduate or postgraduate projects) to bring to the attention of the 
Departmental Ethics Sub-Committee any issues with ethical implications not clearly 
covered by the above checklist. 
 
This form should be submitted to Clare Woodward by email 
(c.a.woodward@durham.ac.uk), in addition to a signed hard copy. Please also provide all 
the information listed below. 
 
a). A brief description of your project including (where appropriate): 
 
1. Title of project. 
2. Purpose of project and its academic rationale. 
3. Brief description of methods and measurements. 
4. Participants: recruitment methods, number, age, gender, exclusion/inclusion criteria, 
incentives (financial or otherwise). 
5. Consent and participant information arrangements, debriefing.  
6. A clear but concise statement of the ethical considerations. 
 
b). If applicable, any invitation letters, information sheets and consent forms. 
 
c). A completed risk assessment form – see http://www.dur.ac.uk/physics/internal/safety/ 
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If any of the above information is missing, your application will be returned to you.  
 
DECLARATION: 
 
The information provided on this form and in the attached documentation is, to the best of 
my knowledge, complete and accurate 
 
 
Signed ________________________________ Date __________________ 
 
Print Name __________________________ (UG or PG Researcher(s), if applicable) 
 
 
Signed ________________________________ Date __________________ 
 
Print Name __________________________ (Lead Researcher or Supervisor) 
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SECTION TO BE COMPLETED FOLLOWING REVIEW BY THE DEPARTMENTAL 
ETHICS ADVISORY COMMITTEE: 
 
The Departmental Ethics Advisory Committee reviewed this application, and decided to: 
• Give advisory approval* 
• Give provisional advisory approval of the application subject to amendment* 
• Defer* 
• Reject* 
• Refer this application* 
[*please delete as appropriate] 
 
Date: ......................................................................................... 
 
The decision will be reported to the Faculty Ethics Committee on: …………….. 
 
Please note that this approval expires: 
1. 12 months after the date of approval, if the project has not started by that date; 
2. Where the project commences within 12 months of the date of approval and 
continues unchanged: three years after the date of approval; 
3. Where there is any change to the project, from the date of that change unless the 
sub-committee’s prior consent for that change is sought; 
4. Where there is any change to the legislation/regulations affecting the ethical 
approval for this project, from the date of that change. 
 
 
SUPPORTING INFORMATION: You are asked to provide all necessary information in 
the space below.  Please ensure that any information given here is clearly cross-
referenced to the relevant question in the form. 
 
1. Title of project:  
 Tracking drugs in the eye using confocal fluorescence microscopy 
 
2. Purpose of project and its academic rationale: 
 The purpose of this study is to measure the natural fluorescence of components in the 
anterior chamber of the eye of healthy volunteers using a novel, non-invasive 
instrument based on confocal fluorescence scanning microscopy. The aim of the main 
research project is to track Alphagan-P (Brimonidine, an ophthalmic drug for treating 
open angle glaucoma) in the eye using a non-invasive method to gain a better 
understanding of how the drug distributes and dilutes in the eye so that a) no further 
animals will have to be sacrificed during the development of the drug to measure the 
concentration in different parts of the eye and b) the measurement of concentrations in 
different parts of the eye will be easier and possible at much more discreet time 
intervals which could lead to a further development of the drug to better reach and 
have a greater effect on the relevant sections of the eye. 
The present study aims to test the non-invasive instrument in vivo on healthy eyes to 
get a measure of the background signal we will have to expect. No drugs will be 
administered in this experiment. Participants will be asked to fixate on a fixation target 
within the instrument and measurements of the fluorescence levels of the components 
in the anterior chambers of their eye will be conducted by scanning a focal point along 
the axis of their eye several times. Preliminary data obtained from fresh dissected 
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sheep’s eyes (cornea, aqueous humour and lens) suggests that the level of 
background fluorescence will be quite high. However to confirm that this is not a by-
product of early decay and to investigate how the fluorescence levels might be 
changing during the course of a day or a week an in vivo study is necessary.  
The results of this study will be used as part of Ms. Buttenschön’s PhD thesis. They 
will also be reported in one or more articles to be submitted to peer-reviewed scientific 
journals.  
 
3. Brief description of methods and measurements: 
 All participants will be healthy adults recruited from the University’s student and staff 
bodies. Each participant will be involved in the study for repeated measurements 
lasting approximately 15 minutes or less 3 times a day for 5 days. The participants will 
first be briefed as to the purpose of the study and asked to provide signed and 
informed consent and to fill in a questionnaire (see Appendix A).  
 The participants will then be asked to find a comfortable position in the provided head 
rest and to look at a fixation target in the instrument. Once the instrument has been 
aligned to their eye by the operator it will be calibrated to the participant’s eye in a first 
measurement phase (approximately lasting 10 minutes or less). The participant will 
also have the opportunity to practice the real scanning situation in this measurement 
phase. They will then be able to relax their eyes and head for a moment if necessary. 
In a second measurement phase lasting approximately 5 minutes or less, the 
fluorescence signal from components in the anterior chamber of the participant’s eye 
will be recorded and saved. The total scanning time will be approximately 45 minutes 
on the first day with the time getting shorter throughout the week once the operator 
and participant are more experienced at aligning their eyes with the instrument. 
 
4. Participants: recruitment methods, number, age, gender, exclusion/inclusion 
criteria, incentives (financial or otherwise): 
 A minimum of 10 and a maximum of 20 people, approximately half male and half 
female, will be recruited from the student and staff bodies of the University. All 
participants will be older than 18 years of age with a spread of participants aged 20 to 
60. All participants will be white-Caucasian since any other population group is heavily 
under-represented within the bodies of the University we are recruiting from. The 
participants will be recruited by Ms. Buttenschön via an invitation letter send by email 
to the research group and via personal conversations. The only exclusion criteria are 
problems with sight or hearing. All participants will be recompensed for their time and 
effort with £5. 
 
5. Consent and participant information arrangements, debriefing. Please attach 
intended invitation letters, information sheets and consent forms: 
 Signed, informed consent will be obtained from all participants prior to the start of the 
experiment. A copy of the combined participant information sheet, questionnaire and 
consent form is attached as Appendix A. Participation in the study is completely 
voluntarily and the participants will be made aware that they are free to withdraw at 
any point during the experiment without giving reason or having to fear adverse 
consequences. If they withdraw they will be given the option to have their data 
destroyed. However if they do not use this option and part of their data is useable for 
this study, we will keep it with their permission. At the end of their experiment session 
the participants will be debriefed and will have the opportunity to ask questions. Once 
the study is complete, a summary of the results will be sent to those participants who 
have chosen to have it sent to them. 
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6. A clear but concise statement of the ethical considerations (including issues 
around deception) raised by the project and how you intend to deal with them. 
Please refer back, as necessary, to the answers you have given to the questions 
above: 
 
• Ms. Buttenschoen and Prof Girkin will adhere to the Physics Department’s health 
and safety regulations and guidelines and have received complete laser safety 
training. 
• The above mentioned personnel are trained and experienced in using the 
instrument. 
• A risk assessment regarding the electrical and laser safety of the instrument has 
been carried out and is attached as Appendix B. The risk has been found to be low. 
• The laser safety of the instrument has been evaluated using the British Standard 
BS EN 60825-1:2007 and the radiation leaving the instrument has been categorised 
as class 1 laser radiation and is safe for long exposure durations (see Appendix C). 
The instrument has been fitted with a laser power monitoring photo diode and a 
shutter so that the beam is cut off in case there is a power surge or a power loss. 
• To help participants to keep their head and eyes as still as possible while still being 
comfortable a head rest and a fixation target are provided. 
• Participants are able to take a break at any time during the experiment if they so 
desire. 
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Tracking ophthalmic drugs in the eye using confocal fluorescence 
microscopy 
 
Principal Investigator: Kim Buttenschön 
Supervisor: Prof. Girkin 
 
PARTICIPANT INFORMATION SHEET 
 
Background: 
The aim of this research project is to build a non-invasive instrument to monitor the 
distribution and movement of Alphagan (a drug for treating open angle Glaucoma) in the 
eye. We are hoping to gain a better understanding of how the drug distributes and dilutes 
in the eye using a non-invasive method so that a) no further animal eyes will have to be 
sacrificed to measure the concentration in different parts of the eye and b) the drug can be 
developed further to have a greater effect in the relevant sections of the eye. 
The present study aims to test the non-invasive instrument in vivo on healthy eyes to get a 
measure of the background signal we will have to expect. No drugs will be used in this 
experiment. 
Our research is a CASE studentship award funded by the EPSRC (Engineering and 
Physical Sciences Research Council) and Lein Applied Diagnostics Ltd. 
 
What is involved? 
We will ask you to put your head in a head rest and keep it as still as possible during the 
measurement. We will also ask you to fixate on a target within the instrument (a green 
LED). We will monitor the position of your eye through a web cam.  
We will then take 5 calibration measurements through the anterior part of your eye (cornea 
and aqueous humour). Both the thickness of your cornea and any fluorescent signal from 
within the anterior chamber of your eye will be recorded. This phase takes about 10 
minutes or less. Once the instrument has been calibrated to your eye, we will take 30 
measurements of your eye. There will be the opportunity to take a break between the 
calibration and the measurements. The measurements will take approximately 5 minutes. 
The total measurement time will therefore not be longer than about 15 minutes. 
The instrument has been tested for eye safety and fulfils all requirements of the laser 
safety standard for a class 1 laser. 
We will record your data by saving it on the computer. The stored data will be anonymous, 
so that no-one other than the research team can identify you with the results from your 
tests. Your data will remain confidential. 
 
What are the benefits? 
The benefits of this project lay mainly in the further development of the drug. The first 
direct benefit will be that no more animal eyes will have to be sacrificed in the future to 
learn the concentration of the drug in different parts of the eye. The second, less direct 
benefit is that we hope to increase the understanding of how the circulation of liquid works 
in the eye and from that how the drug can be altered such that it increases its effect on the 
relevant areas of the eye. 
 
Your participation in the project is entirely voluntary, and you are free to withdraw 
from the research at any time and without any adverse consequences. 
 
If you have any further questions, please ask a member of the research team. 
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Contacts 
Miss Kim Buttenschön (Physics)    k.k.buttenschon@durham.ac.uk 
        0191 33 43532 
Prof. John Girkin (Physics)     j.m.girkin@durham.ac.uk 
0191 33 43589 
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Participant Details 
 
 
 
 
 
 
 
 
Age group:  <24 / 24-34 / 34-44 / >44 
 
 
 Sex:       Male / Female 
 
 
 Will you be wearing contact lenses during the experiment? Yes / No                    
 
   
Do you have diabetes? Yes / No 
 
 
Do you take any regular medication (including the pill)? Yes / No 
 
 
Did you take any medication today? Yes / No 
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CONSENT FORM 
 
 
 
 
 
TITLE OF PROJECT: 
 
 
 
 
(The participant should complete the whole of this sheet himself/herself) 
 
 Please cross out 
     as necessary 
 
Have you read the Participant Information Sheet? YES / NO 
 
 
Have you had an opportunity to ask questions and to 
discuss the study? YES / NO 
 
 
Have you received satisfactory answers to all of your questions? YES / NO 
 
 
Have you received enough information about the study and the  
Intended uses of, and access arrangements to, any data which  
you supply ? YES / NO 
 
Were you given enough time to consider whether you 
want to participate? YES/NO 
 
Who have you spoken to?   Dr/Mr/Mrs/Ms/Prof...................................................... 
 
 
Do you consent to participate in the study? YES/NO 
 
Do you understand that you are free to withdraw from the study: 
 
 * at any time and 
 * without having to give a reason for withdrawing and 
 * without any adverse result of any kind? YES / NO 
 
 
Signed .............................................………................     Date ........................................... 
 
(NAME IN BLOCK LETTERS) ......................................................………........................ 
 
Signature of experimenter.....................…................     Date ........................................... 
 
(NAME IN BLOCK LETTERS) ........................................………….................................... 
 
Tracking ophthalmic drugs in the eye using confocal fluorescence 
microscopy 
GENERAL RISK ASSESSMENT 
Location: 
Physics Department Room 33 (Biophotonics Laboratory) 
 
Activity: 
Measuring natural fluorescence in the anterior chamber of eyes of 
healthy volunteers 
 
Hazards Those at risk Description of risk Risk Controls Risk Rating 
 
Electrical equipment 
 
 
 
Operator, Volunteers 
 
Electric shock  
All electrical and electronic equipment used has 
been PAT tested by trained safety personnel, no 
high voltage or high current equipment is being 
used 
 
LOW 
 
Class 4 laser 
radiation 
 
 
 
Operator, Volunteers 
 
Burns to eyes and skin 
Any laser radiation not categorised as class 1 will 
be enclosed in a metal case fitted with a laser 
safety interlock and laser radiation warning labels. 
No class 4 radiation will be accessible unless the 
casing is opened and the interlock disabled. All 
radiation leaving the instrument is categorised as 
class 1. The instrument is fitted with a laser power 
monitoring photo diode which closes a shutter if 
the laser power exceeds a safe threshold. The 
shutter also closes if there is a power loss.  
 
LOW 
 
 
Risk Rating = Likelyhood x Severity = LOW, MEDIUM or HIGH 
Assessor: 
Name:____________________________________________  Job Title:_______________________________________________ 
Signature:________________________________________  Date:__________________________________________________ 
Date Assessment to be reviewed:............................................ 
UNIVERSITY OF DURHAM - Health and Safety Office 
 
RISK ASSESSMENT FORM  Summary of Assessment - Tick Box 
 
CATEGORY A WORK      
 
 
CATEGORY B WORK                                        
    
FOR RESEARCH WORK 
(include practical undergraduate projects) REFER TO HEALTH & SAFETY OFFICE  
 
 
PART 1. PERSONAL DATA AND DETAIL OF PROJECT/EXPERIMENT 
 
Department Physics     Laboratory 33     Tel. Ext. 43630 
 
Name Kim Buttenschön    Supervisor  Prof John Girkin 
 
Male/Female    Staff/Technician/Student  UG/PG 
 
Degree/Higher Degree Course Starting  Date  August 2011 
 
Proposed finishing date of Project/Experiment Ongoing, reviewed annually 
 
Title of Project/Experiment Tracking ophthalmic drugs in the eye using confocal fluorescence 
microscopy 
 
Description of Project/Experiment.  Give a brief description of Project/Experiment, attaching copy of 
grant submission if appropriate. 
 
A home built ophthalmic instrument based on confocal fluorescence laser scanning microscopy will 
be used to measure the natural fluorescence in the anterior chamber of perfused sheep’s or bovine 
eyes and the eyes of healthy volunteers. The class 4 laser radiation (405nm) is guided into the 
measurement optics by an optical fibre. The beam power is then reduced to class 1 by using neutral 
density filters before it reaches the final optical element and leaves the instrument. A laser power 
monitoring photo diode is incorporated in the instrument which operates a shutter if the laser power 
exceeds a safe threshold. The shutter also closes if there is a power loss. The measurement optics 
and any laser radiation that is not class 1 are enclosed by a light tight metal case that has a laser 
radiation warning label and is fixed with an interlock so that the laser is switched off if the casing is 
opened during instrument operation.  
 
 
 
 
 
.   
Instructions 
 
1. This form is to be completed by the Supervisor in consultation with (any) co-workers. 
2. It encompasses postgraduate research and individual undergraduate project work, and individual research.  (The 
summary assessment is, of course, not appropriate where the researcher works individually.) 
3. It concerns practical work using materials or equipment, and field work but not theoretical or computing work. 
4. It must be signed by the Supervisor or senior researcher and by the co-worker (or student) to indicate that HE or SHE 
has read it.  After completion tick the summary box on the front. 
5. One copy to Department records, one copy to co-worker/student, plus one to HEALTH & SAFETY OFFICE only if 
health surveillance, air monitoring or respiratory/ear protection required. 
6. The aim of the Assessment is to satisfy Regulation 3 of "The Management of Health and Safety Regulations 1992"  
(Risk Assessment).  Should the work depart from the aims, methods or materials envisaged, then a new assessment 
must be carried out. 
PART 2. NATURE OF POSSIBLE HAZARDS 
 
Chemical Hazards  Are chemicals, including proprietary materials, to be used? Yes/No 
  If No ∧ 
   Is Good Lab. Practice Sufficient (see COSHH Code of Practice)? Yes/No 
  If Yes  ∧ 
      * Is there a cyanide/fluorine, 'very toxic' hazard? Yes/No/Possibly 
      * Is there a volatile material hazard? Yes/No/Possibly 
      * Is there an explosive or violent reaction hazard? Yes/No/Possibly 
      * Is there a carcinogenic, mutagenic or teratogenic hazard  
      (see COSHH Code of Practice - Carcinogens)? Yes/No/Possibly 
      * Will hazardous dust or fume be created? Yes/No/Possibly 
 
Ionising Radiation Does project/experiment involve radioisotopes or ionising radiation sources 
Hazards  (α, β, γ, X-ray or neutron emitter/sources)? Yes/No/Possibly 
 
  If No ∧ 
  If Yes Submit written scheme of work to Departmental Radiation Protection Supervisor 
   for approval before work starts 
      * Is the High-Activity Cell (Cobalt 60 source) to be used? Yes/No/Possibly 
 
Laser Hazards      * Are class 3B or 4 lasers to be used? Yes/No/Possibly 
 
Non-Ionising   Is non-ionising radiation, noise or vibration used/generated in the 
Radiation Hazards,  project/experiment? Yes/No/Possibly 
Noise, Vibration  If No ∧ 
  If Yes  
      * Ultra-violet YES/NO, infra-red YES/NO, Microwaves YES/NO, 
   Radio-frequency YES/NO, intense magnetic or electric fields YES/NO, 
   Noise > 85dBA YES/NO, Vibration which reaches the hands or body 
   YES/NO. 
 
Electrical Hazards  Is electrical equipment, other than tested 240V portable appliances  
   connected to mains supply, to be used? Yes/No/Possibly 
  If No ∧ 
  If Yes 
      * Will any electrical equipment using more than 50V a.c. or 100V d.c.  
   be used out of doors or in wet conditions? Yes/No/Possibly 
      * Are voltages > 1000V to be used? Yes/No/Possibly 
      * Are there exposed circuits and terminals with voltages >50Va.c., 100V d.c.   Yes/No/Possibly 
      * Are portable generators to be used? Yes/No/Possibly 
 
Robotic Hazards   Is robotic equipment to be used? Yes/No/Possibly 
  If No ∧ 
  If Yes 
      * Are restricted areas to be entered? Yes/No/Possibly 
      * Are mobile robots to be used? Yes/No/Possibly 
 
Other Hazards      * Are there any other hazards which pose unusually high risks? Yes/No/Possibly 
      * Are explosives to be used? Yes/No/Possibly 
      * Does stored energy, e.g. machine rotation, present a hazard? Yes/No/Possibly 
      * Does the work entail entry to cold rooms or hot rooms, and/or sealed  
   rooms which can be locked? Yes/No/Possibly 
      * Does the work entail work in the field? Yes/No/Possibly 
      * Are there pressure systems or closed systems in which over-pressure 
   or under-pressure can occur? Yes/No/Possibly 
      * Is dangerous apparatus/equipment to be used, e.g. Chainsaw,  
   Stihl Saw, Stunning Guns? Yes/No/Possibly 
 
Biological Hazards  Are biological materials to be used (including exposure to animals or 
   plant allergens)? Yes/No/Possibly 
  If No ∧ 
  If Yes Complete BIO-COSHH form and if the answer to every other question is NO end this  risk 
assessment.  If other hazards are present, the Supervisor shall decide if this or the BIO-
COSHH form, or both, is most appropriate. 
 
If any starred (*) items are marked YES or POSSIBLY then include in assessment. 
PART 3. DETAILS OF ASSESSMENT 
 
The aim of the assessment is to identify preventative and protective measures which must be 
provided and used so that risks to the experiment and others are controlled.  In most cases existing 
Departmental or University procedures will be sufficient but should be referred to. 
 
If any question marked * in part 2 is answered YES then provide written details including safety 
procedure below. 
 
A class 4 laser will be used inside the instrument. It will be reduced in power to class 1 before it 
leaves the instrument. All optics and unsafe laser radiation will be enclosed by a metal or plastic 
casing with a warning label and an interlock that switches the laser off if the casing is opened during 
operation. The instrument will be fitted with a laser power monitoring photo diode which will operate 
a shutter if the laser power exceeds a safe limit. The shutter will also close if there is a power loss. 
Maintenance will only be carried out in a room that is suitable for the use of class 4 lasers and when 
wearing adequate eye protection.  
The instrument may operate using home built electronics in which case the instrument and all 
connected electronic devices will be tested for electrical safety by the in-house specialist. 
 
 
 
 
 
 
GENERAL SAFETY INFORMATION RELATING TO PROJECT/EXPERIMENT 
 
Means of containment  Fume Cupboard Yes/No ……………………………….. …… 
(if applicable) to be   Biological Safety Cabinet Yes/No Grade 
used when appropriate  Total Enclosure Yes/No 
    Local Ventilation Yes/No 
    Other Yes/No  
 
Personal Protection to be 
worn when necessary  Lab Coat Coveralls Coveralls and Hood 
        Hand Protection Yes/No Type ……………………………….. 
   § Respiratory Protection Yes/No Type ………………………………... 
   § Ear Protection Yes/No Type … ……... 
    Eye Protection Yes/No laser safety goggles for maintenance 
    Foot Protection Yes/No  
    Other Yes/No Specify …………………………….. 
 
§ refer to Health & Safety Office. 
PART 4. WASTE DISPOSAL 
 
Will Hazardous wastes arise? No 
 
Waste Disposal (Departmental) practice …  
………………………………………………………………………………………………………………………….……. 
 
………………………………………………………………………………………………………………………….……. 
 
PART 5. MONITORING 
 
Is air monitoring required? (Materials …………………………………………………………………) Yes/No 
 
If YES, REFER TO Health & Safety Office. 
 
Is health monitoring required? Yes/No 
 
Compulsory, ionising radiations classified worker, exposure to animals/plant allergens, exposure to certain 
chemicals (see COSHH). 
 
Voluntary, 3B/4 laser use, noise and vibration exposure, regular exposure to toxic chemical, field work. 
 
Supervisor to submit names to Health & Safety Office (for referral to Occupational Health Adviser) with this 
form. 
 
PART 6. EMERGENCIES 
 
Special action to be taken after Accident.  Indicate special measures needed for the work described in the 
assessment, e.g. first aid, major spillage, electricity/water failure, work in remote or hazardous environments. 
 
The victim is to attend Sunderland Eye Infirmary for assessment in case of class 4 laser radiation eye 
encounter. 
 
PART 7. SUMMARY 
 
Supervisors should identify areas of work within the project in the categories below, which are not mutually 
exclusive.  Category B is the expected initial assessment, as all practical work requires the supervisor's 
approval.  Following demonstration and training, the supervisor may re-categorise some work to A.  The 
Supervisor must give instructions and advice on safeguards, determine the extent and frequency of 
supervision, and state the name of any others used in supervision. 
 
A - NOT to be undertaken without direct supervision. 
 
B - NOT to be started without supervisor's approval. 
 
WORK CATEGORY SUPERVISOR 
 
…… …………….…… ……………………… …… ………… ………………………………. ………. 
 
…… ………………………………………….. …… ………… ………………………………..………. 
 
…………………………………………………. ………………… …………………………………………. 
 
…………………………………………………. ………………… …………………………………………. 
 
…………………………………………………. ………………… …………………………………………. 
 
Signature of Supervisor ………………………………….……………  Date  ……………………………………..…... 
 
Signature of Co-worker/student 
having read the assessment ………………………………………….  Date ………………………………………….. 
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Laser safety evaluation 
 
To calculate how much power is allowed to be put into someone’s eye within a given time frame to 
still keep the instrument eye safe the British Standard “Safety of Laser Products” (BS EN 60825-
1:2007) was used. The value that has to be calculated is the Accessible Emission Limit (AEL.  Since 
our beam is not collimated but depending on the position of the scanning lens with respect to the 
eye either divergent or convergent, the calculation for extended sources is used. The AEL for a class 
1 laser (inherently eye safe) is calculated using table 5 (p. 44): 
 
  3.9  10    39                     (retinal photochemical hazard) and 
  7  10
.   14.8         (retinal thermal hazard) 
 
With  being 1 for λ = 400-450 nm ,  being 66.7 for sources with an angle of >100 mrad and  
being 100s again for sources >100 mrad. Since the value for the photochemical hazard is smaller it is 
the one to be used. 
 
The laser power used will therefore be ≤39 μW. 
